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ABSTRACT 
Gold nanoparticles as potential diagnostic, therapeutic and sensing systems 
have a long history of use in medicine, and have expanded to a variety of 
applications. Gold nanoparticles are attractive in biological applications due to 
their unique optical, chemical and biological properties. Particularly, gold 
nanorods (GNRs) are increasingly used due to superior optical property in the 
near infrared (NIR) window. Light absorbed by the nanorod can be dissipated as 
heat efficiently or re-emitted by the particle. However, the limitations for clinical 
translation of gold nanorods include low yields, poor stability, depth-restricted 
imaging, and resistance of cancer cells to hyperthermia, are severe. A novel 
high-throughput synthesis method was employed to significantly increase in 
yields of solid and porous gold nanorods/wires. Stable functional nanoassemblies 
and nanomaterials were generated by interfacing gold nanorods with a variety of 
polymeric and polypeptide-based coatings, resulting in unique properties of 
polymer-gold nanorod assemblies and composites. Here the use of these 
modified gold nanorods in a variety of applications including optical sensors, 
cancer therapeutics, and nanobiomaterials were described. 
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 1 
CHAPTER 
1. Introduction 
 
1.1 Gold Nanoparticles 
Plasmonic gold nanoparticles are being increasingly investigated as potential 
therapeutics, drug delivery vehicles, imaging agents and diagnostics due to their 
unique properties which include enhance biocompatibility over many other 
metals, ease of chemical conjugation and most importantly, their optical and 
photothermal properties. Localized surface plasmon resonance (LSPR), involves 
the collective oscillation of free electrons in metallic nanoparticles upon light 
excitation. The scattering and absorption properties of gold nanoparticles are 
greatly enhanced upon LSPR excitation, and are dependent on size and shape 
of the nanoparticle as well as the dielectric constant of the surrounding medium1. 
The intensity of absorption and scattering efficacies of gold nanoparticles are 
orders of magnitude higher than most absorbing molecular dyes and scattering 
organic dyes2, which makes them excellent candidates for contrast agents and 
sensors. On the other hand, the photothermal property of gold nanoparticles has 
been employed to generate heat for therapeutic applications. Briefly, free 
electrons on the gold surface oscillate upon laser irradiation, generating ‘hot’ 
electrons due electron-electron repulsion. Hot electrons then collide with Au 
lattice ions resulting in heating of the gold nanocrystal lattice in 1 pico(10-12) 
second, know as electron-phonon interaction. Finally, heat transfer from the Au 
lattice to the surrounding medium through phonon-phonon relaxation in 100 
pico(10-12) second3. Light in the near infrared (NIR) (700-1100 nm) wavelength 
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region penetrates superficial tissue the most (~ 0.5 mm up to several 
centimeters) due to minimal light absorption by water, blood and melanin, and so 
is best suit for photon-based noninvasive in vivo applications4. In particular, gold 
nanoshells, nanorods and nanocages5-7, which absorb light in the NIR region 
resulting in dissipation of heat to the surrounding tissue, have been widely 
explored. 
 
1.2 Synthesis of Gold Nanoparitlces 
1.2.1 Gold Nanospheres 
Gold nanospheres (gold colloids) are commonly prepared via citrate reduction of 
gold salt (HAuCl4) in water, based on methods first introduced by Turkevitch et al. 
in19518. Controlling gold/citrate ratio and temperature during synthesis steps 
determines the size of the gold nanospheres; the size of the gold nanospheres 
typically ranges from between 2-100 nm with a corresponding single surface 
plasmon resonance (SPR) band between 510-570 nm. Many other strategies, 
including the use of various reductants, ligands9,10, dendrimers11,12, and block 
copolymers13, have been reported for the generation of gold nanospheres.  
 
1.2.2 Gold Nanorods 
Gold nanorods have been synthesized through different methods; the following 
three methods are presented in chronological order. Gold nanorods were 
synthesized using a template method introduced by Martin et al.14 Template-
based methods involve deposition of gold within the nanopores of porous 
polycarbonate or alumina template membranes. The diameter and the length of 
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the gold are tunable and can be controlled by pore diameter of template 
membranes and the amount of gold deposited within the membrane pores. After 
deposition, gold nanorods can be collected by dissolution of membrane followed 
by polymer stabilization. A new high through put method has been developed to 
overcome the yield limitations associated with traditional template methods; this 
is described in Chapter 2.  
 
Electrochemical synthesis of gold nanorods was introduced by Yu et al.15 and 
Chang et al.16. The process starts with the consumption of gold metal anode and 
formation of anions in a cetyl trimethylammonium bromide (CTAB) surfactant rich 
electrolytic solution; the anions were then reduced on the cathode surface or 
within the rod-shaped micelles with sonication. The aspect ratio (length divided 
by width) of the rods can be controlled with presence of silver ions at different 
concentration and introduction rate.  
 
Seed-mediated growth method is among the most popular methods for the 
generation of gold nanorods. Developed by Murphy and co-workers17-19, the 
multistep seed-mediated growth method involves: (1) formation of gold seeds by 
reducing of gold salt with strong reducing agent (sodium borohydride, NaBH4) in 
the presence of citrate, (2) growth, using gold seeds as nucleation sites 
introduced into a growth solution of gold salt along with a weak reducing agent 
(ascorbic acid) and CTAB surfactant. In this method, the aspect ratio of rods can 
be controlled based on gold seed concentration; presence of silver ions in the 
growth solution can increase yield of rods. Subsequently, El-Sayed et al.20 
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introduced several modifications to seed-mediated growth method developed by 
Murphy et al., and further improved the yield of rods with an accompanying 
reduction in the formation of byproducts. El-Sayed et al. replaced citrate with 
CTAB surfactant during gold seed synthesis, and adjusted silver ion 
concentration to control the aspect ratio of nanorods between 1.5 and 5. CTAB 
forms a bilayer21 on the surface of the nanorods; repulsion between the cationic 
head groups of the surfactant is known to result in stable aqueous dispersions of 
the gold nanorods. The surface plasmon resonance (SPR) band of gold 
nanorods falls in two regions: (1) A weak band in the visible region around 520 
nm is similar to that of gold nanospheres, which is due the electron oscillations 
along the diameter, known as the transverse band; (2) A strong longitudinal band 
in the NIR region is due to the electron oscillations along the length of the rods. 
This strong longitudinal band is tunable based on the aspect ratio of the gold 
nanorods; the higher the aspect ratio the more red shift of the band will occur 
(Figure 1). 
 
Figure 1.SEM, surface plasmon resonance, and absorption spectrum of GNR. 
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1.2.3 Gold Nanoshells and Gold Nanocages 
Nanoshells are a unique class of nanoparticles with a composite metallic shell 
(e.g. gold) / dielectric core (e.g. silica) structure. The most well known method for 
preparing gold nanoshells (few nanometers thick) with silica core (around 
100nm) was introduced by Oldenburg and Halas et al.22-24. The mono-dispersed 
silica cores were prepared via basic reduction (Na4OH) of tetraethyl orthosilicate 
(TEOS) in ethanol, known as Stober method, and then followed by surface 
amination to provide positively charged of silica cores. The negatively charged 
gold colloid (2-4 nm in diameter) can be adsorbed on the silica surface to provide 
nucleation sites and allow additional gold to be reduced into a complete shell with 
a controlled thickness. Typically, gold nanoshells posses a single SPR band in 
NIR region (700-1100 nm) and can be controlled based on gold shell thickness; 
reducing shell thickness from 20 nm to 5 nm results in absorption peak red shift 
from 700 nm to 1000 nm and is due to increased coupling between plasmons. 
The ratio between scattering and absorbing events of gold nanoshells depends 
on the size of the silica core; smaller silica cores show higher absorption of 
energy, while larger silica cores are more effective at scattering incident light 
energy. Introduced by Xia et al., hollow and porous gold nanocages are formed 
via galvanic replacement reaction between silver nanocubes and HAuCl4 
solution25-27. Deposition of gold atoms and removal of silver atoms on silver 
nanocubes results in formation of Au/Ag alloy shell around partially hollow silver 
nanocubes; followed by different degree of dealloying will result in formation of 
corner-reconstructed Au/Ag nanoboxes and then to Au nanocages with pores in 
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the wall. Hollow and porous gold nanocages posses’ single SRP band around 
800nm was reported by their group. 
 
1.3 Gold-based Sensors 
Localized surface plasmon resonance (LSPR) property of noble metal 
nanoparticles has been employed for numerous biosensing applications. LSPR 
spectrum of the nanoparticle is dependent on the size and shape as well as the 
dielectric constant of surrounding media, and can easily be measured using a 
spectrophotometer. The first type of biosensing is based on colloid aggregation 
of gold. Upon biomolecular interactions, affected spacing between biomolecular 
conjugated gold nanoparticles can result in colloidal color changes; the color 
shifts from blue to red as the interparticle distance increases. This gold colloid 
colorimetric assay was introduced to detect DNA hybridization by Martin et al.28. 
Briefly, a mixture two groups of single stranded DNA-modified gold nanoparticles 
was first prepared;  upon introduction of the third single stranded DNA, 
complementary DNA hybridization lead to aggregation of the gold colloid 
accompany abrupt color change from red to purplish. Increased temperature or 
change in ionic strength resulted in a reverse process. Biosensing based on 
colloidal aggregation has been reported to detect specific targets (e.g. amino 
acids sequences, metal ions) using DNA, protein or antibodies modified gold 
nanoparticles29-34. The second type of gold biosensing is based on change in the 
dielectric constant of gold nanoparticle surrounding medium, leading to a 
dateable LSPR spectrum red shift. It has been demonstrate for detection of 
antigen-antibody recognition events and protein-enzyme interactions using gold 
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nanospheres or gold nanorods35-37. Most importantly, gold nanorods were 
reported to posses higher sensitivity than nanospheres is LSPR-based sensing37. 
Gold nanoparticle-based biosensing have been demonstrate successful and 
promising; however, improve sensitivity to single-molecule detection, integrate 
LSPR spectroscopy with proper molecular identification and multi-fictionalization 
of the system are required for a wide variety of needs. Detection limit can be 
improved by implementation of advance LSPR equipment. Dahlin et al.38 
reported using high-resolution LSPR spectroscopy with a minimum noise level (< 
5 × 10−4 nm, < 5 × 10−6 extinction units); and successfully detected neutravidin 
(deglycosylated version of avidin protein) binding at less than 0.1 ng/cm2 using 
biotin(Vitamin H)-functionalized arrays. LSPR-shift assays can only detect 
binding of molecules; however the identification of unknown molecules cannot be 
achieved with LSPR spectroscopy. Coupling molecular identification techniques 
to LSPR spectroscopy thus is critical. Surface Enhanced Raman Scattering 
(SERS) is a surface-sensitive technique, in which the local electromagnetic fields 
enhance Raman scattering (inelastic scattering) as much as 1014 to 1015 times 
when molecules adsorb on plasmonic nanoparticles39. Since the nanoparticle 
LSPR can be easily tuned (based on shape and size) to maximized SERS; LSPR 
spectral-shift assays have been reported in combination with SERS to 
demonstrate for both molecular quantification and identification40. 
Complementary mass spectrometry (MS) molecular identification with LSPR 
sensors has been proposed and still is in its beginning stages. 
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Large-scale study of proteins is considered the next step in the study of biological 
systems. Multiplex chip based LSPR detector have been demonstrate to provide 
high through put, label-free immobilization of immunoglobulin A (IgA) to a series 
of six antibodies at different concentrations41. In which, a limit of detection of 100 
pg/mL was reported. 
 
1.4 In vivo Imaging 
Several groups have investigated gold nanoparticles as useful contrast agents 
for in vitro darkfield imaging based on their light resonant scattering property. 
Darkfield microscopy works by illuminating the sample with light at an angle and 
collect only the scattered light from the target. Loo et al. demonstrated in vitro 
targeting, imaging as well as ablation of human epidermal growth factor receptor 
2 (HER2) positive cancer cells using antibody-targeted gold nanoshells7,42. El-
Sayed et al. successfully showed in vitro darkfield imaging of cancer cells using 
antibody-conjugated gold nanospheres43 and nanorods5. Even though the 
extinction cross-section of gold nanorods is dominated by absorption the amount 
of scattering is sensitive enough for several imaging techniques. These in vitro 
darkfield microscopy studies indicated that light scattering properties of gold 
nanoparticles can facilitate their use as contrast agents for imaging, while their 
light absorption properties allow for cancer cell ablation due to hyperthermia. 
However, for in vivo imaging applications of gold nanoparticles, the use of 
appropriate scattering-based imaging technologies is necessary. Several 
biomedical imaging modalities, including optical coherence tomography 
(OCT)42,44-48, two photon luminescence (TPL)49-53, photoacoustic tomography 
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(PAT)54-65, surface enhanced Raman scattering (SERS)66-70 and diffuse optical 
spectroscopy (DOS)71have been demonstrated successful for tissue/tumors 
imaging using either passive or active targeting gold nanoparticles as contrast 
agents. Although successful, these optical or acoustic scattering-based imaging 
techniques listed above have limited tissue penetration depths and are therefore 
challenging in cases of deep tissue imaging. Common hospital diagnostic tools, 
such as X-ray computed tomography (CT) and magnetic resonance (MR) 
imaging are better suited for deep tissue in vivo diagnostic with the presence of 
appropriate contrast agents, and have also been investigated for in vivo 
tumor/tissue imaging using gold nanoparticles and Au3Cu1 nanocapsules 
(Copper core with gold shell) as contrast agents72-74. 
 
1.5 Cancer Therapy 
1.5.1 Photothermal Ablation 
Properties such as high conversion of strongly absorbed light to heat, 
photostability, and biocompatibility make gold nanoparticles attractive candidates 
for photothermal therapy as a potential adjunctive therapeutic modality in addition 
to conventional treatments (e.g. surgery, chemotherapy, and radiation therapy). 
The ability to generate moderate to highly elevated temperatures (40-50°C) at a 
desired site with externally tunable control possesses significant promise for 
cancer therapy compared to whole-body hyperthermia. In the last few years, in 
vitro studies of photothermal treatments using immunotargeted gold 
nanoparticles, including gold nanospheres43,75, gold nanorods5, gold nanoshells7, 
gold nanoclusters76 and gold nanocages77, have demonstrated the ability to 
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selectively induce cancer cell damage via hyperthermia, while leaving the non-
targeted cells unaffected. The use of polypeptide-gold nanorod nanocomposites 
for synergistic administration of hyperthermia and chemotherapeutic drugs for 
enhanced ablation of cancer cells have been demonstrated in Chapter 6. The 
following sections focus on in vivo cancer photothermal therapies using gold 
nanoparticles. 
 
1.5.1.1 Gold nanospheres / clusters 
The surface plasmon resonance (SPR) absorption of gold nanospheres is in the 
visible region (~520 nm) and is therefore suitable mainly for superficial cancers 
due to strong absorption of light in this wavelength region by blood. Both pulsed 
and continuous visible-wavelength lasers have been employed for cancer cell 
ablation in vitro43,78. Clustering of antibody-conjugated gold nanoparticles results 
in red-shifting of absorption and formation of microbubble around clusters upon 
pulsed near-IR lasers irradiation, which resulted in effective in vitro and 76,79and in 
vivo cell damage80.  
 
1.5.1.2 Gold nanoshells 
Gold nanoshells consist an ultrathin gold shell surrounding a dielectric core (e.g. 
silica81) and demonstrate a tunable photothermal response to near infrared (NIR) 
light between 650-900 nm. Hirsch et al.82 demonstrated successful irreversible 
thermal destruction of xenograft canine transmissible venereal tumor in female 
non-obese diabetic mice due to significant temperature increase (ΔT= 35°C) 
upon exposure of interstitially injected PEG-conjugated (PEGylated) gold 
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nanoshells to low dose (820 nm, 4 W/cm2) NIR laser. O’Neal et al.83 
demonstrated that xenograft murine colon carcinoma tumor bearing female 
albino mice when intravenously injected with PEGylated gold nanoshells followed 
by laser irradiation (820 nm, 4 W/cm2) for 3 minutes appeared tumor free up to 
few month, while laser treatment alone control animals showed growth in tumor 
size. Stern et al.84 demonstrated high degree (93%) regression of tumor at high 
dose nanoshells (8.5 μl/g) usage using prostate cancer cell (PC-3) bearing male 
athymic (nu/nu) mice; while a slightly lower nanoshells dose (7.0 μL/g) did not 
result cancer cell ablation. Recently, Schwartz et al.85 successfully demonstrated 
passive delivery of PEGylated gold nanoshells to brain tumors in orthotopic 
canine model, and selectively elevate tumor tissue temperature to around 66°C. 
In all cases discussed above, gold nanoshell surfaces were coated with poly 
(ethylene glycol) (or PEG)86,87 by combining thiol group functionalized PEG with 
nanoshells to improve biocompatibility and longer circulation times. PEGylated 
gold nanoshells, preferentially accumulated at the tumor site due to the highly 
permeable and poorly organized vascular networks (enhanced permeability and 
retention or EPR effect)88. In order to further increase the efficiency of in vivo 
photothermal ablation using gold nanoshells, specific molecular targeting 
strategies have also been investigated7. Melancon et al.89employed epidermal 
growth factor receptor (EGFR) targeted hollow gold nanoshells (30 nm average 
diameter) for in vitro photothermal ablation. In addition, the in vivo biodistribution 
of antibody conjugated gold nanoshells was investigated. Targeted gold 
nanoshells showed higher delivery efficacy to tumors than non-targeted 
nanoshells (6.8% ID/g vs 4.6% ID/g) (ID/g: Injected Dose per Gram of Tissue). 
 12 
However a majority of gold nanoshells were found in spleen, liver, and kidney 
(~65% ID/g). 
 
1.5.1.3 Gold nanorods 
Cylindrical gold nanorods also demonstrate a tunable photothermal response to 
near infrared (NIR) light as a function of nanoparticle aspect ratio 
(length/diameter). Different modification strategies have been investigated for 
replacing cetyltrimethyl ammonium bromide (CTAB) on nanorods for use in 
biological applications, due to cytotoxicity of the surfactant. 
 
Huang et al.5 demonstrated in vitro study of anti-epidermal growth factor 
antibodies modified gold nanorods, targeted to malignant oral epithelial cell 
cancer cells, and subjected to laser irradiation from an external source leading to 
the selective localization of hyperthermic treatment. Niidome et al.90 modified 
gold nanorods with polyethylene glycol (PEG), which led to reduced gold 
nanorod (GNR) cytotoxicity while maintaining the stability of gold nanorods in 
mice. Thirty minutes after intravenous injection, half (~54%) of the injected 
PEGylated gold nanorods remained in the blood vessels of mice, while 
unmodified CTAB gold nanorods were seen to accumulate in the liver. El-Sayed 
et al.91 demonstrated photothermal therapy of subcutaneous squamous cell 
carcinoma xenografts grown in nude mice using non-targeted PEGylated gold 
nanorods irradiated by near-infrared (NIR) laser (1.7-1.9 W/cm2, 10 min). Two 
weeks after nanorod injection, greater than 96% decrease in average tumor 
growth (ΔV= ~900 mm3) was observed when tumors were directly-injected with 
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PEGylated gold nanorods (45 µL, OD800= 40); while >74% decrease in average 
tumor growth was seen in the case where PEGylated gold nanorods (100 ul, 
OD800= 120) were injected intravenously. Importantly, heating efficiencies in the 
case of direct injection was similar to that observed with gold nanoshells 
(3.59±0.5 vs. 3.74±0.7).82Kawano et al.92 demonstrated the site specific 
accumulation of poly (N-isopropylacrylamide) (PNIPAM) encapsulated gold 
nanorods can be induced by laser due to rapid photothermal phase transition of 
the nanoparticles, allowing light controlled targeted delivery. In which, 
nanoparticles were accumulated at tumor site due to hydrophobic interaction 
induced by the photothermal effect. Their results showed ~10% of injected 
PNIPAM coated gold nanorods accumulated at the irradiated site after laser 
irradiation and ~46% of injected PNIPAM coated gold nanorods accumulated in 
lungs after 30 min. PEGylated gold nanorods were used as a control to show 
dispersion in blood. The worrying problem will be the non-specific accumulation 
of PNIPAM coated gold nanorods. 
 
Studies on biodistribution and stability of intravenously injected PEGylated gold 
nanorods in mice indicated that higher PEG grafting levels helped avoid the 
reticuloendothelial system (RES) circulation. A PEG to gold molar ratio of 1.5 
was reported as optimum for circulation as well as the enhanced permeability 
and retention (EPR) effect. The uptake in the liver was saturated at 19.5 μg of 
nanorod injection dose, in addition to non-specific accumulation in the spleen and 
tumor93,94. Subsequent studies demonstrated that gold nanorods grafted with 5 
kilo Dalton (kDa) or 10kDa PEG showed higher circulation stability in mice than 
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those conjugated with 2kDa or 20kDa.94 Suppression of tumor growth following 
near-infrared pulsed laser irradiation was more effective in the case of direct 
intratumoral injection of nanorods compared to when nanorods were 
administered intravenously. This result correlates well with the biodistribution 
study of PEGylated nanospheres in tumor bearing mice model by Zhang et al59, 
which reported that 20 nm gold nanospheres coated with PEG (5kDa) exhibited 
the lowest uptake by reticuloendothelial cells and the slowest clearance from the 
body.  
 
Goodrich et al.95 demonstrated photothermal therapy using PEGylated gold 
nanorods in murine colon cancer model. Tumor-containing animals were 
intravenously (tail vein) injected with PEGylated gold nanorods followed by 
photothermal treatment; approximately 44% of the photothermally treated mice 
(nanorod and laser treated) survived after 60 days of treatment, while the mean 
survival time for the “nanorod alone” and “ laser irradiation alone” groups were 
9.5 and 9.7 days respectively. Substantial accumulation of gold nanorods was 
found in the liver, spleen and lymph nodes 30 days post injection. These results 
are not only important for the development of gold nanorods-based photothermal 
therapies, but also emphasize the importance of specific targeting strategies in 
order to increase efficacy and decrease in non-specific accumulation in different 
organ sites.  
 
1.5.2 Drug Delivery 
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Surface-modified gold nanospheres96-98, gold nanoshells99-101, and gold 
nanorods51,102 have been successfully employed for delivering various 
therapeutics, including plasmid DNA, small interfering RNA (siRNA), and 
chemotherapeutic drugs to cancer cells. Various controlled delivery mechanisms 
including, pulsed laser induced cleavage of gold-thiol bonds99,103, drug release 
under acidic pH environment97, controllable bond strength (covalent vs. 
hydrophobic/electrostatic) based diffusion96, photothermal modulation and NIR-
induced surface coating shrinkage104 have been investigated for delivery using 
gold nanoparticles. PEG-grafted gold nanospheres were covalently linked with 
tumor necrosis factor alpha (TNF-α), which is a cytokine with anticancer efficacy 
known to enhance hyperthermic injury105-107. TNF-α loaded nanoparticles were 
intravenously injected in murine fibrosarcoma-bearing mice via the tail vein, and 
the combination of TNF-α and hyperthermia led to increased tumor recession 
compared to the individual treatments acting alone. In the study, hyperthermia 
was carried out through immersion of tumor and its surrounding tissue in 
hyperthermic temperature water bath instead of selective activation of 
photothermal effect of gold nanospheres by laser, presumably since the SPR 
band of gold nanospheres is in the visible wavelength region. Chen et al.108 
reported that delivery of methotrexate (MTX), a dihydrofolate reductase inhibitor, 
by gold nanospheres suppressed Lewis lung carcinoma tumor growth in mouse 
while direct delivery of MTX at the same drug dose showed no effect. Recently, 
Lu et al.103 successfully demonstrated in vivo and in vitro NIR-induced silencing 
of NF-kB p65 via receptor targeted hollow gold nanospheres carrying siRNA 
recognizing NF-kB p65 subnits. HeLa cervical cancer xenograft-bearing mice 
 16 
were injected intravenously with folate receptor-targeted PEGylated hollow gold 
nanospheres carrying p65 siRNA. Following circulation for 6 hours, tumors were 
treated with moderate NIR irradiation (50 mW/cm2) for 1 minute. Down-regulation 
of NF-kB was observed only in tumors irradiated with NIR light which induced a 
shape transformation of gold nanoparticles leading to siRNA release to the 
cytosol, in a process called photothermal transfection. In addition, it was 
demonstrated that photothermal transfection of NF-kB p65 siRNA can 
successfully sensitize tumors to irinotecan, a chemotherapeutic drug, leading to 
inhibition of tumor growth. 
 
1.6 Summary 
NIR absorbing gold nanoparticles can be used as therapeutic agents either 
through photothermal ablation (efficient conversion of light energy into heat) or as 
drug delivery devices; also they have been successfully demonstrate as contrast 
agents for numerous of imaging modalities as well as for sensing applications. 
However, beside for drug delivery application, the use of NIR absorbing gold 
nanoparticles can be restricted by the limited tissue penetration depths of NIR 
light, and are therefore challenging for in vivo deep tissue light based-therapy or 
imaging. Numerous surface functionalized gold nanoparticles have been 
demonstrated to improve theranostic and sensing systems. The following studies 
and proposed work focus on the surface modification of gold nanorods, which is 
critical to advancing the use of gold nanoparticles in medical and sensing 
nanotechnology. 
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CHAPTER 
2. Multisegment High Throughput Synthesis of Gold Nanorods and 
Nanowires via Templated Method 
 
2.1 Introduction 
The field of nanotechnology has revolutionized numerous research fields 
including material science, electronics, optics, energy systems, and medicine109. 
Metallic nanowires/rods in particular had significant applications in 
sensing/detection110-115, catalysis116, electrical devices117,118, and fuel cells119,120. 
Numerous techniques for synthesizing metallic nanowires have been reported121-
127. However, most methods are only suitable for laboratory small-scale research 
applications, but are not practical for larger-scale, low-cost generation of 
nanomaterials. Martin et al. have mentioned “if practical applications (for 
nanomaterials) are to be realized, methods for mass-producing template-
synthesized nanostructures will be required122.”  
 
This chapter describes a high-throughput method for generation of gold nanorods 
and nanowires using multisegment template-assisted synthesis with an eye 
towards the increasing the yield of nanorods and nanowires. The study was 
carried out in collaboration with Jason Burdick (graduate student), and Professor 
Joseph Wang128. Template-directed electrodeposition within cylindrical 
nanopores of a porous membrane represents an attractive and reproducible 
approach for preparing metal nanowires and nanorods of different aspect ratios 
(with diameters of 10-300 nm and lengths of 50-1000 nm)124. In this method, a 
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thin conductive layer (e.g. Ag, Au, Cu) is sputtered onto one end of the porous 
alumina templates. From which desired metallic nanoparticles can be 
electrodeposited within the pores of alumina. The final stage involves the 
selective dissolution of both the alumina membrane and the conductive layer, in 
the presence of polymeric stabilizer (e.g. polyvinyl pyrrole). While the above 
method is useful for preparing nanorods and nanowires, it suffers from certain 
disadvantages. First, only a very small portion of the porous template is 
commonly used for generating nanowires; for example, commercial alumina 
templates (Whatman Anodisc) use < 5% of the membrane for nanowire growth, 
while most of the membrane is used for mechanical support or left unused.129 
Second, the fragility of the alumina templates further limits the throughput of this 
method and necessitates the development of alternative methods for increasing 
the yield from a single membrane. Finally, the high cost of metals such as gold 
and silver make current approaches unfeasible for the scale-up of nanowire 
production. As a result, novel methods are required for short processing times, 
and low processing costs involved with the generation of large batches of 
nanowires that are associated with existing methods. 
 
A new multisegment templated synthetic process, described in this chapter, was 
developed for preparing gold nanorods and nanowires in order to improve the 
throughput and lower the cost by using most of the cylindrical pores of the 
membrane. This simple method, illustrated in Figure 2, involves the sequential 
electrodeposition of segments of a desirable metal that resists chemical etching 
(e.g. gold) and very short segments (‘gaps’) of a non-desirable “sacrificial” metal 
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susceptible to chemical etching (e.g. silver) into the template membrane. 
Following this alternate multisegment deposition, the template first is dissolved 
then followed by selective dissolution of the sacrificial metallic gaps, leading to 
the generation of multiple nanowires of the desirable metal from each pore. The 
final step involves the introduction of surface coating (e.g. polyvinylpyrrolidone 
PVP, polystyrene sulfonate PSS) to prevent nanowires aggregation. The 
simplicity and cost-effectiveness of the new multisegment template method was 
evaluated for the generation of both, solid and porous gold nanowires. This 
approach results in considerable savings in material requirements, processing 
times and costs, and is a generic method that can be applied for scaling up the 
generation of other metal nanowires (which resist chemical etching) in concert 
with short segments of other ‘non-desirable’ metals which are susceptible to such 
etching. 
 
Figure 2.SEM images and schematic of membrane template with single and 
multisegment approach. 
 
2.2 Materials and Methods 
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2.2.1 Materials 
Alumina membranes (pore size, 200 nm; thickness,60 μm) were purchased from 
Anodisc Whatman (Cat. No. 6809-6022; Maidstone, UK); Table 1 describes the 
details of the membrane specifications. Gold targets for membrane sputtering 
were purchased from Denton Vacuum (Moorestown, NJ). Gold and silver plating 
solutions (Orotemp 24 RTU RACK and 1025 RTU @ 4.5 Troy/Gallon, 
respectively) were obtained from Technic Inc. (Anaheim, CA). All chemicals were 
used as received. Nanopure water was employed for all solution preparation and 
rinsing steps (18 MΩ, ELGA purelab-ultra model Ultra Scientific, Marlow, 
Buckinghamshire, UK). 
 
Table 1.Details of anodisc alumina membranes with a specified pore size of 200 
nm and thickness of 60 μm. 
Pore size 200 nm 
Pore density 109 /cm2 
Membrane diameter 25 mm 
Initial cost of individual membranes 2.5 
Number of pores per membrane 5*109 
Membrane thickness 60 µm 
 
2.2.2 Instrumentation 
 
Gold sputtering machine, Denton Vacuum Desk III TSC (Moorestown, NJ, USA) 
was used for membranes sputtering. Potentiostatic electrodeposition of metals 
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was carried out with a CHI 621A potentiostat (CH Instruments, Austin, TX).  
Platinum wire and Ag/AgCl (3M KCl, CH Instruments) served as the counter and 
reference electrodes, respectively. All working electrode potentials are with 
respect to Ag/AgCl reference electrodes. Optical images were acquired with a 
Nikon Eclipse 80i microscope (Nikon Corp., Tokyo, Japan) outfitted with a 
Photometrics CoolSnap CF camera (Roper Scientific, Duluth, GA). Scanning 
electron microscopy (SEM) images were obtained with an FEI XL30 SEM 
instrument (FEI Co., Hillsboro, OR), under an accelerating potential of 30 kV.   
 
2.2.3 Preparation of Nanoporous Alumina Membrane 
In addition to those purchased alumina membranes (pore size, 200 nm; 
thickness, 60 μm), alumina membranes with a pore size of ~30 nm were self-
prepared by anodizing pure (99.99%) aluminum in an acidic electrolyte at varying 
potentials and below ambient temperatures to prevent dissolution of oxidized 
structures in acidic electrolytes and local heating. Briefly, prior to anodization, 
pure (99.99%) aluminum foil was washed with (1M, 1mL) NaOH sodium 
hydroxide to remove surface grease. Nanoporous alumina templates were 
prepared using a dc power supply. Al foil was anodized in a 1.8M H2SO4 solution 
at 18°C at a constant applied voltage 15 V for 15 minutes, then followed by 20 V 
for 2 hr 20 min. Alumina removal was carried out in an aqueous mixture of 0.1M 
copper chloride (CuCl2) and 20% vol Hydrogen Chloride (HCl) at 25°C for about 
2 minutes. Removal of the barrier oxide layer was carried out by chemical 
etching in 5 vol% phosphoric acid (H3PO4) for 30 minutes. 
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2.2.4 Layered Template Synthesis 
A thin layer of gold film was first sputtered on the branched side of the alumina 
membranes providing an electrical contact for the subsequent electrochemical 
deposition steps. Sputtered membranes were then transferred to a three-
electrode electrochemical growth cell where a sacrificial layer silver was first 
deposited at 2 coulombs charge throughout the branched area and into the body 
of the membrane at a working electrode potential of -0.9 V. Alternating layers of 
gold and silver were then deposited on top of the sacrificial silver layer; each 
gold-silver layer comprised of 0.7 coulombs of gold and 0.1 coulombs of silver, 
both deposited at -0.9 V. Gold and silver solutions were removed and added in 
repeats without disassembling the growth cell which is a significant time-saving 
advantage of the current nanowire synthesis method. During the solution 
replacement, the membrane, the growth cell, and the reference and counter 
electrodes were rinsed with nanopure deionized water again without disassembly 
of the growth cell. Upon completion of multisegment growth, a final rinse was 
performed and the membrane was removed from the growth cell.  Membranes 
were then divided such that 25 % of the membrane area was saved for imaging 
and 75 % was dissolved for analysis of nanowire yields. The alumina membranes 
were first dissolved with 3 M NaOH for 15 minutes and rinsed, following which, 
the silver segments were dissolved with 35 v/v% concentrated HNO3 for another 
15 minutes with agitation and sonication. Free gold nanowires were then 
precipitated via centrifugation and rinsed in nanopure water repeatedly until a 
neutral pH was achieved. Scanning electron microscopy (SEM) images used to 
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determine membrane yield were from 1:10 dilutions of the final 1 mL nanowire 
suspension volume.  
 
2.3 Results and Discussion 
The current high-throughput method relies on the alternate deposition of two 
types of metals, one that is resistant to chemical etching (the target nanowires) 
and one that is susceptible to such etching (the short removable gap segment). 
This is similar to on-wire fabrication of nanogap structures130,131. This concept has 
been demonstrated for the generation of both, solid and porous gold nanorods / 
nanowires using intermediate silver segments that can be selectively removed 
using nitric acid. Figure 2 shows SEM images and a schematic of the single layer 
and multisegment methods employed for the generation of solid gold nanowires. 
Nanorods, 700 nm in length and 200 nm in diameter, were generated using 
alumina templates with a 3 µm sacrificial silver layer and approximately 100 nm 
silver layer(s) between gold layers. As seen in the figure 4, the sequential 
electrodeposition of gold and silver segments results a significant usage of the 
available volume of the cylindrical pores in the alumina membrane. While the 
traditional single-layer method uses only 3 µm of the pore height, the 
multisegment method exploits 24 µm of the pore height (seen as dark grey in 
Figure 3), resulting in an eight-fold increase in the yield of gold nanowires for a 
single membrane. The SEM image of the cross-section multicomponent 
nanowires containing alternating layers of gold/silver generated upon dissolution 
of the alumina membrane (prior to the dissolution of the silver ‘gaps’) is shown in 
Figure 3. The shorter silver sections (dark grey color) are separated by the longer 
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gold nanowire segments (lighter grey). The length of the gold and silver 
segments can be controlled based on the charge used in the electrodeposition of 
these metals. 
 
 
Figure 3.SEM image of 10 gold segments with silver gaps. (Scale bar, 2 μm) 
 
Figure 4 demonstrates a comparison of the yield of gold nanowires obtained by 
the single- and multisegment methods. These SEM images compare nanowires 
generated using a single layer (left) and 25 layers (right), respectively. The top 
images (A) are concentrated nanowire samples at a high magnification while the 
bottom ones (B) are for a 10-fold diluted sample at a 25-fold lower magnification. 
Comparison of the left and right images clearly demonstrates the high yield 
obtained by the multilayer approach in a single experimental run. The center plot 
demonstrates the estimated yield from nanowire samples obtained using different 
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numbers of alternating gold-silver layers grown in one AAO template. This plot 
indicates that the yield scales linearly with the number of layers employed over 
the entire 1-25 layers range. The yield was estimated by feeding SEM 
micrographs (with the same acquisition parameters) of the freestanding 
nanowires from different samples (number of layers= 1, 10, 15, 25) into a Matlab 
program. The program applied thresholding to the images, then counted the 
number of white pixels in the image and with proper calibration correlated the 
number of white pixels to the number of nanowires in the sample. A 25-fold 
improvement in throughput is thus obtained for a single AAO template.  
 
 
Figure 4.Estimation of the number of nanorods from different multilayer samples. 
 
In addition to the generation of solid gold nanorods/nanowires, high-yield 
synthesis of porous gold nanorods/nanowires, highlights the versatility of the 
templated multisegment method. High surface areas of porous, metallic 
nanowires can be exploited for drug delivery, catalysis, sensing, and energy 
storage applications. In this method, a single Au-Ag mixture plating solution was 
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used in connection to different deposition potentials for depositing alternate alloy 
and silver segments. Following sodium hydroxide-based dissolution of the 
membrane template, a single nitric-acid treatment was used for dissolving the 
intermediate silver layers as well as for etching the silver from the alloy segment. 
Such selective dealloying of the silver resulted in the high-yield generation of 
porous gold nanorods/nanowires. Figure 5 A and B are grown from a single Au-
Ag (85-15%) plating solution by varying the deposition potential between -1.2 V 
and -0.6 V, respectively. The porosity of such nanowires can also be tailored by 
controlling the composition of the plating solution132. The new high-throughput 
method therefore allows for the preparation of mixture of nanowires of different 
porosities, by simply adding gold to the plating solution after deposition of each 
alloy-silver bisegment. 
 
 
Figure 5.Porous gold nanorods. (Scale bar, 200 nm) 
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The cost of production of nanorods/nanowires is an important consideration in all 
practical applications. In order to investigate the cost-effectiveness of the 
multisegment templated approach, an analysis that compares the material 
requirements, cost, and time required for generating 25 batches of gold 
nanowires using the single layer method was carried out, and compared to 
twenty five gold nanowire segments generated using the multisegmented 
deposition method. Table 2 compares the materials savings associated with the 
multisegment templated approach compared to the traditional single-layer 
method; the gold requirements are the same in both cases since this is the basis 
of comparison between the two methods. However, approximately 14-fold less 
silver is required using the multisegment method. The use of a new template 
membrane for every batch of the single-layer method necessitates the deposition 
of a sacrificial silver layer for each step; both these add significantly to the 
material requirements of the traditional method. The multisegment method, on 
the other hand, uses only one membrane and requires only one sacrificial silver 
layer. Taken together, the multilayer method results in significant material 
savings for the number of alumina templates used, the amount of silver plating 
solution used, and the amount of post growth solution used (not shown). 
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Table 2. Comparison of materials used in single layer and multisegment method. 
 Single Layer Method 
Multilayer 
Method 
Volume of Gold per Pore 0.022 μm3 0.55 μm3 
Volume of Gold per Membrane 0.11 mm3 2.75 mm3 
Volume of Silver per 
Pore 
(Sacrificial Silver) 0.094 μm3 0.094 μm3 
(Silver “gaps”)  0.075 μm3 
Volume of Silver per Membrane 0.471 mm3 0.85 mm3 
Material required toprepare 25 
segments of gold nanorods 
(Gold) 2.75 mm3 2.75 mm3 
(Silver) 11.78 mm3 0.88 mm 
 
Table 3 compares the cost requirements for the synthesis of nanowires using the 
single and multisegment methods. As expected, the cost-effectiveness of the 
multisegment method scales according to the number of layers employed. In 
other words, the multisegment method becomes more attractive as the number 
of layers is increased. For the current process (25 nanowire batches), the 
multisegment process is cheaper than the single-layer method by a factor of 25 
saving up to $155. Finally, the high-throughput nature of the multisegment 
method results in considerable savings in processing times (Table 4). While the 
single layer method requires over one day for generating 25 batches of gold 
nanowires, the multisegment method is capable of accomplishing this task in a 
matter of 5 hours, resulting in a significant (> 5-fold) saving in processing times 
(22.5 h).  
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Table 3.Cost analysis comparing single layer and multisegment methods. 
 Single Layer Method Multilayer Method 
Membrane cost $2.5 * 25 $2.5 
Gold electrical cost $4* 25 $4 
Gold solution $0.06 $0.06 
Silver solution $0.25 $0.02 
   
Total $162.8 $6.6 
 
Table 4.Comparison of processing time using single and multisegment method. 
 Single Layer Method Multilayer Method 
Gold electrical contact 8 min 8 min 
Sacrificial silver layer 20 min 20 min 
Gold layer 9 min 9 min 
Silver layer  1 min 
Gold layer  9 min 
Remove alumina 15 min 15 min 
Remove silver 15 min 15 min 
 *repeat above steps 25 times *repeat silver and gold layer 24 times
Total 27.9 hr 5.1 hr 
 
Using commercially available alumina membranes, solid and porous 
nanorod/wires, with a diameter ~200 nm had been successfully synthesized 
using a high throughput technique. However, smaller sized particles are required 
for effective endocytosis by epithelial cells and reticuloendothelial clearance133,134. 
As a result, alumina membranes with a pore size of ~30 nm (Figure 6) were 
generated by anodizing pure (99.99%) aluminum in an acidic electrolyte for 
preparation of NIR absorbing gold nanorods and bi-segmented gold/polymer 
nanorods. Porous membranes had been created in slightly soluble electrolytes 
(e.g. sulfuric, phosphoric, chromic and oxalic acid)135. In our case, sulfuric acid 
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was employed. Upon electrochemical anodization of aluminum, hydrogen 
evolves at the cathode; oxidization occurs at the anode electrode.  
 
 
Figure 6.SEM (A) and AFM (B) characterization of alumina membrane template 
for preparing GNRs. Represented Scale bar 200 nm. Image courtesy of 
Professor Joseph Wang. 
 
Electrodeposition was carried out to generate smaller sized nanoparticles using 
these self-prepared porous alumina membranes. Figure 7A shows the SEM 
image of gold nanorods prepared at a deposit charge at 0.03 Coulombs; Figure 
7B shows the spectra of NIR-absorbing gold nanorods at various deposition 
charges-0.025, 0.03 and 0.07 Coulombs. The relatively poor homogeneity of the 
nanorod colloid (formed at 0.03 C) in Figure 7A resulted in a broad longitudinal 
band falling between 650-950 nm (Figure 7B) which can possible limit the 
efficacy of photothermal effect. However, slight increases in deposition charge 
resulted in a significant shift of the gold nanorod LSPR spectrum from near to far 
infra-red as seen in Figure 7B. 
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Figure 7.(A) SEM image of GNRs prepared via electrodeposition of gold in 
alumina template at a deposition charge of 0.03C. (B) Spectra of NIR absorbing 
gold nanorods at various deposition charges. 
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Figure 8.Possible generation of bi-segmented gold (white segment) and 
polypyrrole-COOH (grey segment) nanorod. 
 
Figure 8 demonstrates the possible generation of bi-segmented gold with 
polypyrrole-COOH nanorod (further elemental analysis needs to be carried out 
to verify polypyrrole segment). Moreover, it was found that insufficient 
stabilization leads to aggregation of gold nanorods, presumably due to high van 
der Waals interactions between these similar nanoparticles. Taken together, 
these challenges associated with generation of nanoscale gold rods using 
template method will require development of more sophisticated synthesis 
techniques. As a consequence, chemically synthesized GNRs were used for our 
studies on photothermal ablation of cancer cells. The simplicity of this technique, 
in concert with reliable optical properties and relative homogeneity of the nanorod 
population, made it appropriate for our applications. 
 
2.4 Conclusion 
In summary, A multisegment template approach for the high-throughput, cost-
effective generation of solid and porous gold nanorods/nanowires have been 
developed. The method results in significant savings in material and processing 
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costs and overall processing times. While the method has been presented for the 
generation of gold nanorods/nanowires, the approach can be readily extended to 
other metals via a judicious selection of the non-desirable gap metals. Additional 
segments (e.g., nickel) could be added to the gold segment to facilitate magnetic 
manipulation (for drug delivery and/or imaging applications). It is anticipated that 
this approach can facilitate larger-scale synthesis of metallic nanorods/nanowires 
for a variety of biomedical or energy related applications. 
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CHAPTER 
3. Cationic Polymer Coated Nanorods for Photothermal Ablation and Non-
viral Gene Delivery 
 
3.1 Introduction 
Nanoparticles have the potential to transform medicine by impacting 
therapeutics, drug delivery platforms, imaging agents, and diagnostics136-140. 
Unique optical and photothermal properties of gold nanoparticles make them 
attractive candidates drug delivery and near infrared (NIR) bio-imaging 
applications. As described previously, gold nanorods posses a tunable 
photothermal response in the near infrared (NIR) region based on nanoparticle 
aspect ratio141,142. In addition, gold nanorods have been employed in 
diagnostics143,144, therapeutic systems145-148, imaging149, sensing150-152, and 
responsive materials / assemblies153,154.  
 
In Chapter 2, high throughput template technique was implemented to generate 
rod-shaped nanoparticles leading to increased throughput and decreased cost. 
However, the heterogeneity and instability of the smaller sized gold nanorods 
synthesized via template electrodeposition could limit their applications. 
Therefore, this chapter focuses on the investigation of the stabilization of 
chemically (seed growth method) synthesized gold nanorods using polymers for 
photothermal ablation and gene delivery. 
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The seed growth method, also known as cetyltrimethyl ammonium bromide 
(CTAB)-templated growth, is one of the most widely used technique for making 
homogeneous gold nanorods (GNRs) colloids155. GNRs with peak longitudinal 
wavelengths in the visual and near-infrared region of the absorption spectrum 
can be reproducibly synthesized using this method. The stability of gold 
nanorods is maintained via CTAB molecules that form a bilayer ‘shell’ around the 
gold nanorod ‘core’. The electrostatic repulsion between the cationic quaternary 
ammonium head groups of the CTAB surfactant results in stable gold nanorod 
dispersions in aqueous media. However, due to the high toxicity of CTAB 
molecules, various modification strategies156-162, have been demonstrated to 
replace CTAB on nanorods in order to improve biocompatibility and reduce 
toxicity of gold nanorods for biological applications156,163. 
 
This chapter describes that cetyltrimethyl ammonium bromide (CTAB)-based 
gold nanorods, prepared by the commonly used seed-mediated method, 
demonstrate poor stability in phosphate buffered saline (PBS), serum-free media 
(SFM) and serum-containing media (SCM), depending on the number of 
centrifugation steps carried out to remove excess CTAB from the dispersion. 
Layer-by-layer deposition164 of cationic polymers (polyelectrolytes) generated in 
our laboratory165 was used in order to increase the short-term and long-term 
stability of gold nanorods in biological media. Polyelectrolyte-coated gold 
nanorods exhibit excellent long-term optical stability in all three biologically media 
even after four weeks of storage. In addition, stabilization of the optical response 
resulted in a reliable, photothermal response of the well-dispersed gold nanorods 
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over the period of investigation. Cytotoxicity evaluation indicated that gold 
nanorods coated with these polymers were less cytotoxic to mammalian cells 
than those covered with 25kDa polyethyleneimine (pEI25). Stable and 
biocompatible polyelectrolyte-coated nanorods were investigated for the 
photothermal ablation of PC3-PSMA cells using NIR laser irradiation. Sub-toxic 
concentrations of these nanorods were also employed for delivering plasmid 
DNA to these cells. Coating with cationic polyelectrolytes can lead to stable, 
biocompatible gold nanorod assemblies that can be useful for a variety of 
applications including non-viral gene delivery and photothermal ablation of 
cancer cells. 
 
3.2 Materials and Methods 
3.2.1 Materials 
Sodium borohydride, powder, reagent grade, ≥98.5%, cetyl trimethylammonium 
bromide (CTAB), 95%, gold (III) chloride trihydrate (HAuCl4·3H2O), 99.9+%, L-
ascorbic acid, reagent grade, ethyleneglycol diglycidyl ether (EDGE) and 3,3'-
diamino-N-methyl dipropylamine (3,3’), and branched poly(ethyleneimine) (MW = 
25,000, MN = 10,000; henceforth called pEI25) were purchased from Sigma-
Aldrich. Crystalline silver nitrate was purchased from Spectrum and poly(styrene 
sulfonate, sodium salt; henceforth called PSS) (MW14,900) was purchased from 
Polysciences, Inc. All chemicals were used as received without further 
purification.  
 
3.2.2 Generation of Gold Nanorods (GNRs) 
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Gold nanorods were synthesized using the seed-mediated method as reported 
by El-Sayed et al.155 First, a seed solution was prepared by adding 0.6 mL iced 
water-cooled sodium borohydride (0.01 M) in order to reduce a solution of 5 mL 
CTAB (0.2 M) (cetyl trimethylammonium bromide) in 5mL auric acid (0.0005 M) 
(HAuCl4.3H2O). Secondly, the growth solution was prepared by 70 μL L-ascorbic 
acid (0.0788 M) reduction of 5 mL CTAB (0.2 M) in 5mL auric acid (0.001 M) 
(HAuCl4.3H2O) containing 250 μL silver nitrate (0.004 M). Seed solution (12 μl) 
was introduced to a 10 mL growth solution which resulted in the generation of 
gold nanorods after four hours of continuous stirring (250 rpm) at 29°C. Gold 
nanorods that possessed absorbance maxima (λmax) at different wavelengths 
(750-900 nm) in the near infrared (NIR) region of the absorption spectrum were 
generated by slightly tuning silver nitrate amount (250-290 μL) in this method.  
 
3.2.3 Polymer Synthesis and Characterization 
Polymerizations were carried out as described previously in collaboration with 
Sutapa Barua165. Briefly, ethyleneglycol diglycidylether (EGDE; 2.3 mmol) was 
reacted with equimolar quantities of 3,3'-diamino-N-methyl dipropylamine (3,3’) 
resulting in the formation of the EGDE-3,3’ cationic polymer165. Neat, as-
purchased solutions were employed in the polymerization reaction, which was 
carried out in 7 mL glass scintillation vials for 16h. Following completion of the 
reaction, the resulting polymer was diluted to a concentration of 2 mg/mL in 
phosphate-buffered saline (0.01 X PBS, 1X PBS diluted 100 fold; pH=7.4, final 
salt concentration 1.5 mM). The solution pH was adjusted to 7.4 using 30 vol% 
hydrochloric acid in deionized (DI) water in order to compensate for the basicity 
 38 
of the cationic polymer. Polymer formation was confirmed using Fourier 
Transform Infrared (FT-IR) spectroscopy and the molecular weight was 
determined using gel-permeation chromatography as described previously165. 
 
3.2.4 Generation of Polyelectrolyte (PE) Gold Nanorods (PE-GNRs) 
Dispersion 
Gold nanorods were coated with polyelectrolytes (PEs) using a layer-by-layer 
deposition approach. Briefly, gold nanorods (ODλmax= 0.5), in 1.5 mL 
microcentrifuge tubes, were first centrifuged at 6000 rcf for 10 min using a 
Microfuge 18 Centrifuge (Beckman Coulter) in order to remove excess CTAB. 
Following removal of the supernatant, nanorods were resuspended in 0.5 mL of 
poly(styrene sulfonate) or PSS solution (2 mg/mL PSS in 0.01X PBS; ~1.5mM 
salt concentration) and were immediately sonicated for 25 min leading to the 
formation of PSS-CTAB-GNRs. Excess PSS was removed by centrifugation at 
6000 rcf for 10 min, and different amounts of cationic polyelectrolytes, either 
pEI25 or EGDE-3,3’ polymer, were added and sonicated for 25 minutes, leading 
to the formation of pEI25-PSS-CTAB-GNRs or EGDE3,3’-PSS-CTAB-GNRs. 
Finally, cationic polyelectrolyte coated gold nanorods (PE-GNRs) were 
centrifuged and re-suspended in different aqueous media (DI Water, PBS, 
serum-free media, or serum-containing media) to monitor their stability. The 
conditions for generating these different PE-GNRs are summarized in Table 5.  
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Table 5.Composition of the PE-GNR assemblies employed for study. 
First Layer 
Polyelectrolyte
Polyelectrolyte 
Concentration 
(mg / mL) 
Second Layer 
Polyelectrolyte
Polyelectrolyte 
Concentration 
(mg / mL) 
PSS  2  EGDE-3,3’  0  0.2 0.4  1  2  3  
PSS  2  25kDa pEI  0.2 0.4 1  2  3  4  
 
3.2.5 Determination of Short- and Long-Term Optical Stability 
CTAB-gold nanorods with optical density 0.5 at 800 nm were first prepared and 
dispersed in deionized (DI) water using the seed-mediated method. Aliquots (0.5 
mL) of CTAB gold nanorods, placed in 1.5 mL centrifuge tubes, were centrifuged 
and resuspended in the same volume of DI water, 1X PBS, serum-free medium 
(SFM) or serum-containing medium (SCM). Absorption spectra were determined 
at different times using a temperature-controlled plate reader (Biotek Synergy 2) 
for up to 48 h; spectra were typically measured between 400-999 nm. 
Absorbance spectra were monitored every week for a period of four weeks as 
described above for long -term optical stability studies.  
 
3.2.6 Determination of Photothermal Response 
Dispersions of CTAB- (1 h) or PE-coated (1 h and 4 weeks) gold nanorods in 
serum free media (RPMI-1640 medium plus 1% penicillin / streptomycin) were 
employed for determining the temperature response of gold nanorods following 
exposure to near-infrared (NIR) laser treatment. Stable, EGDE3,3’-PSS-CTAB-
gold nanorods were prepared and diluted to form a stock solution with a 
maximum optical density of 0.22 at 770 nm (maximal absorbance wavelength). A 
titanium CW sapphire (Ti:S) laser (Spectra-Physics, Tsunami) pumped by a solid 
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state laser (Spectra-Physics, Millennia) was used for determining the 
photothermal response. Samples were diluted and placed in a 96 well plate 
(diameter ~6.4 mm, height ~10.7 mm) in the path of the laser (diameter of the 
laser spot was 2 mm). The laser was turned on for 15 min and the temperature of 
the dispersion was monitored using a k-type thermocouple; laser output was 
fixed at 600 mW (20 W/cm2).  
 
3.2.7 Cell Culture 
RPMI 1640 with L-Glutamine and HEPES (RPMI-1640 medium), Pen-Strep 
Solution: 10,000 units /mL Penicillin and 10,000 µg/mL Streptomycin in 0.85% 
NaCl, and fetal bovine serum (FBS) were purchased from Hyclone. Serum-free 
medium (SFM) is RPMI-1640 medium plus 1% antibiotics. Serum-containing 
medium is SFM plus 10% FBS. The PC3-PSMA human prostate cancer cell 
line166 was a generous gift from Dr. Michel Sadelain of the Memorial Sloan 
Cancer Center, New York, NY. Cells were cultured in a 5% CO2 incubator at 
37oC using RPMI-1640 medium containing 10% heat-inactivated fetal bovine 
serum (FBS) and 1% antibiotics (10,000 units /mL penicillin G and 10,000 µg/mL 
streptomycin). 
 
3.2.8 Cytotoxicity of Polyelectrolyte (PE)-Coated Gold Nanorods 
Stable polyelectrolyte (EGDE3,3’-PSS-CTAB and pEI25-PSS-CTAB) gold 
nanorods with absorbance maximum at 770 nm were prepared as described 
above. PC3-PSMA human prostate cancer cells were seeded in a 24 well plate 
with a density of 50,000 cells per well and allowed to attach overnight at 37°C, in 
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a 5% CO2 incubator. Different amounts of polyelectrolyte-coated gold nanorods 
(PE-GNRs, dispersed in serum-free media) were added into each well and the 
final volume in each well was brought up to 500 μL with serum-free media. Cells 
were incubated for 5 h to determine the cytotoxicity of PE-GNR assemblies. 
Following incubation, cells were treated with 100μL of 4μM ethidium homodimer-
1 (EthD-1; Invitrogen) and 2μM Calcein AM (Invitrogen) for 30 min and imaged 
immediately using Zeiss AxioObserver D1 inverted microscope (10 × X/0.3 
numerical aperture (NA) objective; Carl Zeiss MicroImaging Inc., Germany). 
Fluorescence using excitation at 530 nm and emission at 645 nm were used for 
the microscopy; dead/dying cells with compromised nuclei stained positive (red) 
for EthD-1. Quantitative analyses of PE-GNR induced cell death were carried out 
by manually counting the number of dead cells in all cases using the Cell 
Counter plug-in in ImageJ software (Rasband, W. S., ImageJ, U.S. National 
Institutes of Health, Bethesda, MD, http://rsb.info.nih.gov/ij/, 1997-2005). The 
number of dead cells in both live and dead controls was determined for at least 
two independent experiments, and their average values were calculated. The 
number and percentage of red fluorescent cells was determined for each 
concentration of PE-GNR assemblies as a function of dose.  
 
3.2.9 Photothermal Ablation of PC3-PSMA Cells using EGDE3,3’-PSS-
CTAB-GNRs 
Stable polyelectrolyte gold nanorods (EGDE3,3’-PSS-CTAB-GNR) with an 
optical density 0.2 at 800 nm were prepared as described above. PC3-PSMA 
human prostate cancer cells were seeded in a 96 well plate with a density of 
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30,000 cells/well and allowed to attach overnight at 37°C, in a 5% CO2 incubator. 
PE-GNRs (EGDE3,3’-PSS-CTAB-GNR) were diluted to an optical density of 0.1 
with serum-free media. The laser excitation source was tuned to 800 nm in order 
to coincide with the longitudinal absorption maximum of the EGDE3,3’-PSS-
CTAB-GNR. First, cell culture media was replaced by 200 μl of EGDE3,3’-PSS-
CTAB-GNR solution (OD800= 0.1) followed by exposure to laser irradiation for 7 
min at different  power densities (7.5 - 25 W/cm2). The temperature of the 
dispersion was measured using a K-type thermocouple immediately after 
removal of the laser treatment. Following treatment, EGDE3,3’-PSS-CTAB-GNR 
containing media was removed and immediately replaced with fresh serum-
containing cell culture media and the cells were returned to the 37°C incubator. 
After 24 h, cells were treated with 4 μM ethidium homodimer-1 (EthD-1; 
Invitrogen) for 30 min and imaged using Zeiss AxioObserver D1 inverted 
microscope (10 × X/0.3 numerical aperture (NA) objective; Carl Zeiss 
MicroImaging Inc., Germany). Fluorescence using excitation at 530 nm and 
emission at 645 nm were used for the microscopy; dead/dying cells with 
compromised nuclei stained positive (red) for EthD-1. Quantitative analysis of 
PE-GNR induced cell death was carried out by manually counting the number of 
dead cells in all cases using the Cell Counter plug-in in ImageJ software 
(Rasband, W. S., ImageJ, U.S. National Institutes of Health, Bethesda, MD, 
http://rsb.info.nih.gov/ij/, 1997-2005). The number of dead cells in both live and 
dead controls was determined for at least two independent experiments, and 
their average values were calculated. 
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3.2.10 Transfection of PC3-PSMA Cells using PE-GNRs 
3.2.10.1 Plasmid DNA Loading on PE-GNRs 
The pGL3 control vector (Promega Corp., Madison, WI), which encodes for the 
modified firefly luciferase protein under the control of an SV40 promoter, was 
used in transfection experiments. E.coli (XL1 Blue) cells containing the pGL3 
plasmid DNA were cultured overnight (16 h, 37 °C, 150 rpm) in 15 mL tubes 
(Fisher) in 5 mL Terrific Broth (MP Biomedicals, LLC) containing 1 mg/mL 
ampicillin (Research Products International, Corp.).  The cultures were then 
centrifuged at 5400 g and 4°C for 10 min. Plasmid DNA was purified according to 
the QIAprep Miniprep Kit (Qiagen®) protocol and DNA concentration and purity 
were determined based on absorbance at 260 and 280 nm determined using 
NanoDrop Spectrophotometer (ND-1000; NanoDrop Technologies). Plasmid 
DNA concentrations of 100-130 ng/µl were used in all experiments and the 
volume was adjusted in order to load 350 ng of plasmid on PE-GNRs prior to 
transfection. PE-GNRs (optical density 0.25 * 10-2) were mixed with 350 ng 
pGL3 plasmid DNA in the presence of serum-free media for 30 min. The PE-
GNR-pGL3 plasmid assemblies were then centrifuged at 6,000 rcf for 10 min. 
The plasmid amount of DNA remaining in the supernatant after centrifugation 
was determined using calibration of fluorescence intensity vs. plasmid DNA 
concentration (not shown); ethidium bromide was used for calibrating DNA 
amounts. 
 
3.2.10.2 Transfections 
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Cellular transfection was carried out in collaboration with Sutapa Barua. PC3-
PSMA cells were seeded in 24-well plates (Costar) at a density 
of50,000cells/well and allowed to attach overnight. PE-GNR-pGL3 plasmid 
assemblies were added to each well in the presence of serum-free media for 6 h; 
CTAB-GNRs with equivalent amounts of plasmid DNA were used as controls. 
The media was then replaced with serum-containing media for 48 h following 
which cells were permeabilized with 100 µL of cell lysis buffer (Promega, 
Madison, WI). The luciferase activity in cell lysates was measured using a 
luciferase assay kit (Promega, Madison, WI) using a plate reader (Bio-Tek 
Synergy 2). The relative light units (RLU) determined from the assay were 
normalized with respect to protein concentration in the cell lysates, measured 
using the Pierce® BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL). 
Luciferase activity in cell lysates was expressed as relative light units (RLU) per 
milligram (mg) of protein. Transfection experiments were performed at least in 
triplicate.  
 
3.3 Results and Discussion 
3.3.1 Polyelectrolytes Enhanced Short-Term and Long-Term Stability of 
Gold Nanorods Dispersed in Biologically Relevant Media 
The short-term stability of as-prepared CTAB gold nanorods (CTAB-GNRs) was 
investigated in four different aqueous biologically relevant media: de-ionized (DI) 
water, phosphate-buffered saline (PBS), serum-free media (RPMI-1640) and 
serum-containing media (RPMI-1640 + 10% fetal bovine serum or FBS). The 
nanorods were centrifuged once as part of the synthesis protocol and 
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resuspended in equivalent volumes of the respective media in order to remove 
excess CTAB and prevent CTAB crystallization in the aqueous dispersion at 
ambient temperature. The short-term optical stability was determined by 
monitoring the longitudinal peak in the near infrared region of the absorbance 
spectrum as a function of time for 48 h. Gold nanorods dispersions demonstrated 
excellent stability in DI water (Figure 9A) and in serum-containing media (SCM; 
Figure 9D); the longitudinal peak was maintained over the period of the 
investigation (48h). It is possible that interactions with serum proteins (e.g. 
albumin) resulted in enhanced stability of gold nanorods in serum-containing 
media167,168. However, the absorbance of CTAB-GNRs decreased rapidly in PBS 
(Figure 9B) and serum-free media (SFM; Figure 9C). A 30-40% decrease of the 
absorbance values of the initial values was observed two hours of dispersion in 
the two media, indicating rapid nanorod aggregation in PBS and SFM. The 
aggregation is induced presumably due to the higher salt concentration (~150 
mM) of these solutions, which screened repulsive interactions between individual 
CTAB-covered nanorods. 
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Figure 9.Short-term optical stability of CTAB-gold nanorods (CTAB-GNRs) 
dispersed in different biologically relevant media. 
CTAB-GNRs, optical density 0.5 at 800 nm, were centrifuged once and 
resuspended in same volume of (A) deionized or DI water, (B), phosphate-
buffered saline (PBS) (C) serum-free medium, and (D) serum-containing 
medium. Absorbance spectra were monitored from 400 nm to 999 nm for up to 
48 h in respective media. 
 
Multiple centrifugation rounds are thought to be necessary to successfully 
remove excess CTAB from gold nanorod dispersions5. However, removal of 
CTAB molecules self-assembled on the surface of the gold nanorods results in 
aggregation and loss of stability of the nanoparticles. I investigated the role of 
subsequent centrifugation rounds on the stability of CTAB-GNRs in aqueous 
media. In this case, long-term (up to four weeks; Figure 10) stability of CTAB-
GNRs following two additional rounds of centrifugation was monitored. While 
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CTAB-GNRs maintained stable in DI water, aggregation occurred in PBS, SFM, 
and SCM after a total of three times centrifugation (including the one round 
necessary in the preparation of gold nanorods), leading to a complete loss of 
their light absorption properties in the near infrared region (Figure 10). While the 
stability of CTAB-GNRs is excellent in DI water, their poor stability in biological 
media can limit their utility in biological applications.  
 
 
Figure 10.Long-term UV-visible spectrums of CTAB-GNRs dispersed in different 
biologically relevant media. 
CTAB-GNRs, optical density 0.5 at 800 nm were centrifuged three times and 
resuspended in same volume of (A) deionized water, (B) PBS and (C) serum-free 
medium, and (D) serum-containing medium. Spectra were measured 
immediately following preparation (“Week 0”), 1, 2, and 4 weeks after 
preparation. Similar results were seen with GNRs with a maximal absorption 
peak at 750 nm. 
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Various strategies have been reported for enhancing the stability of nanoparticles 
in aqueous media. For example, self-assembly / conjugation with polyethylene 
glycol (PEGylation) is a widely used method for enhancing nanoparticle stability 
and increasing biocompatibility169. Unfortunately, the presence of PEG on 
nanoparticle surface results in reduced interactions with proteins and uptake by 
cells169. This is not desirable in cases where the nanorods might be employed for 
applications which require cellular binding and uptake (e.g. gene delivery). It was 
hypothesized that coating CTAB-GNRs with cationic polyelectrolyte layers could 
result in stable dispersions of gold nanorods that also demonstrate high gene 
delivery and photothermal ablation efficacies. Cationic polymers developed in our 
laboratory were employed for this purpose. 
 
CTAB-GNRs were first coated with the anionic polymer poly(styrene sulfonate) 
(PSS); free PSS was removed by centrifugation of the resulting PSS-CTAB-
GNRs followed by removal of supernatant. The PSS-CTAB-GNRs were then 
resuspended in solutions containing different concentrations of the cationic 
polymers pEI25 or EGDE-3,3’ (prepared in our laboratory) in 0.01 X PBS (PBS 
diluted 100 fold; pH=7.4, final salt concentration 1.5 mM) leading to the formation 
of pEI25-PSS-CTAB-GNRs or EGDE3,3’-PSS-CTAB-GNRs. The EGDE-3,3’ 
cationic polyelectrolyte was generated using the ring opening polymerization of 
ethyleneglycol diglycidylether and 3,3'-diamino-N-methyl dipropylamine as 
described previously165. Following equilibration with PSS-CTAB-GNRs, excess 
cationic polymer was removed by centrifugation and the polyelectrolyte-nanorod 
assemblies were dispersed in serum-free medium in order to investigate their 
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optical stability. The use of low concentrations of the EGDE-3,3’polymer did not 
enhance the stability of the gold nanorods (Figures 11A and 11B), which 
aggregated presumably due to bridging between the PSS layer and EGDE-
3,3’polymer layer between different nanorods leading to loss of the longitudinal 
peak in the NIR region. However, ‘recovery’ of the NIR peak was made possible 
by increasing the concentration of the EGDE-3,3’ polymer  (Figures 11C and 
11D). Increasing EGDE-3,3’ polymer adsorption on PSS-CTAB-GNRs leads to 
inter-particle repulsion due to an increase in cationic charges on the surface, and 
therefore, results in enhanced stability of the GNR dispersion. The short-term 
stability of these dispersions was significantly enhanced at EGDE-3,3’ polymer 
concentration at 3 mg/mL compared to CTAB-GNRs (Figure 11D).  
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Figure 11.Stability of EGDE3,3’-PSS-CTAB-GNRs, in serum free media (SFM) 
as monitored by the transverse and longitudinal absorption peaks. 
CTAB nanorods were coated with the anionic polyelectrolyte PSS (2mg/mL), 
followed by coating with different concentrations of EGDE-3,3’ cationic 
polyelectrolytes, (A) 0 mg/mL, (B) 0.2 mg/mL, (C) 1 mg/mL, and (D) 3 
mg/mLEGDE-3,3’ polymer. The absorption spectra of polyelectrolyte-coated 
GNRs were monitored for up to 36 h using a temperature-controlled plate reader. 
See Experimental section for details. 
 
Similar trend was found with using another cationic polymer, 25 kDa 
polyethyleneimine (pEI25), for stabilizing GNRs (Figures 12A-D). Low 
concentrations of pEI25 resulted in aggregation and loss of the NIR absorption 
peak due to bridging with the anionic PSS layers, while stable pEI25-PSS-CTAB-
GNRs dispersions were formed in the media with an increase in pEI25 
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concentration. The amount of cationic polyelectrolyte required for NIR peak 
recovery was similar in cases of both, the EGDE-3,3’ polymer and pEI25.  
 
 
Figure 12.Stability of pEI25-PSS-CTAB-GNRs in serum free media as monitored 
by the transverse and longitudinal absorption peaks. 
CTAB-gold nanorods were coated with the anionic polyelectrolyte PSS 
(2mg/mL), followed by coating with different concentrations of pEI25cationic 
polyelectrolytes, (A) 0.2 mg/mL, (B) 0.4 mg/mL, (C) 1 mg/mL, and (D) 3 mg/mL, 
pEI-25k polymer. The absorption spectra of polyelectrolyte-coated GNRs were 
monitored for up to 36 h using a temperature-controlled plate reader. See 
Experimental section for details. 
 
In addition to the study of short-term stability with PE-GNR assemblies, 
polyelectrolytes were investigated for maintaining the longer-term stability of 
nanorod dispersions. The NIR light absorption properties of EGDE-3,3’ and 
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pEI25-based gold nanorods remained invariant over a period of four weeks in 
serum-free media (Figure 13A and13B). The near-infrared (NIR) absorption peak 
(~770 nm) was maximal following immediate preparation of the nanorods (0 day) 
in serum-containing media.  However, the peak absorbance value settled to a 
lower maximum in one week and was found to be stable thereafter. It is possible 
that serum-polyelectrolyte interactions result in the precipitation of a portion of 
the nanorods dispersed in serum-containing media over the period of one week, 
leading to a reduction in the NIR peak absorbance. Taken together, it can be 
seen that polyelectrolytes stabilize gold nanorod dispersions in both serum-free 
and serum-containing media over extended periods of time, making this a viable 
strategy for their use in biological applications.  
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Figure 13.Long term UV-visible spectra of polyelectrolyte–coated gold nanorods 
dispersed in serum-free media and serum-containing media 
EGDE3.3’-PSS-CTAB-GNRs (λmax = 770 nm) dispersed in serum-free media (A) 
and serum-containing media (C); pEI25k-PSS-CTAB-GNRs dispersed in serum-
free media (B) and serum-containing media (D). 
 
3.3.2 EGDE3,3’-PSS-CTAB-GNRs Demonstrate Lower Cytotoxicities that 
pEI25-PSS-CTAB-GNRs 
The cytotoxicity of pEI25-PSS-CTAB-GNRs compared to that of EGDE3,3’-PSS-
CTAB-GNRs with PC3-PSMA human prostate cancer cells was evaluated. 
Following treatment with different PE-GNR concentrations (Figure 14 (i)), cells 
were treated with ethidium homodimer which fluoresces red in dead/dying cells; 
and the phase contrast and fluorescence microscopy images of cells were 
collected (Figures 14 (ii) and 14 (iii)). In figures 14 (ii) – 14 (iv), EGDE3,3’-coated 
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In order to determine if increased stability resulted in stable photothermal 
properties over a period of time, the photothermal response of PE-GNRs were 
determined both, one hour after preparation as well as after four weeks of 
storage in serum-free media. PE-stabilized gold nanorods demonstrated a 
reproducible photothermal response as a function of the nanorod concentration 
in the dispersion (Figure 15). The temperature of the media rose rapidly in the 
first five minutes of laser exposure after which, the temperature either rose 
gradually as in the case of higher nanorod concentrations or remained invariant 
as in the case of lower nanorod concentrations. Interestingly, the steady-state 
temperature of the dispersion increased by approximately 10°C following a 
doubling of the gold nanorod concentration (as determined by the nanorod 
optical density), indicating that the photothermal response of PE-GNR dispersion 
followed Arrhenius-like behavior. Importantly, the photothermal response of 
EGDE3,3’-coated gold nanorods after four weeks of storage closely followed the 
same trend observed for freshly prepared nanorods for all concentrations 
employed in the investigation (Figure 15). However, CTAB-GNRs demonstrated 
a lower photothermal response compared to EGDE3,3-PSS-CTAB-GNRs at 
similar concentrations only one hour after preparation; while the temperature 
increase with EGDE3,3-PSS-CTAB-GNRS (OD = 0.22) was approximately 
53°Cafter 15 min of exposure to the laser, the temperature of a dispersion 
containing a higher concentration of CTAB-GNRs (i.e. OD = 0.5) rose only to 
32°C after an equivalent laser exposure time. Expectedly, these results correlate 
well with optical stability in that, gold nanorods that demonstrate stable optical 
behavior also demonstrate effective photothermal behavior. Conversely, 
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temperature of approximately 42°C following 7 min of laser irradiation (Figure  
15).  Laser irradiation induced significant cell death in PC3-PSMA human 
prostate cancer cells after 24 h of PE-GNR treatments (Figure 16 (ii) A and B). 
Although cell morphology remained invariant immediately after PE-GNR/laser 
treatment, extensive changes in cell morphology and high ethidium homodimer 
staining of compromised nuclei were seen after 24 h, indicating that cell death 
occurred presumably due to apoptosis of these cells. Negligible loss of cell 
viability was observed in PC3-PSMA cells treated with EGDE3,3’-PSS-CTAB-
GNRs but not exposed to NIR laser irradiation (Figure 16 (ii) C, D), laser alone 
(Figure 16 (ii) E and F); the viability of these cells was similar to untreated PC3-
PSMA cells (Figure 16 (ii) G and H).  
 
(i) 
 
(ii) 
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 (iii) 
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(iv) 
Treatments Details Media Temp. (°C) 
a Live Control: No treatment. 22±0.5 
b Laser Control: Laser 25 W/cm2 for 7 min 25±0.7 
c PE-GNR Control: Laser 0 W/cm2 for 7 min 22±0.5 
d Laser treatment: PE-GNR + 7.5 W/cm2 laser for 7 min 30±0.3 
e Laser treatment: PE-GNR + 15 W/cm2 laser for 7 min 35±0.6 
f Laser treatment: PE-GNR + 20 W/cm2 laser for 7 min 41±1.0 
g Laser treatment: PE-GNR + 25 W/cm2 laser for 7 min 43±0.6 
Figure 16.Photothermal Ablation of PC3-PSMA human prostate cancer cells 
using EGDE3,3’-PSS-CTAB-GNRs. 
(i) Absorbance spectrum of EGDE3,3’-PSS-CTAB-GNRs used in the 
photothermal ablation studies.(ii)Phase contrast images (A, C, E, G) and 
fluorescence microscopy images (B, D, F, H) of PC3-PSMA cells treated as 
described below; red fluorescence is due to ethidium homodimer staining of 
compromised nuclei. Scale bar: 200 μm. A, B: EGDE3,3’-PSS-CTAB-GNRs + 
laser (7 minutes; power density: 20 W/cm2). C, D: EGDE3,3’-PSS-CTAB-GNRs 
(without laser treatment). E, F: laser alone (no nanorods). G, H: No treatment. (iii) 
Photothermal ablation of PC3-PSMA cells using EGDE3,3’-PSS-CTAB-GNR 
(PE-GNR) assemblies (OD= 0.1) as a function of laser power density. (iv) 
corresponded temperature at different treatment conditions. 
 
PC3-PSMA cells were treated with EGDE3,3’-PSS-CTAB-GNR assemblies (OD 
= 0.1) and subjected to different power densities ranging from 7.5 - 25 W/cm2 in 
order to investigate if tuning laser power densities resulted in differential cell 
death. As seen in Figure 16 (iii), increasing laser power density resulted in an 
increase in media temperature in correlation with the extent of PC3-PSMA cell 
death. Interestingly, PC3-PSMA cell death was as high as 55% and 70%, 
following laser treatment at power densities 7.5 W/cm2 and 15 W/cm2, even 
though the media temperature was only 30oC and 35oC, respectively. This 
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apparent discrepancy can be explained due to two reasons. First, the 
temperature measurements were carried out immediately after the laser was 
turned off. It is possible that these recordings were somewhat lower than those 
during the photothermal treatment, especially in the case of cells directly in the 
path of the laser spot which was 2 mm in diameter (well diameter ~6.5 mm). 
Second, it is important to note that negligible cell death was seen immediately 
after the seven-minute laser treatment and that the cell viability was determined 
24 h after the photothermal treatment. It is possible that a significant number 
cells die due to the bystander effect170 over the 24 h period following signals from 
those cells directly in the path of the laser. While these two factors can explain 
the high levels of PC3-PSMA cell death observed in these experiments, the role 
of the bystander effect on PE-GNR induced hyperthermic ablation of cancer cells 
have not been directly determined as part of this investigation. As may be 
expected, higher laser power densities resulted in higher PC3-PSMA cell death(> 
85%). Cells treated with the laser alone (without PE-GNRs) and PE-GNRs alone 
(without laser irradiation) did not induce PC3-PSMA cell death. 
 
It is important to point out that a balance exists between polyelectrolyte 
cytotoxicity and PE-GNR-induced hyperthermic ablation of cancer cells. While 
low concentrations of polyelectrolytes are not sufficient for either stabilizing 
GNRs or for inducing hyperthermic temperatures, higher concentrations are 
cytotoxic and are therefore, not useful in hyperthermic ablation of cancer cells. 
As a result, concentrations of EGDE3,3’-PSS-CTAB-GNRs that were not toxic to 
PC3-PSMA cells but demonstrated photothermal activity were chosen for the 
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ablation of these cells. In contrast, pEI25-coated GNRs were highly toxic to the 
cells at concentrations that would result in hyperthermic temperatures (> 40°C) 
and therefore, were not included in this study. The use of such untargeted PE-
GNRs can be useful in the hyperthermic ablation of relatively accessible tumors 
such as bladder or prostate tumors.  
 
3.3.5 EGDE3,3’-PSS-CTAB-GNRs Successfully Deliver Exogenous DNA to 
Prostate Cancer Cells In Vitro. 
Cationic polymers have emerged as promising candidates for delivering 
exogenous nucleic acids, including plasmid DNA, to a variety of mammalian 
cells171-173.The efficacy of stable PE-GNR assemblies to bind and deliver plasmid 
DNA to PC3-PSMA cells in vitro was investigated. Greater than 95% of the 
original plasmid DNA amount (350 ng) was loaded on PE-GNRs, while only 50-
55% was loaded on equivalent amounts of CTAB-GNRs (Table 6).  
 
Table 6 Loading of pGL3 plasmid DNA on CTAB-GNR and PE-GNRs. 
Plasmid DNA (350 ng) was loaded on gold nanorods (optical density, OD = 0.25 
*10-2) for 30 min following which, the nanorods were centrifuged and supernatant 
was assayed for DNA content using ethidium bromide. The amount of plasmid 
DNA loaded on gold nanorods was determined by mass balance and the DNA-
loaded assemblies were used in the transfection experiments. Representative 
loading experiments are shown in the table. 
 
Optical 
Density 
(a.u.)  
* 10-2 
Initial 
pDNA 
(ng) 
pDNA (ng) 
in the 
supernatant 
pDNA 
(ng) 
loaded 
on the 
GNRs 
% pDNA 
loaded 
on the 
GNRs 
CTAB-GNR 0.25 350 170.6 179.4 51.25 
EGDE3,3’-PSS-CTAB-
GNR 0.25 350 10.6 339.4 96.97 
pEI25k-PSS-CTAB-GNR 0.25 350 15 335 95.71 
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Different sub-toxic concentrations of PE-GNRs loaded with pGL3 plasmid DNA 
were delivered to PC3-PSMA cells; luciferase protein expression was used as a 
reporter for transgene expression. GNR concentrations were kept below OD 
0.25*10-2 in order to compare the transfection activity of EGDE-3,3’ polymer with 
that of pEI25 which was toxic to cells beyond this concentration (Figure 14). 
EGDE3,3’-based PE-GNRs resulted in up to ten-fold higher transgene 
expression in PC3-PSMA cells compared to pEI25-based PE-GNRs (Figure 17) 
after 48 h following transfection. CTAB-GNRs did not demonstrate any 
transfection activity under these conditions (not shown), presumably due to a 
combination of low DNA loading, nanoparticle aggregation which can lead to 
reduced cellular uptake, and inherently poor transfection efficacy174,175. The use 
of polyelectrolytes not only overcomes the poor GNR stability associated with 
CTAB, but also facilitates higher plasmid DNA binding and enhanced transfection 
activity of the resulting assemblies. The lower cytotoxicity of EGDE3,3’-PSS-
CTAB-GNRs makes it an attractive vector for non-viral gene delivery, compared 
to assemblies based on pEI25. Taken together, these results indicate that 
interfacing engineered polyelectrolytes with gold nanorods results in stable 
multifunctional assemblies that possess photothermal ablation, gene delivery, 
and optical imaging capabilities145,149,176-178 all on a single platform.  
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Figure 17. Transfection of PC3-PSMA human prostate cancer cells using 
EGDE3,3’-PSS-CTAB-GNRs and pEI25-PSS-CTAB-GNRs. 
PC3-PSMA cells were treated with different concentrations of PE-GNRs 
containing 350 ng of pGL3 plasmid for 6 h. Luciferase expression, in relative 
luminescence units or RLU was analyzed 48 h following transfection and 
normalized to protein content in each case (RLU /mg). The normalized luciferase 
expression for EGDE3,3’-PSS-CTAB-GNRs is reported relative to that for pEI25-
PSS-CTAB-GNRs. CTAB-GNRs did not demonstrate any transgene expression 
activity at similar optical densities. Asterisks indicate p values < 0.02 determined 
using two-tailed Student’s t-test for a minimum of three independent experiments. 
 
3.4 Conclusions 
Gold nanorods prepared using the widely used CTAB-based seed-mediated 
method demonstrate poor stability in phosphate buffered saline (PBS), serum-
free media (SFM) and serum-containing media (SCM) following centrifugation. A 
layer-by-layer deposition of polyelectrolytes was employed in order to enhance 
the short-term and long-term stability of gold nanorods in these media. 
Polyelectrolyte-coated gold nanorods (PE-GNRs) demonstrate excellent long-
term optical stability in all three media as determined by their optical properties 
even after four weeks of storage. Stabilization of the optical response, in turn, 
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resulted in a reliable photothermal response of the well-dispersed gold nanorods 
over the period investigated, which facilitated their successful use in the 
photothermal ablation of PC3-PSMA human prostate cancer cells using near 
infrared laser irradiation. Gold nanorods coated with the recently developed 
EGDE-3,3’ polymer in our laboratory demonstrated lower cytotoxicities and 
higher transfection efficacies than 25kDa poly(ethyleneimine) or pEI25, which is 
a current standard for polymer-mediated gene delivery. While EGDE-3,3’-coated 
GNRs demonstrated higher toxicities than CTAB-GNRs at similar optical 
densities, PE-GNRs possess greater advantages including stable photothermal 
properties, higher transfection efficacies, and the ability to further derivative 
residual reactive amines165. These results indicate that cationic polyelectrolytes 
can lead to stable, biocompatible and multifunctional gold nanorod assemblies, 
which can be useful for a variety of simultaneous applications including biological 
sensing, optical imaging, non-viral gene delivery, and localized hyperthermia. 
Further discovery and engineering of polyelectrolytes that optimize toxicity, 
stability, and gene delivery efficacy will be required in case of polyelectrolyte-
coated assemblies. While the current in vitro results are indeed encouraging, 
future studies on therapeutic efficacy, biocompatibility, and biodistribution in 
appropriate animal models will be needed in order to fully realize the potential of 
these assemblies. 
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CHAPTER 
4. Gold Nanorods Induced Extracellular Hyperthermic Ablation of Cancer 
Cells and Spatiotemporal Distribution 
 
4.1 Introduction 
Most previous studies have focused on nanoparticle-mediated ‘intracellular’ 
hyperthermia in which, gold nanoparticles are first internalized by cells followed 
by laser irradiation to induce temperature elevation leading to cell damage. In this 
approach, hyperthermic temperatures are generated inside cancer cells by the 
internalized nanoparticles. An alternate approach is to use plasmonic 
nanoparticles in the extracellular space of the cancer cells, mimicking their 
extravasation from the leaky tumor vasculature into this region, particularly in 
cases of poor or sluggish flow in vivo. Laser irradiation of nanoparticles in the 
extracellular space leads to generation of heat outside the cell (extracellular 
hyperthermia) which can be employed for cancer cell ablation.  
 
Various mathematical models have been developed to study the different 
physical and transport mechanisms that play a role in using nanoparticles for 
hyperthermic cancer treatment. Heat transport in tissues has been studied for a 
number of decades and is now largely based on the use of on the Pennes’ bio-
heat equation179. The heat transport equation has been used by a number of 
researchers for the specific problem of laser induced heat generation/transport 
from gold nanoparticles180-183. The spatial transport of nanoparticles, which is 
governed by nanoparticle diffusion and binding, has also been modeled 
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previously184. Finally, hyperthermal cell injury/death has been modeled using the 
Arrhenius rate model, isoeffective dose model, and other models185. 
 
While the use of intracellular hyperthermia has been extensively explored, the 
objective of the work is to present a mathematical model and experimental 
results for heat generation, heat transport, and cellular injury/death for the laser 
induced heating of nanorods dispersion outside prostate cancer cells. 
Spatiotemporal profiles of temperature increase following laser irradiation of gold 
nanorods were determined experimentally and were used to evaluate the 
mathematical model. The validated temperature model was then used to predict 
cell death following gold nanorod induced extracellular hyperthermia and the 
model predictions were quantitatively compared to experimental results. Last, the 
model was used to predict how selective binding of gold nanorods to cancer cells 
might influence the efficacy of extracellular hyperthermia. 
 
The experimental work described in this Chapter was carried out by me, Huang-
Chiao Huang, under Dr. Kaushal Rege’s (PI’s) guidance; the theoretical modeling 
was done by Professor Jeffrey J. Heys, Department of Chemical and Biological 
Engineering, Montana State University. 
 
4.2 Materials and Methods 
4.2.1 Experimental 
4.2.1.1 Generation of gold nanorods 
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Gold nanorods were synthesized using the seed-mediated method155 following 
the same procedure in Chapter 3.2.2, this method was employed to generate 
gold nanorod population that possessed absorbance maxima at λmax= 800 nm. 
Gold nanorods dispersion was further diluted with deionized (DI) to obtain 
specific optical density (OD800) (Figure 18). 
 
 
Figure 18.Absorbance spectrum of gold nanorods employed in the current study 
indicated different concentrations as determined using optical densities. 
 
4.2.1.2 Preparation of PEGylated nanorods 
Thiolated poly(ethylene glycol) (mPEG-SH, MW5000) was obtained from 
Creative PEGworks. The polymer (3 mg/mL) was added to GNR (optical density 
0.5 at λmax= 800 nm) and the dispersion was sonicated for thirty minutes. After 
sonication, the mPEG-SH-GNR mixture were centrifuged at 6,000 rcf for ten 
minutes in order to remove excess mPEG-SH molecules, followed by 
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resuspension in serum-free media, resulting in stock mPEG-GNR dispersions 
with final optical densities (OD800) of 0.15 and 0.2. 
 
4.2.1.3 Photothermal response of GNR and determination of spatiotemporal 
temperature profiles 
The photothermal response of gold nanorods (CTAB-GNRs) to laser irradiation 
was determined using a titanium CW sapphire (Ti:S) laser (Spectra-Physics, 
Tsunami) pumped by a solid state laser (Spectra-Physics, Millennia). The 
experiment was carried out in a 24 well plate (15.6 mm internal diameter of the 
well). The laser excitation source was tuned to 800 nm (2 mm diameter) in order 
to coincide with the longitudinal absorption maximum of the CTAB-GNR 
dispersions (1 mL) with various optical densities (OD800= 0.065, 0.148, 0.285, 
and 0.50) . A fixed laser power density of 20 W/cm2 was employed for fifteen 
minutes. The dispersion temperature was monitored using a FLUKE 54 II (Type 
J) thermocouple immediately after  laser irradiation at three different locations, 
(1) center, (2) 4 mm from center, (3) at the edge of the well (Figure 19). 
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PSMA cell cultured 96 well plates were replaced by 200 µl of mPEG-GNR 
(OD800= 0.15 and 0.2, in serum free media). PEGylated nanorods were used in 
cell ablation studies in order to minimize adhesion to the cell surface and 
maintain them in dispersion in the extracellular space. As before, the laser 
excitation source was tuned to 800 nm (2 mm diameter) in order to coincide with 
the longitudinal absorption maximum of the mPEG-GNR; a fixed laser power 
density of 20 W/cm2 was used for different exposure times (4, 8, 12, and 20 min), 
while monitoring the dispersion temperature using a FLUKE 54 II (Type J) 
thermocouple immediately after laser exposure. The mPEG-GNR dispersion was 
immediately removed and replaced by fresh serum containing media after laser 
exposure. 
 
4.2.1.6 Cell viability assay (MTT) 
 Cell viability was assayed 24 h after laser irradiation, using MTT cell proliferation 
assay kit (ATCC CA#30-1010k). Following addition of the MTT reagent (6 h at 
37oC), cells were treated with a lysis buffer from the kit and kept at room 
temperature in the dark for 4 h in order to carry out complete lysis and 
solubilization of the MTT product. The absorbance of each well was measured 
using a plate reader (Bio-Tek Synergy 2) at 570 nm. For data analysis, 
absorbance readouts were normalized to the live (untreated) and dead (5 µl of 30 
% hydrogen peroxide-treated) controls. 
 
4.2.2 Theoretical Model 
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The modeling of GNR use in hyperthermal cancer treatment requires a three part 
model, and is provided by Dr. Jeffery Heys: (4.2.2.1) a heat transport (or energy 
balance) equation, (4.2.2.2) a cell death model, and (4.2.2.3) a GNR spatial 
distribution model.  Each of the three parts is described below. 
 
4.2.2.1 Heat transport model 
The temperature distribution model for either a fluid or tissue containing GNRs is 
based on the Pennes’ bio-heat equation 179,183 with an additional term to account 
for energy released by the GNRs:  
பT
ப୲
ൌ α׏ଶT ൅ Q
஡C౦
൫1 െ 10ି୓D൯ ൅
୵C౦ౘ
஡C౦
ሺT െ Tୠሻ                       (1) 
Where the first term on the right side is heat conduction (diffusion), the second is 
plasmonic heating by the GNRs from laser irradiation, and the third term is heat 
transfer due to blood flow. The parameters used in the model are defined in 
Table 7.  
 
Table 7. Heat transport model parameters based on 182,186 
 
 
The incident laser power (5 to 20 W/cm2) was divided by the sample depth to 
obtain Q, the laser power per volume required in equation 1. The value used for 
each parameter is consistent with values used previously by others except for the 
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thermal diffusivity, which is approximately twice the value for pure water.  The 
thermal diffusivity value utilized in the model was chosen because it gave the 
best agreement with the experimental data as described later in the results 
section. It is also reasonable to assume that the presence of a high concentration 
of GNR in the solution would significantly increase the thermal diffusivity of the 
solution187. 
 
Three types of boundary conditions are commonly used during the solving of the 
heat transfer model (Figure 20). First, if the surrounding fluid or tissue is held at a 
fixed temperature, a Dirichlet condition can be applied, which specifies the 
temperature along the boundary. Second, a heat flux or Neumann boundary 
condition can be used in conjunction with Newton’s law of cooling to give: 
k பT
ப୬
ൌ UሺT െ T଴ሻ                                                   (2) 
Here, U is the overall heat transfer coefficient for the region adjacent to the 
model boundary, and T0is the bulk temperature of the surroundings. The final 
type of boundary condition is a symmetry condition, which is equivalent, in 
practice, to a zero temperature gradient boundary condition.  The model domain 
and boundary conditions are shown in Figure 4.3.  For the in vitro cell culture 
based system described here, Uair= 0.08 (W/m2°C),Uwall= 1X10-5 (W/m2°C), and 
k= 1 (W/m°C) were used in the model, and Tair and Twall were measured to be 
23°C. 
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Figure 20.The model domain (grey) represents a symmetrical cross-section of a 
well in a plate. 
The top boundary is the air-solution interface, the right and bottom boundaries 
are plate-solution interfaces, and the left boundary (dotted line) is the symmetry 
axis 
 
4.2.2.2 Cell death model 
Cell injury and death is predicted using the Arrhenius injury model182,188.  The cell 
injury rate is calculated by 
k ൌ Ae
షE౗
౎T                                                          (3) 
Where Eais the activation energy, R is the gas constant, T is the temperature, 
and A is a scaling factor. The values for Ea and A were determined for the 
experimental cell line studied here using isothermal cell viability tests, and the 
values used in the model are A= 6X1029s-1, and Ea= 200 kJ/mol. These values 
are consistent with the values measured for similar cell lines and tissues189,190.  
Finally, the cell injury rate is integrated over time to account for injury 
accumulation, and the fraction of tissue that is injured over time is given by 
FD ൌ 1 െ e
ି ׬ ୩ ୢ୲
౪
బ                                                       (4) 
Thus healthy tissue has FD= 0 and dead tissue has FD= 1.  
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4.2.2.3 GNR spatial distribution 
The distribution of GNRs in the extracellular dispersion is governed by diffusion, 
binding, unbinding, and cell internalization events. Initial studies on tumor 
spheroids have established the potential for mathematical models to accurately 
model the spatial distribution of nanoparticles184, but the general applicability of 
these models to other tissues and nanoparticle systems is still unknown.  It is, in 
general, difficult to estimate the diffusivity of the nanoparticles in the tissues, and 
the rate of particle binding, unbinding, and internalization within the cell are 
challenging to measure.  
 
It is possible to obtain a simplified model for the problems of interest here using 
scaling analysis.  The diffusivity of nanoparticles in water is very small (< 10-8 
cm2/s), and the diffusivity within a tissue is even smaller184.  The result of the 
small diffusivity is that diffusion through only a 100 µm of tissue requires a 
number of hours depending on the concentration and temperature184. The 
internalization of particles into cells is also relatively small for the time scales of 
interest here because the internalization rate is typically an order of magnitude 
less than the unbinding rate.  This means that a GNR attached to a cell surface is 
10 times more likely to go back into solution than to be internalized. Of course, 
internalization is largely irreversible, so given sufficient time many particles will 
be internalized, but this can take a few hours. 
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For the systems of interest here, it is valid to assume that most GNRs do not 
diffuse into tissue and are not internalized by the cells, but they remain in the 
extracellular dispersion or bound to the surface of the tissue. The concentration 
of bound particles is governed by the equation 
பCౘ
ப୲
ൌ kୟCୠୱC െ kୢCୠ                                         (5) 
Where Cb is the concentration of bound particles, Cbs is the concentration of open 
binding sites, C is the concentration of free particles in solution, and kb and kd are 
the association (binding) and disassociation (unbinding) rates, respectively. If 
sufficient time has elapsed before turning on the laser, equilibrium is achieved so 
the binding model can be simplified using a pseudo-steady-state assumption.  
The concentration of bound particles then becomes 
Cb= keqCbs    (6) 
Where keq=/ka’/kd and Ka’=kaC. The particle contrast (i.e., the ratio in bound 
particles between health and cancerous tissues) is determined by the ratio of 
binding site concentration between healthy and cancerous tissues. 
 
4.3 Results and Discussion 
The first set of model validation results focuses on the comparison of the heat 
transfer model with experimental temperature measurements with different ODs 
(i.e., different GNR concentrations) and different laser irradiation levels. The first 
experimental conditions used a 24-well plate and 4 different OD800 (0.065, 0.148, 
0.285, and 0.50).  The temperature was measured at 4 different locations within 
a well, and two different samples at each OD800 were employed. The 
 77 
experimental measurements and simulation predictions at three radially spaced 
points in the domain are shown in Figure 21. 
 
 
Figure 21.Experimental temperature measurementsand heat transfer model 
predictions. 
Experimental temperature measurements (2 samples, circles and crosses) and 
heat transfer model predictions (solid lines for three radial points in the domain) 
for 4 different OD800s - (a) 0.065, (b) 0.148, (c) 0.285, and (d) 0.50. 
 
Significant spatial differences were not seen in the current set up indicating that 
even though the laser diameter was only 2 mm in a well of approximately 16 mm 
diameter, the heat transfer was rapid throughout the gold nanorod dispersion. 
The model predictions are in good agreement with the experimental 
measurements for all optical densities, and the largest errors occur at the lowest 
optical density.  However, even at the lowest optical density, the experimental 
measurement and model prediction agree once steady-state is achieved. The 
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model simply predicts a slightly faster heating rate than is measured 
experimentally. The model predicts the temperature distribution throughout the 
well being irradiated with the laser. Figure 22 shows the temperature contours 
within the well, and as expected, the highest temperatures occur along the well 
axis where the laser is focused, and the coolest temperatures occur near the wall 
at the surface of the fluid. 
 
 
Figure 22.Temperature distribution within the well for an OD=0.45. 
The temperature is reported in K, and approximate locations of the 
thermocouples are shown by ‘X’. 
 
The second set of comparisons between experimental measurements and the 
heat transfer model uses GNR dispersions in a 96-well plate and different laser 
energy levels. The results are summarized in Figure 23 and show good 
agreement at the lower two laser energy levels. At the highest laser energy level, 
the model predicts a higher temperature than is measured experimentally, 
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especially at steady-state. The most likely cause for this difference is the 
assumptions behind Newton’s law of cooling for the upper boundary. This 
boundary condition lumps radiative cooling, evaporative cooling, and convective 
cooling into a single parameter that is independent of temperature. In other 
words, it assumes that all these energy loss mechanisms are (linearly) 
proportional to the temperature. In reality, none of these energy loss mechanisms 
are linear with temperature changes, and these nonlinear effects become 
important at temperatures above 50°C or 60°C191. 
 
 
Figure 23.Heat transfer model prediction at different radial locations (solid lines) 
and experimental temperature measurements (open circles and crosses) at three 
different laser energy levels. 
(a) 0.008 W/mm3, (b) 0.016 W/mm3, and (c) 0.032 W/mm3. 
 
Once acceptable agreement between the heat transfer model and experimental 
measurements was achieved, the next set of validation experiments focused on 
the cell death model. The GNR dispersion with cells attached to the bottom of the 
well was then irradiated for 0, 4, 8, 12, or 20 minutes, and the temperature was 
also monitored immediately after switching the laser off. A cell viability assay was 
conducted after irradiation, and the viability measurements were compared to 
model predictions. Figure 24 shows the temperature and cell viability results for a 
GNR solution with an OD800of 0.15.  
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Figure 24. (a) Temperature measurements and model predictions for a GNR 
dispersion with OD800= 0.15. (b) Cell Viability measurements and predictions for 
different laser irradiation times. 
 
The model predictions of the temperature are slightly lower than the experimental 
measurements for lower laser exposure times, and are slightly higher for 
exposure times greater than five minutes. The cell death predictions deviate 
slightly from experimental measurements, but these differences can be expected 
from the temperature predictions. Lower values of temperature at the initial laser 
exposure times (< 5 minutes) result in predictions of high cancer cell viability. 
Conversely, higher temperature predictions lead to modest over-estimatation of 
cell death predictions (or lower predictions of cell viability values). The model and 
experimental results for a GNR solution with an OD800= 0.2, shown in Figure 25, 
are similar to the OD800= 0.15 results. Here, the temperature agreement and cell 
viability agreement are improved, with the largest errors being in the early cell 
viability results. The temperature within the well varies both temporally and 
spatially.  
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Figure 25.(a) Temperature measurements and model predictions for a GNR 
dispersion with OD800=0.20. (b) Cell Viability measurements and predictions for 
different laser irradiation times. 
 
To help visualize the impact of the spatial temperature variation on cell viability, 
the well bottom in the model was covered with a monolayer consisting of 
approximately 13,000 cells. Each cell was assigned a random number between 0 
and 1, and when the cell viability dropped below that random number, the cell 
was removed from the model. Figure 26 shows the viable cells after 10 minutes 
and after 18 minutes of laser irradiation. The solution in the well above the cells 
contained GNR with an OD800= 0.2. Despite the small spatial temperature 
differences, there is a lower loss of cell viability for the outer regions of the well. 
The higher temperatures at the center result in a higher rate of cell death.  
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Figure 26.Cell viability predictions. 
Viability predictions for approximately 13,000 cells along the bottom of the well 
after laser irradiation for (a) 10 minutes and (b) 18 minutes with GNR solution at 
OD800= 0.20. The cells disappear when their cell viability level falls below a 
randomly assigned threshold. 
 
The final model prediction is speculative in nature, and was carried out to 
elucidate the role of nanoparticle binding to cell surface on hyperthermia. Some 
evidence has shown that cancer cells are more susceptible to damage from 
elevated temperatures than healthy cells due to the hypoxic environment192. To 
model this impact, it was assumed in the model that the inner 1.2 mm (in 
diameter) of a 6mm well was cancerous cells, and for these cells, Ea= 198 kJ/mol 
was used instead of Ea= 200 kJ/mol to simulate the increased heat sensitivity. 
Further, GNRs can be conjugated with cancer cell targeting antibodies that will 
increase their potential for binding to malignant cells versus healthy cells. To 
model the impact of this change, the GNR concentration was increased by 20% 
near the cancer cells versus the healthy cells, which represents an assumed 
increase of 20% in the number of binding sites for cancerous versus healthy 
cells. It is important to remind the reader that the targeted nanorods in this case 
are still external to the cell and have not been internalized. The predicted living 
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cell populations at the bottom of the well are once again shown for ten and 
eighteen minutes of laser irradiation in Figure 27. At the ten-minute point, 31% of 
the healthy cells have been killed, and 65% of the cancer cells have died. At the 
eighteen-minute point, 71% and 96% of the healthy and cancer cells, 
respectively, have died. 
 
 
Figure 27.Cell viability predictions for approximately 13,000 cells along the 
bottom of the well after laser irradiation. 
(a) 10 minutes and (b) 18 minutes with GNR solution at OD800=0.17. The inner 
1.2 mm has cancerous cells with lower activation energy for cell injury and an 
increased number of GNR binding site (simulating targeting delivery of GNRs to 
cancer cells). The cells disappear when their cell viability level falls below a 
randomly assigned threshold. 
 
The model parameters were changed only a small amount between the results 
shown in Figures 26 and 27. However, the impact on cell death over the tumor 
region in the model was far greater, overall, than the small individual changes to 
cell injury activation energy and GNR concentration. This dramatic change is 
simply a result of the impact of these two parameters being multiplicative (or 
geometric) instead of additive (or arithmetic). Multiplicative interactions can 
 84 
cause multiple small changes to result in a large change overall, much larger 
than simply adding up the small changes. 
 
4.4 Conclusions 
In this Chapter, the nanorod dispersion was irradiated with near infrared (NIR) 
laser and the spatiotemporal distribution of temperature was determined 
experimentally. This information was employed to develop and validate 
theoretical models of spatiotemporal temperature profiles for gold nanorod 
dispersions undergoing laser irradiation, and the impact of the resulting heat 
generation on the viability of human prostate cancer cells. A cell injury/death 
model was then coupled to the heat transfer model to predict spatial and 
temporal variations in cell death and injury. The model predictions agreed well 
with experimental measurements of both, temperature and cell death profiles. 
Finally, the model was extended to examine the impact of selective binding of 
gold nanorods to cancer cells compared to non-malignant cells, coupled with a 
small change in cell injury activation energy. The impact of these relatively minor 
changes results in a dramatic change in the overall cell death rate. Taken 
together, extracellular hyperthermia using gold nanorods is a promising 
therapeutic strategy and tailoring the cellular binding efficacy of nanorods can 
result in varying therapeutic efficacies using this approach.  
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CHAPTER 
5.Optically / Photothermally Responsive Polypeptide Conjugated Gold 
Nanorod Assemblies 
 
5.1 Introduction 
Chapter 3 demonstrated that polyelectrolyte coated gold nanorods absorb near 
infrared (NIR) light converting this energy to heat for photothermal ablation, in 
which PE-GNRs can be used as a potential drug delivery device. This chapter 
describes an investigation into interfacing proteins/polypeptides with 
nanoparticles to generate novel functional nanomaterials for sensing, tissue 
engineering, and/or drug delivery applications. Optically responsive 
nanoassemblies have demonstrated promise as molecular-scale switching 
devices193,194, sensors195-197, drug delivery systems198-202, and for biomedical 
imaging145,203.The ability to convert incident light energy to heat energy due to 
surface plasmon resonance activity makes gold nanorods attractive candidates 
for modulating polypeptide (or protein) structure / phase transition using optical 
methods (i.e. near infrared light). While the ability to induce irreversible structural 
change in proteins can play a role in therapeutic applications, the ability to 
reversibly control protein structure lends flexibility for a variety of applications 
including site-specific drug delivery, biosensors, and switching.  
 
Elastin-like polypeptides (ELPs) are derived from a portion of mammalian elastin 
characterized by the sequence, VPGXG, where V=valine, P=proline, G=glycine, 
and X=any amino acid except proline. ELPs exhibit a thermally induced phase 
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transition at the inverse transition temperature (Tt), characterized by reversible 
intramolecular contraction and intermolecular coacervation204. The transition 
temperature (Tt) is the temperature at which hydrophobic folding and assembly 
transition occurs. Below Tt, ELP dissolved in aqueous solution; upon heating, 
ELPs undergo a phase separation, commonly known as coacervation. Further 
heating of ELP leads to coalescence of coacervate into larger droplets205. The 
phase transition of ELP is reversible and can be easily characterized based on 
turbidity measurement vs temperature plot; Tt is defined as the temperature at 
50% the maximum turbidity of solution. The thermal transition behavior of ELPs 
is reversible and has been exploited in a number of applications including, 
bioseparations206-208, drug delivery209-213, sensors214-216, and tissue 
engineering217,218. These reports have traditionally employed thermal activation 
as means of inducing phase transitions in ELPs. However, the ability to remotely 
and reversibly control the thermal response may be critical in applications such 
as targeted hyperthermia to tumors that may require precise spatial control in 
deep-seated tissues.  
 
The formation of gold nanorod (GNR)-elastin-like polypeptide (ELP) 
nanoassemblies whose optical response can be remotely controlled based on 
near-infrared (NIR) light exposure has been demonstrated. In this study, 
cysteine-containing ELPs (denoted C2ELP due to the presence of two cysteines 
in the ELP repeat sequence) were self-assembled on gold nanorods (GNRs) 
leading to GNR-C2ELP nanoassemblies. Exposure of GNR-C2ELP assemblies to 
NIR laser resulted in the heating of GNRs due to surface plasmon 
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resonance219,220. Heat transfer from the GNRs resulted in a temperature increase 
of the self-assembled C2ELP above its transition temperature (Tt)204,206,221, 
leading to a detectable phase transition and aggregation of the GNR-C2ELP 
assemblies. This phase transition was quantified using an optical readout, based 
on an increase in the optical density of the GNR-C2ELP dispersion. This optical 
response was seen only in the case of GNR-C2ELP nanoassemblies. While a 
photothermal response was observed in the case of a dispersion consisting of 
GNRs alone, no optical response could be seen due to the absence of the 
C2ELP. As expected, C2ELP solutions demonstrated neither a photothermal nor 
an optical response. The reproducibility and reversibility of optical response of 
GNR-C2ELP nanoassemblies was demonstrated across multiple cycles following 
exposure and removal of the laser irradiation. Studies described in this chapter 
demonstrate that polypeptides can be interfaced with GNRs resulting in optically 
responsive nanoassemblies, with potential applications in (bio)sensing, tissue 
engineering, and drug delivery. 
 
5.2 Materials and Methods 
 
5.2.1 Design, Expression, and Purification of C2ELP 
This portion of the work was carried out in collaboration with Dr. Zaki Megeed 
and Dr. Piyush Koria at the Center for Engineering in Medicine, Massachusetts 
General Hospital and Harvard Medical School in Boston, MA. 
 
5.2.1.1 C2ELP gene synthesis 
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Cysteine-containing ELPs were formed via recursive directional ligation221, 
yielding the following amino acid sequence, where cysteine residues are shown 
in bold and underlined font; the name C2ELP denotes the two cysteines that are 
part of the ELP repeat sequence: 
MVSACRGPG-(VG VPGVG VPGVG VPGVG VPGVG VPG)8–(VG VPGVG 
VPGVG VPGCG VPGVG VPG)2-WP 
Briefly, oligonucleotides encoding the ELP were cloned into pUC19, followed by 
cloning into a modified version of the pET25b+ expression vector at the sfiI site221. 
E. coli BLR (DE3) (Novagen) was used as a bacterial host. 
 
5.2.1.2 C2ELP expression and purification 
Expression vector pET25b+, containing C2ELP cassette was transformed into 
BLR cells. A starter culture of 50 mL was then inoculated overnight in terrific 
broth. The next day the 50 mL culture was added to a 1 L culture. The 1 L flasks 
were then inoculated overnight in an incubator shaker at 250 rpm and 37°C. 
Bacterial cells were harvested by centrifugation at 4°C the next day. The 
bacterial pellet was resuspended in 1X phosphate buffered saline (PBS) and the 
cells were disrupted by sonication on ice. The lysate was cleared by 
centrifugation followed by a polyethyleneimine treatment (final concentration: 
0.5% w/v) in order to precipitate soluble nucleic acids. After another round of 
centrifugation to pellet nucleic acids, the cleared supernatant containing C2ELP 
was transferred to a clean centrifuge tube. The tube was heated to 45°C in 
presence of 1M NaCl to precipitate C2ELP. A warm centrifugation at 45°C was 
carried out to pellet C2ELP. The supernatant was then discarded and the pellet 
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was re-solublized in PBS in the presence of 10 mM DTT. Another cold spin at 
4°C was performed to remove insoluble contaminants. This cycle was repeated 
two more times. For the final resuspension step, C2ELPwas resuspended in 
purified water and then lyophilized and stored at 4°C.  
 
5.2.1.3 C2ELP characterization 
The lyophilized C2ELP was resuspended in 1X phosphate buffer saline (PBS). 
The resuspended material was then subjected to SDS-PAGE under denaturing 
conditions in order to determine the purity of the polypeptide. The gel was then 
stained with simply blue safe stain (Invitrogen, Carlsbad, CA) to visualize the 
proteins. As seen in Figure 28, C2ELP corresponds to a molecular weight of 
~22kDa. 
 
Figure 28.Denaturing SDS-PAGE analysis of C2ELP employed in the current 
study. 
The molecular weight of the polypeptide was 22kDa. 
 
5.2.2 Determination of Tt of C2ELP 
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The inverse transition temperature (Tt) of C2ELP was characterized by monitoring 
the absorbance of C2ELP solution at 610 nm as a function of temperature with a 
UV-visible spectrophotometer (Beckman DU530) in 0.5X PBS. Briefly, 1 mL of 
C2ELP was placed in a disposal cuvette. The temperature of C2ELP was tuned 
by placing the C2ELP-containted cuvette into a Precision 288 Digital Water Bath 
(Thermo Scientific) and was recalibrated by Digi-Sense Type J Thermocouple 
before absorbance measurement. The absorbance of C2ELP was monitored at 
610 nm with a UV-visible spectrophotometer (Beckman DU530) immediately 
after withdrawing the cuvette out of the water bath. The Tt is defined as the 
temperature at half the maximum absorbance value of C2ELP solution. The 
temperature response of the C2ELP indicated a Tt value of 33.4°C (Figure 29). 
The absorbance at 610 nm was selected for determining the Tt value since gold 
nanorods show the lowest absorbance at this wavelength (Figure 30) as a result 
of which, the absorbance of the solution is indicative of turbidity increase due to 
C2ELP alone.  
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Figure 29.Temperature-dependent phase transition of C2ELPas measured by 
change in optical density at 610 nm (OD610) indicates a transition temperature (Tt) 
of 33.4ºC. 
 
5.2.3 Generation of Gold Nanorods 
Gold nanorods were synthesized using the seed-mediated method as described 
by El-Sayed et al.155 Following the same procedure in Chapter 3.2.2, this method 
was employed to generate two different gold nanorod populations that possessed 
absorbance maxima at (λmax) at 710nm and 810nm, respectively. Each nanorod 
population was diluted with DI water to an optical density ~0.5 (Figure 30). 
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Figure 30.Absorption spectra of gold nanorods generated using the seed-
mediated method. 
The nanorods demonstrated peak absorbances at 710 nm and 810 nm and are 
denoted as GNR (710 nm) and GNR (810 nm), respectively. 
 
5.2.4 Generation of Gold Nanorod / C2ELP Nanoassemblies 
C2ELP (2 mg/mL in 1X PBS) was added into deionized (DI) water at a 1:1 volume 
ratio, to form C2ELP solution (1 mg/mL in 0.5X PBS; “C2ELP alone”). Gold 
nanorods (1mL; λmax=710 nm or 810 nm) in DI water having an absorbance of 
~0.5 were added to an equal volume (1 mL) of 1X PBS in order to bring the final 
concentration to 0.5X PBS (“GNR alone”). The absorbance of the resulting 
solution was verified to be similar for all cases following mixing. C2ELP (Tt= 
33.4°C) was self-assembled on gold nanorods overnight leading to formation of 
the nanoassemblies via gold-thiol bonds (“GNR- C2ELP assemblies”). Briefly, 
1mL of C2ELP (2 mg/mL in 1X PBS) was mixed with 1 mL of GNR dispersion in 
DI Water to form a 2 mL GNR-C2ELP dispersion (1 mg/mL in 0.5X PBS). Prior to 
self-assembly, 20 mg of Reductacryl® resin (EMD Biosciences Inc.) were added 
to C2ELP (1 mL) for 15 min in order to reduce the cysteines in the polypeptide. 
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Reduced C2ELP was separated from the Reductacryl® resin by centrifugation at 
13,000 rpm for 10 minutes and immediately added to gold nanorods at a 
volumetric ratio of 1:1 and stirred overnight at room temperature. Equivalent 
concentrations of gold nanorods (without self-assembled C2ELP) and C2ELP 
(without gold nanorods) were used as controls in the subsequent experiments.  
 
5.2.5 Optical Response of GNR-C2ELP Nanoassemblies 
A titanium CW sapphire (Ti:S) laser (Spectra-Physics, Tsunami) pumped by a 
solid state laser (Spectra-Physics, Millennia) was used for the laser irradiation 
experiment. The excitation source was tuned to 720 nm or 810 nm in order to 
coincide with the longitudinal absorption maximum of the GNR-C2ELP 
nanoassemblies and GNRs in the two cases, respectively. In case of GNR (λmax= 
710 nm), self assembly with C2ELP resulted in a slight red shift of the 
absorbance peak to 720 nm resulting in GNR-C2ELP (λmax= 720 nm) (Figure 31). 
As a result, the laser was tuned to the absorption maximum of the 
nanoassemblies. In the second case, GNR (λmax= 810 nm), laser wavelength that 
corresponded with the absorption maximum of the nanorods was used. The 
wavelength of the laser was tuned to the same wavelength as the maximal 
absorbance of the GNR-C2ELP nanoassemblies to maximize photothermal effect 
efficacy of the nanorods. 
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Figure 31.Absorbance spectrum of GNR (λmax= 710 nm) and GNR (λmax= 710 
nm)-C2ELP nanoassemblies at 25oC (<Tt). 
A red-shift can be observed in the longitudinal peak in case of the nanorod 
polypeptide assemblies resulting in peak absorbance at 720 nm of the GNR-
C2ELP (λmax= 720 nm) nanoassemblies. 
 
As with the Tt measurements before, absorbance at 610 nm was employed for 
evaluating the optical response of the GNR-C2ELP nanoassemblies. The optical 
response of 1 mL GNR-C2ELP assemblies in response to laser exposure in 0.5X 
PBS was first characterized by monitoring the absorbance at 610 nm using with a 
UV-visible spectrophotometer (Beckman DU530) as a function of the employed 
laser power.  Briefly, GNR, C2ELP, and GNR-C2ELP dispersion (1 mL in disposal 
cuvettes) were exposed to laser light at different power densities (0-510 mW) for 
5 minutes. The laser, tuned to 720 nm or 810 nm (~2 mm diameter beam) was 
focused through the center of the cuvette in a vertical fashion. The temperature 
of the all solutions and dispersions were monitored as a function of the laser 
power using a Digi-Sense Type J Thermocouple.  
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In order to obtain the kinetics of the optical response and the corresponding 
temperature response, cuvettes containing 1 mL of GNR-C2ELP dispersion, GNR 
dispersion or C2ELP solution were exposed to a maximum laser power (460 mW 
for GNR (λmax=720 nm); 510 mW for GNR (λmax=810 nm) for different periods of 
time (0-10 min) beginning at room temperature. The optical response was 
characterized by monitoring the absorbance at 610 nm (OD600) as a function of 
time with a UV-visible spectrophotometer (Beckman DU530); as before, the 
kinetics of the temperature response were monitored using a Digi-Sense Type J 
Thermocouple. 
 
5.3 Results and Discussion 
Environmentally responsive biomolecules and nanoparticle-biomolecule systems 
are being actively pursued with an eye towards enhancing sensing, therapeutic, 
and device capabilities222. Temperature-based control is a powerful strategy for 
generating robust environmentally responsive systems. However, localized 
control of temperature can be of importance in biological applications including 
tumor-targeted hyperthermia223, functional devices224, and cell patterning225. The 
temperature-responsive properties of elastin-like polypeptides (ELPs) were 
interfaced with the ability to remotely tune the thermal response of gold nanorods 
using near infrared irradiation, in order to generate optically responsive 
nanoparticle-polypeptide assemblies. 
 
A 22 kilo Dalton (kDa), cysteine-containing elastin-like polypeptide (C2ELP; 
Figure 28 and 29), was expressed in E. Coli and purified as described in the 
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methods section previously221. The inverse transition temperature (Tt) of C2ELP 
was experimentally determined to be 33.4oC (Figure 29). Gold nanorods (GNRs) 
(710 nm and 820 nm; Figure 30)were generated using the seed-mediated 
chemical synthesis method155. C2ELP (Tt=33.4oC) was first reduced using 
Reductacryl® (in order to reduce cysteines) and then self-assembled on GNR 
(λmax= 710 nm). Upon incubation with C2ELP, the maximal absorbance peak 
showed a slight red-shift to 10 nm due to the self assembly of the polypeptide on 
the nanorods226 (Figure 31) indicating the formation of GNR-C2ELP (λmax= 720 
nm) nanoassemblies.  
 
The optical response of the GNR-C2ELP (λmax= 720 nm) nanoassemblies was 
investigated using near infrared (NIR) laser-irradiation. Figure 32a shows the 
change in absorbance as a function of laser power following exposure of the 
GNR-C2ELP (λmax= 720 nm) nanoassemblies to a 720 nm NIR laser for 5 
minutes. While no change in dispersion optical density was observed for laser 
powers below 300 mW, a sharp transition and strong optical response were 
observed for laser powers in excess of 350 mW, indicating that energy from the 
laser was converted into heat due to the plasmonic properties of gold nanorods. 
This, in turn, resulted in an increase in temperature of the self-assembled elastin, 
leading to the aggregation of GNR-C2ELP (λmax= 720 nm) and the observed 
optical response. I measured the solution temperature using a J-thermocouple 
(Figure 32b) and correlated it with the profile with laser power employed in order 
to investigate the observed photothermal response. The observed temperature at 
a laser power of 300 mW was 32.8°C, which is below the Tt (33.4°C) of the self-
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assembled C2ELP. However, when the laser power was increased to 400 mW, 
the temperature of the GNR- C2ELP dispersion reached 35.3°C (>Tt) following 
the five minute NIR exposure. This resulted in a sharp increase in the optical 
density, indicating that laser powers higher than 350 mW were required for 
inducing the optical response. The range of laser power (350-650 mW) and / or 
power densities (5-7 W/cm2) that induce the optical response described in the 
above experiments is either significantly lower227,228 or comparable229,230 to those 
used in other reports in the literature on NIR-mediated photothermal activation of 
gold nanoparticle-based systems. These results are consistent with expected 
behavior in that, the optical response due to ELP self-assembly was seen 
beyond a threshold laser power which was necessary to raise the ELP 
temperature beyond its corresponding Tt.  
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Figure 32.Optical response (in optical density at 610 nm) of gold nanorod (GNR; 
λmax= 720 nm)-C2ELP assemblies. 
(a) Optical response and (b) temperature response as a function of laser power 
following 5 minute exposure to 720 nm laser. Kinetics of (c) optical and (d) 
temperature response of GNR-C2ELP assemblies following excitation with 720 
nm laser. Lines connecting data points are for visualization only. 
 
The kinetics of the optical response were then investigated by measuring the 
absorbance of GNR-C2ELP (λmax= 720 nm) as a function of time(Figure 32c); in 
addition the kinetics of the optical response were correlated with the kinetics of 
temperature increase (Figure 32d) in order to explain the photothermal effect. 
Figure 32c shows the optical response of GNR-C2ELP (λmax= 720 nm), GNR, and 
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C2ELP as a function of laser exposure time. The laser power was fixed at the 
maximum power (460 mW) in order to reliably generate the maximal optical 
response. The optical density of the GNR-C2ELP (λmax= 720 nm) nanoassemblies 
increased sharply after two minutes of laser exposure and reached a plateau 
after five minutes. Although the maximal optical response was observed five 
minutes following laser exposure, a detectable response was observed after only 
two-and-a half minutes of laser exposure time. In contrast, no change in optical 
density was seen either in the case of nanorods alone or C2ELP alone, indicating 
that the optical response was specific to nanorod-polypeptide assemblies. Figure 
33 shows digital snapshots of the time-dependent phase transition and optical 
response of GNR-C2ELP (λmax= 720 nm) nanoassemblies as a function of time 
following laser exposure (laser power= 460 mW); the respective laser exposure 
times (in minutes) are shown by the timer in the background. As seen in the 
figure, the GNR-C2ELP (λmax= 720 nm) dispersion continued to be optically clear 
after one minute of laser exposure time. However, the solution turbidity increased 
after three minutes of laser exposure and reached a maximum in five minutes. 
The optical density remained invariant following five minutes of laser exposure 
consistent with the absorbance measurements in Figure 32c.  
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Figure 33.Digital images of the optical response of GNR (λmax= 720 nm)-C2ELP 
nanoassemblies as a function of laser exposure time. 
Change in optical density remained invariant after 5 minutes following laser 
exposure. The corresponding laser exposure times can be seen in the timer in 
the background. 
 
The temperature response of the GNR-C2ELP (λmax= 720 nm) was determined as 
a function of time and compared with the response of solution containing C2ELP 
alone and nanorods dispersion alone. The observed temperatures of the GNR-
C2ELP dispersion were 33.6°C, 35.5°C, and 37.4°C following 3, 4, and 5 minutes 
of exposure with 720 nm laser, respectively (Figure 32d). The time required for 
the solution temperature to increase beyond the transition temperature of C2ELP 
following NIR irradiation was well correlated with the observed change in solution 
optical density (Figure 32c). In addition, the kinetics of temperature increase of 
GNR-C2ELP nanoassemblies closely followed the rise in temperature of GNR 
alone. Thus, although the temperature of GNRs alone rose faster than GNR-
C2ELP nanoassemblies (as may be expected), no change in optical response 
was observed in the former case (Figures 32c and 32d). No change in solution 
temperature was observed with C2ELP alone upon exposure to the laser, which 
explains the lack of optical response in this case. In order to examine if the 
observed optical response was reversible, GNR-C2ELP (λmax= 720 nm) 
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assemblies were subjected to five alternating cycles in which the laser exposure 
was turned on for 5 minutes and then turned off for 5 minutes. Following laser 
exposure (laser power = 460 mW) for five minutes, the absorbance of the 
dispersion increased up to 1.2 absorbance units indicating formation of the 
aggregated nanoassemblies (Figure 34). The optical density of the dispersion 
returned to baseline values in approximately two minutes following removal of the 
laser excitation. This behavior was reproducible over the five cycles tested, 
indicating that the optical response of the GNR-C2ELP assemblies was indeed 
reversible and reproducible across multiple cycles.  
 
 
Figure 34. Reversibility of optical response of GNR-C2ELP (λmax = 720 nm) 
assemblies. 
GNR-C2ELP assemblies were subjected to alternating cycles laser exposure in 
which the laser was turned on and off for five minutes each. The absorbance of 
the suspension was noted as a function of time. 
 
The optical response was also evaluated with another set of gold nanorods that 
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GNR (λmax= 810 nm), the laser wavelength was tuned to the maximal peak 
absorbance of the nanorods (i.e. 810 nm) and not to the peak absorbance of the 
nanoassemblies. ELP self-assembly was shown to result only in a minor red-shift 
of the peak absorbance peak (Figure 31) of the nanorods. As a result, the laser 
was tuned to the peak absorbance of the nanorods in this case. As with the 
GNR-C2ELPλmax= 720 nm) assemblies, the temperature profile (Figure 35b) of 
these nanoassemblies closely followed the laser power employed (Figure 35a). 
The optical response was specific to the GNR-C2ELP nanoassemblies; no 
change in absorbance was seen with solutions containing C2ELP alone and 
nanorods alone (Figure 35c). Finally, the optical response of the GNR-C2ELP 
nanoassemblies closely followed the kinetics of temperature increase (Figure 
35d). The increase in temperature in case of GNR (λmax= 810 nm)-C2ELP closely 
followed that of GNR (λmax= 810 nm) alone. However, the optical response was 
seen only in case of the former due to the presence of the self-assembled 
C2ELP. These results are consistent with those observed with the GNR-C2ELP 
(λmax= 720 nm) assemblies indicating that the optical response can be obtained 
with nanorods that absorb at different wavelengths of the near-infrared region of 
the absorption spectrum, which further expands the application range of these 
nanoassemblies.  
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Figure 35.Optical response (in absorbance units at 610nnm) of gold nanorod 
(GNR; λmax= 810 nm)-C2ELP assemblies. 
(a) Optical response and (b) temperature response as a function of laser power 
following 5 minute exposure to 810 nm laser. Kinetics of(c) optical and (d) 
temperature response of GNR-C2ELP nanoassemblies following excitation with 
810 nm laser. Lines connecting the data points are for visualization only. 
 
5.4 Conclusions 
In this Chapter, I have investigated novel optically responsive polypeptide-based 
nanoassemblies in which, heat transfer from NIR-absorbing gold nanorods 
resulted in a conformational change in the self-assembled elastin-like polypeptide 
(ELP) leading to a detectable optical response. In addition to GNRs, carbon 
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nanotubes231,232 and magnetic nanoparticles233-235, which have been reported to 
generate heat upon exposure to laser or RF field, may be interfaced with ELP for 
thermal, photothermal, and magnetothermal applications (e.g. sensing). Such 
ability to control nanoscale assembly and nanomaterial properties by optical 
manipulation can be exploited in the development of novel sensors, drug delivery 
systems, functional molecular and nanoscale devices, and imaging agents.  
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CHAPTER 
6. Investigation of Phase Separation Behavior and Formation of Plasmonic 
Nanocomposites from Polypeptide-Gold Nanorod Nanoassemblies 
 
6.1 Introduction 
Chapter 5 demonstrated the remote and reversible control of the photothermal 
response of GNR-C2ELP nanoassemblies. This chapter investigates the use of 
multiple cysteines within the polypeptide sequence in order to facilitate 
irreversible cross-linking with GNRs leading to GNR-ELP nanocomposites. It was 
hypothesized that increasing the number the thiol-containing amino acid, 
cysteine, within the ELP sequence, from C2ELP to C12ELP (or C8ELP), will 
facilitate inter-polypeptide and polypeptide-gold nanorod (GNR) cross-linking, 
resulting in the formation of GNR-CnELP nanocomposites. Specifically, the 
effects of CTAB (used for templating the synthesis of gold nanorods), and GNR 
concentrations on modulating the C12ELP transition temperature and GNR-
C12ELP nanocomposite formation were investigated. Moreover, the phase 
separation behavior and kinetics of GNR-C12ELP nanocomposite formation were 
followed using a mathematical model. These nanocomposites have potential 
applications in drug delivery materials, wound healing and related topical skin 
diseases, scaffolds for tissue engineering and antibacterial films. 
 
6.2 Materials and Methods 
6.2.1 Materials 
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Cetyltrimethyl ammonium bromide (CTAB), gold (III) chloride trihydrate 
(HAuCl4•3H2O), L-ascorbic acid, sodium borohydride and silver nitrate were 
obtained from Sigma-Aldrich. Dithiothreitol (DTT) and Reductacryl® resin were 
purchased from EMD. All chemicals were used as received without further 
purification. 
 
6.2.2 Gold Nanorod Synthesis 
Gold nanorods were synthesized using the seed-mediated method155 as 
described in Chapter 3.2.2 previously. This method was employed for generating 
gold nanorods (GNRs) that possessed absorbance maxima (λmax) in the near 
infrared (NIR) region of the light absorption spectrum. Specifically for this study, 
nanorod aliquots, with an initial CTAB concentration of 100 mM, were pelleted by 
centrifugation (6000 rcf, 10 min), following which, the clear supernatant was 
removed, and resuspended in nanopure water to various final volumes. Further 
centrifugation, decantation and dilution steps allowed the generation of a series 
of nanorod samples(0.1-2.9mM) with various concentrations of CTAB (0.5-8 
mM).Note that CTAB concentration (0.0013-0.038 mM)bound to the surface of 
the gold nanorods(0.1-2.9 mM)is negligible compared to free CTAB molecules 
(0.5-8 mM) in the dispersion236. In all cases, the concentration of gold in GNRs 
was determined using inductively coupled plasma optical emission spectrometry 
(ICP-OES, iCAP 6000 Series, Thermo Electron Corporation), and are reported in 
terms of millimolar units. 
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6.2.3 Synthesis, Expression, and Purification of Cysteine containing 
Elastin-like Polypeptides (ELPs) 
Elastin-like polypeptides containing eight or twelve cysteines (C8ELP or C12ELP), 
were generated using recursive directional ligation method described 
previously237. C8ELP and C12ELP respectively contain eight and twelve cysteines 
residues (shown in bold) in the sequence: MVSACRGPG-(VG VPGVG VPGVG 
VPGVG VPGVG VPG)8-(VG VPGVG VPGVG VPGCG VPGVG VPG)8 or12-WP. 
Both C8ELP and C12ELP were generated, expressed, purification lyophilized and 
stored at room temperature as described previously in Chapter 5.2.1237. 
 
6.2.4 Determination of Transition Temperature (Tt) 
The transition temperatures (Tt) of C8ELP and C12ELP were characterized as 
described in Chapter 5.2.2 previously. The temperature response of the C8ELP 
and C12ELP indicated transition temperature (Tt) values of 31.3°C and 30.5°C. 
 
6.2.5Formation of Elastin-like Polypeptide-Gold Nanorod (GNR-C12ELP) 
Nanoassemblies 
Gold nanorods, in presence of different CTAB concentrations (described 
previously) were incubated with C12ELPovernight at 4°C, leading to formation of 
the nanoassemblies mediated by gold-thiol bonds237,238. Briefly, prior to self-
assembly, C12ELP was treated with Reductacryl® resin for 15 min at a 1:5 weight 
ratio, in order to reduce the cysteines in the polypeptide chain. Reduced C12ELP 
(2 mg/mL in 1X phosphate buffered-saline or PBS) was separated from the 
Reductacryl® resin by centrifugation at 8,000 rcf for 10 min and mixed with GNR 
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dispersions at a volumetric ratio of 1:1. This resulted in the formation of a series 
of GNR-C12ELP nanoassemblies in 0.5X PBS and differing CTAB concentrations. 
It should be noted that the concentration of C12ELP was always kept at 0.023 mM, 
while the CTAB and GNR concentrations were varied from 0.25 to 4 mM and 
0.05 to 1.45 mM, respectively.C12ELP solutions with various concentrations of 
CTAB (no gold nanorods) were prepared in 0.5X PBS as controls.  
 
6.2.6Preparation of Solid-Phase GNR-C12ELP Nanocomposites from Liquid-
Phase Nanoassemblies 
Nanocomposites were prepared by incubating 1.5 mL GNR-C12ELP 
nanoassemblies in a 1 cm diameter home-made acrylic column deviceat37°C (or 
60°C) for 4 h. This system resulted in the formation of the nanocomposite film on 
a circular cover slip originally placed at the bottom of the device. Following 
nanocomposite formation, the clear supernatant was removed from the column, 
and the absorption spectra of the GNR-C12ELP nanocomposite were determined 
using a plate reader (Biotek Synergy 2) at room temperature; absorption spectra 
were measured between 400-999 nm with 5 nm intervals. 
 
6.2.7Kinetics of Phase Separation of Liquid-Phase Nanoassemblies leading 
to Formation of Solid-Phase Nanocomposites 
Aliquots of 200 μLGNR-C12ELP nanoassemblies and C12ELPsolutions, initially at 
4°C, were placed in a plate reader set to 37°C in order to facilitate phase 
separation and formation of nanocomposites. A spectrophometric assay was 
employed to monitor the change in sample turbidity as a function of time in order 
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to investigate the phase separation process. The optical densities of 
C12ELPsolution and GNR-C12ELP dispersion were monitored at 800 nm and at 
λmax of GNR, respectively, as a function of time and CTAB concentration. The 
temperature, which increased from 4 to ~37°Cin a nonlinear fashion, was 
monitored as a function of time using a FLUKE 54 II (Type K) thermometer 
throughout the incubation period (Note: the solution temperature, remained 
steady in the range of 35 ± 2°Cafter 30 minutes). 
 
6.2.8Modeling Phase Transition and Nanocomposite Formation Kinetics 
A double-exponential model, described previously in the literature239, was used to 
fit the optical density curve of the phase separation process leading to 
nanocomposite formation in Matlab (The MathWorks, Natick MA). The model 
was used mainly to compare nanocomposite formation under the different 
conditions employed. 
 (7) 
In this model, y and y0 represent the optical densities at t and t close to ∞, 
respectively. Coacervation and maturation constants were indicated by kc and km, 
respectively, while a and bare proportionality factors. In this model, the velocity of 
coacervation, Vc is defined as a*kc and the velocity of maturation, Vm, is defined 
as b*km.  
 
6.2.9Photothermal Properties of Nanocomposites 
A titanium CW sapphire (Ti:S) laser (Spectra-Physics, Tsunami) pumped by a 
solid-state laser (Spectra-Physics, Millennia) was used in order to investigate the 
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photothermal properties of the nanocomposites prepared under different 
conditions. The excitation source was tuned to overlap with the longitudinal 
maxima of the nanocomposites. A GNR-C12ELP nanocomposite film was placed 
at the bottom of a 24-well plate (Corning) and covered with 500 μl of 1X PBS as 
the supernatant. Laser light (20 W/cm2) was focused at the center of the 
nanocomposite for 15 min. The supernatant temperature was monitored by 
FLUKE 54 II (Type K) thermocouple as a function of time during laser exposure. 
Laser irradiation of 1X PBS solution in a 24-well plate in the absence of the 
nanocomposite film was used as control; temperature remained invariant at 24± 
0.5°C after 15 min laser exposure. 
 
6.2.9 Dissolution of GNR-C12ELP Nanocomposite 
For dissolution experiments, the PBS supernatants were removed from individual 
GNR-C12ELP nanocomposites and replaced with equivalent volumes of 10 mM 
dithiothreitol (DTT) solution for 30 minutes at 4°C, following which, absorbance 
spectra were determined as a function of time in order to investigate dissolution 
kinetics. Detailed dissolution kinetics of GNR-C12ELP nanocomposites were 
investigated using three different DTT concentrations (1, 5, 10 mM). In this 
experiment, the PBS supernatants were removed from individual GNR-C12ELP 
nanocomposites and replaced with equivalent volumes a reducing agent, 
dithiothreitol (DTT); the supernatant optical density was monitor using plate 
reader at a fixed wavelength (in this case, the λmax of the GNR spectrum) for 2 
hours at 4°C. The dissolution percentage was calculated based on the initial, final 
and real-time measurement values of OD. 
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6.2.10Fourier Transform Infrared (FT-IR) Spectroscopy 
Gold nanorods and C8ELP and C12ELP-based nanocomposites were loaded on a 
germanium attenuated total reflectance (GATR) crystal such that they covered 
the central area of the crystal. The sample chamber was equilibrated to 
approximately 4 mbar pressure in order to minimize the interference of 
atmospheric moisture and CO2. The absorption spectrum was measured 
between 650 and 4,000 cm-1 using a Bruker IFS 66 v/S FT-IR spectrometer and 
the background spectrum was subtracted from all sample spectra as described 
previously.165 
 
6.2.10 Field-Emission Scanning Electron microscopy (SEM) 
SEM samples were prepared by placing GNR-C12ELP nanocomposites on a flat 
alumina substrate. The nanocomposite on the substrate was allowed to dry out in 
open laboratory atmosphere. SEM images were obtained with an environmental 
field-emission SEM (PHILIPS FEI XL-30 SEM) operating an accelerating voltage 
of 25 kV, and several magnifications between 2500 and 20,000 X. 
 
(NOTE: Nanocomposite formation kinetics study was carried out usingGNR-
C12ELP nanoassemblies; dissolution study and material characterization was 
investigated using both GNR-C8ELP and GNR-C12ELP) 
 
6.3 Results and Discussion 
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In this study, I investigated factors that influenced the formation of GNR-C12ELP 
nanocomposites, with an eye towards gaining a better understanding and control 
of the formation of these novel environmentally responsive materials. Schematics 
depicting the individual components (GNR and CTAB), GNR-ELP 
nanoassemblies in dispersion and solid-phase nanocomposites are shown in 
Figure 36. The presence of CTAB is critical for GNR formation and for 
maintaining GNR stability in aqueous media, although appropriate surface 
modification strategies can be employed instead of CTAB in order to maintain the 
stability of GNRs once formed51,240,241. Due to this key role, the effects of CTAB 
on the transition temperature of C12ELP and formation of GNR-C12ELP 
nanocomposites were first investigated. The role of GNR concentration on the 
formation of the nanocomposites was also studied. 
 
 
Figure 36.Schematic of the different processes involved in formation of solid-
phase ELP-GNR nanocomposites. 
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The concentration of free CTAB molecules was controlled as described in the 
experimental section. (B) Cysteine-containing elastin-like polypeptides (CnELPs; 
n=12 in the polypeptide repeat sequence) were self-assembled on GNRs via 
gold-thiol bonds, leading to the formation of GNR-ELP nanoassemblies as liquid-
phase dispersions. Presence of high concentration of free CTAB molecules (> 
2mM) can inhibit the self-assembly of ELPs onto GNRs. (C) Increasing the 
dispersion temperature of ELP-GNR nanoassemblies above its characteristic Tt 
resulted in the formation of ELP-GNR aggregates due to coacervation, leading to 
increase in turbidity. (D) Coalescence of the GNR-ELP aggregates resulted in 
decreased turbidity and leading to formation of solid-phase nanocomposite in a 
process termed maturation. (E) Precipitation of these coalesced aggregates led 
to the formation of solid-phase nanocomposites. 
 
6.3.1 Effect of CTAB on Transition Temperature of C12ELP Solutions 
C12ELP,in the absence of CTAB, demonstrated a transition temperature (Tt) 
at30.4±0.3°C (Figure 37), which was similar to our previous observations238.The 
transition temperature (Tt) of the free C12ELPunderwent a slight decrease 
(2.64±0.3°C; p-value <0.001) as the CTAB concentration in solution increased 
from 0 to 0.5 mM, but began to increase significantly at higher CTAB 
concentrations (≥2 mM)(Figure 38 A). In our hands, the critical micelle 
concentration (CMC) of CTAB at room temperature in 0.5XPBS solution (salt 
concentration ~75 mM)was determined to be 0.1 mM (Figure 39). This is close to 
previously observed values242,243 and indicates that all CTAB concentrations in 
the current study were above the CMC of the surfactant. 
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Figure 37.Temperature-dependent phase transition of C12ELP 
C12ELP phase transition measured by the change in optical density at 800 nm 
(OD800) indicates a transition temperature (Tt) of 30.4°C (representative plot from 
n=4) in the absence of CTAB. The Tt is defined as the temperature where the 
turbidity (optical density) reaches 50% of the maximum value. The line 
connecting the data points is included only to aid visualization of data. 
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Figure 38.Transition temperatures of C12ELP and GNR-C12ELP 
nanoassemblies. 
(A) Transition temperatures (Tt) of C12ELP as a function of CTAB concentration. 
The Tt of C12ELP increased significantly for CTAB concentrations>2 mM. (B) 
Transition temperature (Tt) of GNR-C12ELP nanoassemblies (dispersions) as a 
function of CTAB concentration. Increase in Tt of nanoassemblies is significant 
for higher concentration of CTAB (> 2mM). (C)Tt of GNR-C12ELP dispersion 
plotted as a function of GNR concentration suggest that the nanorods have 
minimal influence on the Tt of GNR-C12ELP nanoassemblies.(D) Comparison of 
transition temperatures of GNR-C12ELP andC12ELPat different CTAB 
concentrations. The data points fall along the solid y = x diagonal line (for 
visualization), indicating that transition temperatures of GNR-C12ELP 
nanoassemblies followed similar trends to those observed in case of free C12ELP 
solutions (i.e. in the absence of GNRs). 
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Figure 39.Critical micelle concentration (CMC) of CTAB in 0.5 X PBS (~ 75 mM 
salt concentration). 
CMC was determined to be approximately 0.1 mM using a tensiometer 
(BiolinScientific, Sigma/701). 
 
The initial modest depression of the Tt at low CTAB concentrations is presumably 
due to the hydrophobic interaction between CTAB and C12ELP leading to salting 
out of the polypeptide, which is similar to previous observations205.The increase 
in transition temperature at higher CTAB concentrations is presumably due to 
surfactant-polypeptide interactions, which, in concert with the electrostatic 
repulsion between the CTAB cationic head groups from the C12ELP-bound 
micelles, reduce the propensity of ELP molecules to aggregate and 
coacervate205,244.  
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C12ELPs were first self-assembled on GNRs at 4°C (<Tt of C12ELP) by means of 
gold-thiol bonds (Figure 36 A and 36B). A red-shift of approximately 10 nm was 
observed in the maximal absorbance peak, which indicated the formation of 
GNR-C12ELP nanoassemblies (colloidal dispersions)237,245(Figure 40). Up to 90% 
of the initial C12ELP was bound to GNRs under low CTAB concentrations (e.g. 
0.25 mM). However, high CTAB concentrations inhibited the binding of C12ELP to 
GNRs (Figure 41).Thus, in presence of higher CTAB concentrations; the 
transition temperature of GNR-C12ELP nanoassemblies is an ensemble property 
of both, bound and unbound C12ELP. 
 
 
Figure 40.Absorbance spectra of GNR dispersion, GNR-C12ELP nanoassemblies 
and GNR-C12ELP nanocomposite. 
Arrows indicated the maximal absorbance peak. GNR (19 µg/mL) dispersion was 
mixed with C12ELP (1 mg/mL) overnight at 4°C (CTAB at 0.25 mM), then 
subjected to 37°C incubation for 4 h to allow GNR-C12ELP nanocomposite 
formation. A 10 nm red-shift in the maximal absorbance peak, is an indicator of 
the self-assembly of C12ELP on GNR dispersion. 
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Figure 41.Binding of C12ELP to GNRs. 
(A) Loading of C12ELP on GNRs. Aliquots of GNR (19µg/mL) samples were 
mixed with different amount of C12ELP (0-1700 μg/mL) overnight (CTAB at 0.25 
mM), the amounts of C12ELP conjugated on GNR were determined using BCA 
protein assay. (B) Loading of C12ELPas a function of CTAB concentration. 
Aliquots of GNR (19µg/mL) samples with various CTAB concentrations (0-2.5 
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mM) were mixed with C12ELP (~700 μg/mL) overnight, the percentages of 
C12ELP conjugated on GNR were determined using BCA protein assay. 
 
Two sets of experiments were performed to investigate the influence of CTAB 
and GNR concentrations on the transition temperature ofGNR-
C12ELPdispersions. First, the transition temperature of GNR-
C12ELPnanoassemblieswas determined as a function of CTAB concentration at a 
fixed concentration of C12ELP (0.023 mM) and GNRs (0.24 mM) (Figure 
38B).Higher concentrations of CTAB (>2mM) resulted in significant increase in 
the transition temperature of the nanoassemblies. This is presumably since 
higher CTAB concentrations impeded the temperature-induced aggregation and 
collapse of C12ELP. 
 
Secondly, the effect of GNR concentration on the transition temperature of the 
GNR-C12ELPnanoassemblieswas also studied. In this study, both CTAB (0.25 
mM or 1 mM) and C12ELP (0.023 mM) concentrations were held constant, while 
GNR concentrations were varied from0.05-1.45 mM. Changes in GNR 
concentration did not influence the transition temperature of GNR-
C12ELPdispersions (Figure 38C), indicating minimal effect of GNRs under these 
conditions. 
 
These studies demonstrated that CTAB-dependent transition temperatures of 
GNR-C12ELPnanoassemblies followed similar trends to those observed in case 
of free C12ELPsolutions (i.e. not immobilized on GNRs), as shown by the data in 
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Figure 38D, most of which lie close to the y=x line. This may be expected since 
the transition temperature is a property of the polypeptide and not that of GNRs. 
 
6.3.3.Phase Separation of GNR-C12ELPNanoassemblies Leading to 
Nanocomposite Formation: Effect of CTAB Concentration 
Incubating CTAB-containing gold nanorods and cysteine-containing ELPs below 
the transition temperature of the polypeptide resulted in the formation of well-
dispersed nanoassemblies. However, incubation at temperatures above Tt 
results in temperature-triggered, entropy-dominated phase transition of 
C12ELP204,221, which, in concert with GNR-thiol and intra-and inter-molecular 
cysteine-cysteine cross-linking, resulted in the formation of maroon-colored 
plasmonic nanocomposites(Figure 42A-E).The colored appearance is due to 
surface plasmon resonance of gold nanorods as described previously238.An 
average red-shift of 36±11 nm was observed in the maximal absorbance peak 
indicating further change in local refractive index environment upon 
nanocomposite formation(Figure 40).  
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Figure 42.Optical images of solid-phase nanocomposites formed by the phase 
separation of GNR-C12ELP dispersions at different CTAB concentrations and 
temperatures. 
(A) 0.25 mM (37°C), (B) 1 mM (37°C), (C) 1.5 mM (37°C), (D) 2 mM (60°C) and 
(E) 2.5 mM (60°C) with fixed C12ELP (0.023 mM) and GNR (0.24 mM) 
concentrations. Image (F) and (G) are phase contrast microscopy images of 
GNR-C12ELP nanocomposite (0.25 mM CTAB concentration) and C12ELP 
coacervates, corresponding to the digital snapshots in image (H).Incubation of 
GNR-C12ELP nanoassemblies above their characteristic Tt results in the 
formation of crosslinked, stable maroon-colored nanocomposites. Incubation of 
C12ELP alone above its characteristic Tt resulted in coacervate formation. 
 
The effect of CTAB concentration on formation of nanocomposites was studied 
using optical methods. In these studies, the concentrations of both, GNR (0.24 
mM) and C12ELP (0.023 mM), were held constant, while CTAB concentration in 
the system varied from 0.25 to 3 mM. Reproducible formation of maroon-colored 
nanocomposites was observed in cases where the CTAB concentration was less 
than 1.5 mM (Figures 42A, 42B and 42C). 
 
The optical density of the GNR-C12ELP dispersion (nanoassemblies) was 
monitored at λmax (780 nm) of GNRs (different shaped markers in Figure 4) in 
order to investigate the kinetics of nanocomposite formation. The red dotted line 
in Figure 4indicates the temperature profile of the dispersion. In this system, 
increase in optical density is typically due to the aggregation and therefore, local 
 122 
enrichment, of ELP or ELP-GNR nanoassemblies, in a process known as 
coacervation. These coacervates consist of enriched GNR-C12ELP aggregates 
dispersed throughout the aqueous phase (Figure 36C).  Decrease in optical 
density can be due to (i) coalescence of coacervates into large droplets leading 
to decreased scattering as part of maturation of coacervates, or (ii) loss in GNR 
colloidal stability51. 
 
At 4°C (t= 0), all GNR-C12ELP nanoassemblies in dispersions have the same 
optical density (~0.3), indicating that all dispersions had the same GNR 
concentration (0.24 mM). No phase changes occurred at this temperature 
(<Tt).Upon increase in temperature with time, GNR-C12ELP nanoassemblies 
underwent a slight decrease in optical density (~0.04±0.02) in the first ten 
minutes for CTAB concentrations between 0.25 and 1.5 mM (Figure 43A). This 
minimal decrease in optical density may be explained by loss of colloidal stability 
of a portion of GNRs following structural changes in C12ELP upon temperature 
change. ELPs can help stabilize GNR dispersions at 4oC, but as the temperature 
is increased, aggregation of ELPs can lead to loss of stability of a portion of 
GNRs. However, further aggregation of ELPs results in formation of coacervates, 
a process characterized by increase in O.D. Increasing the CTAB concentration 
results in delay in the increase of the O.D. (or onset of coacervation). This is 
consistent with the propensity of CTAB to inhibit the formation of GNR-C12ELP 
assemblies and increase the Tt, all of which contribute to delayed coacervation. 
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Figure 43.Kinetics of formation of GNR-C12ELP solid-phase nanocomposites 
from liquid-phase nanoassemblies as a function of CTAB concentration. 
(A) 0.25 - 1.5 mM CTAB, (B) 2-3 mM CTAB. GNR (0.24 mM) and C12ELP (0.023 
mM) concentrations were kept constant in all cases. Open markers indicate 
measured optical densities at 780 nm (OD780). Solid lines represent the 
mathematical fit (equation 7) of experimental optical density data, while the red 
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dotted line represents the dispersion temperature profile. Nanoassemblies with 
CTAB concentration between 0.25 and 1.5 mM underwent an initial rapid rise 
(coacervation) followed by a gradual decrease (maturation) in turbidity. The 
temperature varied during the coacervation stage, and optical density increases 
were observed between ~28-37oC. The temperature was largely invariant during 
the maturation and precipitation stage. Negligible phase separation of 
nanoassemblies was observed at CTAB concentration between 2 and 3 mM. In 
the figure legend, (CTAB) indicates concentration of CTAB. 
 
The initial decrease in optical density is followed by the coacervation stage, 
which is characterized by a rapid increase in optical density. As the CTAB 
concentration in GNR-C12ELP dispersion increased from 0.5 to 1.5 mM, the 
onset of coacervation was delayed from 5 min to 10 min, and the maximal optical 
density was lowered from 0.92 to 0.45. This indicated that lower amounts of 
GNR-C12ELP nanoassemblies underwent phase separation at higher CTAB 
concentrations. This decrease in the maximal optical density of the curve can, in 
part, be explained by the inhibition of C12ELP binding to gold nanorods at higher 
CTAB concentrations(Figure 41).The final maturation stage corresponds to a 
steady decrease in optical density, due to increase in size of the coacervates 
(Figure 1D). Eventually, precipitation of these leads to the formation of solid-
phase nanocomposites (Figure 42A-C). 
 
The formation of extensively cross-linked GNR-C12ELPnanocomposites differs 
from conventionally observed ELP aggregation (coacervation) and maturation 
(coalescence of coacervates into droplets), which is typically reversible in the 
coacervation stage and forms precipitates only upon extended (e.g. overnight) 
heating246,247.Optical microscopy (Figure42F) showed uniform and extensive 
cross-linking of GNR-C12ELPnanocomposites; these materials are stable at 4°C 
 125 
for more than one year. On the other hand, C12ELP,in the absence of GNRs, 
formed small precipitate droplets(Figure 42G) held together primarily by 
hydrophobic interactions. These precipitate droplets were easily dissolved and 
washed away in aqueous solutions(PBS) at low temperatures (4°C). 
 
In presence of higher CTAB concentrations(2.5 and 3 mM), GNR-
C12ELPnanoassembliesdid not form solid-phase nanocomposites at 37°C (data 
not shown), which is due to the higher transition temperature of the 
nanoassemblies (≥50°C) (Figure 38B). However, violet-colored nanocomposites 
were formed at 60°C, which was higher than the transition temperature under 
these CTAB concentrations (Figure 42D and 42E). The color shift from maroon to 
violet is presumably due to the surface plasmon coupling of aggregated gold 
nanorods34, which resulted in decrease of the maximal absorbance peak due to 
loss of optical properties51(Figure 44).These observations support the 
photothermal responses of these nanocomposites;C12ELP–GNR 
nanocomposites formed at higher CTAB concentrations(2.5 and 3 mM) 
demonstrated less pronounced thermal responses upon laser irradiation 
compared to nanocomposites formed at low CTAB concentrations (0.25, 1, 1.5 
mM), even though the GNR concentrations were same in all cases(Figure 45). In 
presence of CTAB concentrations of 3 mM or more,GNR-C12ELP 
nanoassemblies showed no change in optical density at 37oC (Figure 43B), 
indicating that the nanoassemblies remained stable as dispersions due to 
sufficient amount of the stabilizing surfactant (CTAB). 
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Figure 44.Absorbance spectra of nanocomposites formed using C12ELP -GNR 
dispersion at various CTAB concentrations. 
GNR-C12ELP dispersions containing 1 and 1.5 mM CTAB were incubated at 
37°C for 4 h to allow formation of nanocomposites (solid lines). GNR-C12ELP 
dispersions containing 2 mM CTAB were incubated at 60°C for 4 h to allow 
formation of nanocomposites (dotted line). Note that a slight difference in 
thickness of each nanocomposite can result in changes in the intensity of optical 
density. Thus, the spectra of nanocomposites were normalized to posses same 
the optical density value at 400 nm for better comparison. 
 
 
Figure 45.Photothermal responses of C12-ELP GNR nanocomposites. 
Nanocomposites formed from dispersions at different CTAB concentrations and 
temperatures (A) 0.25 mM (37°C), (B) 1 mM (37°C), (C) 1.5 mM (37°C), (D) 2 
mM (60°C) and (E) 2.5 mM (60°C). Nanocomposites were exposed to laser at 20 
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W/cm2 for 15 min; the supernatant temperature was recorded as a function of 
time (n=4). Less pronounced photothermal responses were observed in 
nanocomposites formed at higher CTAB concentrations (2.5 and 3 mM). 
 
The above results indicate that three distinct phenomena could be observed 
following incubation of GNR-C12ELP nanoassemblies at 37°C (>Tt). First, at 
CTAB concentrations between 0.25 and 1.5 mM, phase separation of the 
nanoassemblies led to nanocomposite formation at 37oC. Second, at CTAB 
concentrations from 2 to 2.5 mM, minimal phase separation of nanoassemblies 
took place, and no formation of nanocomposites was observed. This CTAB 
concentration range may be viewed as a ‘transition’ region in which case, 
nanocomposite formation was observed at higher temperatures (60oC), which 
was a direct influence of CTAB on the transition temperatures of both, C12ELP 
solutions (Figure 38A) and GNR-C12ELP nanoassemblies (Figure 38B). Third, at 
CTAB concentrations of 3 mM and higher, the nanoassemblies did not undergo 
phase separation, showed no change in GNR optical density, demonstrated 
stable dispersions, and no nanocomposite formation was observed.  
 
6.3.4. Mathematical Analyses of GNR-C12ELP Nanocomposite Formation: 
Effect of CTAB Concentration 
The effect of CTAB concentration on the formation of C12ELP-GNR 
nanocomposites was further studied using a double-exponential kinetic model 
(equation 7) previously described in the literature for investigating aggregation 
and coacervation kinetics of ELP239. The model was employed to fit the observed 
optical density data in order to primarily enable a quantitative comparative study 
between different processing conditions employed (e.g. different CTAB 
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concentrations). Our data on the kinetics of formation of GNR-ELP 
nanocomposites qualitatively mirror coacervation and maturation observed 
previously for ELP alone (i.e. in the absence of GNRs)239. As a result, the double-
exponential model was considered relevant for investigating GNR-C12ELP 
nanocomposite formation. 
 
The double-exponential model (equation 7) may be viewed as a solution to first 
order consecutive reactions consisting of ELP dispersion Æ ELP aggregates 
Æcoalescence of ELP aggregates/nanocomposite formation, in which, optical 
density is a surrogate for the concentration of aggregates. The first step, ELP 
dispersion Æ ELP aggregates, is the coacervation step associated with the 
coacervation constant (kc),whereas the second step, ELP aggregates 
Æcoalescence of ELP aggregates/nanocomposite formation, is the 
maturation/precipitation associated with the maturation constant (km). Given that 
the temperature varies from ~28-37°C during the coacervation stage, viewing the 
double-exponential model purely as a first-order rate model is not strictly valid. 
However, since the temperature remains largely invariant over the course of the 
maturation stage, it may be possible to view this portion in terms of a kinetic rate 
model. Given these limitations, the derived parameters, although similar to first-
order rate constants, were used primarily for comparing different processing 
conditions in the current study.   
 
The double-exponential model, employed to fit the optical density measurements 
in Figure 38A (solid lines), provided means to follow the overall phase separation 
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process as an initial coacervation (exponential growth in optical density) phase 
and a subsequent maturation phase (exponential decay in optical density). The 
growth and decay constants, with units of 1/time, can represent coacervation and 
maturation constants, (kc and km) respectively. Constants (kc and km), in concert 
with their concentration proportionality factors (a and b),were employed to 
calculate the coacervation velocity (Vc=akc) and maturation velocity (Vm=bkm), 
respectively, as defined previously239. Based on the maximum optical density and 
the shape of the curve, the mathematical model allowed derivation of the relative 
constants of the coacervation and maturation processes for comparison between 
different processing conditions. These derived parameters were used to compare 
the effects of CTAB and GNR during GNR-C12ELP phase separation leading to 
nanocomposite formation. In all cases, the coefficient of determination (R2) 
values were greater than 0.98, with most being higher than 0.99.The 
coacervation and maturation velocities of nanocomposite formation ranged from 
~0.1-3.8 and ~0.02-0.1 (OD/min) respectively. These are similar to those 
reported in the literature for other ELPs (in the absence of GNRs); while Vc 
ranged between 0.6-4 (absorbance/min) and Vm ranged between 0.025-0.6 
(absorbance/min)239. 
 
Analyses of the coacervation constant and velocity from the model indicated that 
the presence of CTAB has a potent effect on the coacervation constant and 
velocity of coacervation of GNR-C12ELP nanocomposites, but less effect on the 
maturation stage (Figure 46). This is similar to the effect of CTAB on C12ELP 
coacervation in the absence of GNRs (Figure 47A). The coacervation constant 
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(kc) and velocity (Vc) decreased as the CTAB concentration rose from 0.25 to 1.5 
mM. This is similar to the behavior of unbound C12ELP (Figure 47B and 47C), 
except in case of 0.5 mM CTAB, which showed the highest value of the 
coacervation constant. Interestingly, presence of 0.5 mM CTAB also resulted in 
the lowest transition temperature of C12ELP (Figure 38A). As CTAB 
concentration increased from 0.5 to 2 mM in C12ELP solutions, a decrease in Vc 
was observed, which corresponded to the slight increase of Tt of GNR-C12ELP 
(Figure 38B). Overall, in case of both, GNR-C12ELP and C12ELP, the 
coacervation constant (kc) and velocity (Vc) values were reduced at higher CTAB 
concentration.  
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Figure 46.Analyses of GNR-C12ELP coacervation and maturation kinetics as a 
function of CTAB concentration. 
(A) GNR-C12ELP coacervation constant (kc) and maturation constant (km) as a 
function of CTAB concentration. (B) GNR-C12ELP coacervation velocity (Vc) and 
(C) GNR-C12ELP maturation velocity (Vm) as a function of CTAB concentration. 
Coacervation constant (kc) and velocity (Vc) of GNR-C12ELP were reduced at 
higher CTAB concentration where the aggregation of GNR-C12ELP was inhibited. 
On the other hand, CTAB has minimum effect on the maturation constant (km) 
and velocity (Vm). 
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Figure 47.Formation kinetics of C12ELP in presence of various CTAB 
concentrations. 
(A) Coacervation and maturation kinetics of C12ELP in presence of various CTAB 
concentrations (0-2 mM). Open markers indicated measured optical densities at 
800 nm (OD800). Red dotted line represents the temperature profile of the 
polypeptide solution. Solid lines are mathematical fits of the measured optical 
density using equation 7. Similar to figure 4A, the initial rise in turbidity, known as 
coacervation, is followed by the maturation stage, characterized by a steady 
decrease in turbidity. The OD800 data were fit in order to obtain: (B) C12ELP 
coacervation constant (kc)and maturation constant (km) as a function of CTAB 
concentration. (C) C12ELP coacervate velocity (Vc) and (D) C12ELP maturation 
velocity (Vm) as a function of CTAB concentration.  
 
Changing CTAB concentration from 0.25 to 1.5 mM did not affect the maturation 
constant (km) and velocity (Vm) in case of both GNR-C12ELP nanocomposites as 
well as C12ELP coacervates (Figures 46C and 47D). These data suggest that 
higher CTAB amounts inhibit the initial coacervation of GNR-C12ELP and C12ELP, 
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partly by reducing loading of the polypeptide on GNRs, and partly by enhancing 
the transition temperature. However, once the coacervates are formed, CTAB 
does not affect their subsequent coalescence and maturation, which ultimately 
leads to nanocomposite formation. This is consistent with previous observations 
which indicate that the maturation step is primarily a diffusion-limited process239.  
  
In addition to obtaining quantitative information on phase separation processes, 
the model was employed for comparing nanocomposite formation under different 
conditions. For the same CTAB concentration, it was found that both, the 
constants and velocity of coacervation and maturation, as determined from the 
double-exponential model, were higher for GNR-C12ELPs compared to C12ELP 
(Figure 48). As seen in the figure, GNRs only slightly increased the velocity of 
coacervation Vc, but significantly enhanced the velocity of maturation Vm. It is 
possible that the initial coacervation phase is dominated by C12ELP interactions, 
and that the density and surface area of gold nanorods play a key role in 
enhancing contact between coacervates, leading to their maturation and 
precipitation. The presence of gold nanorods therefore facilitates inter- and intra-
molecular cross-linking of GNR-C12ELP nanoassemblies, which results in higher 
coacervation and maturation velocities, albeit the effect on maturation is 
significantly higher. 
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Figure 48. Comparison of model derived parameters. 
Comparison of (A) coacervation constant (kc), (B) maturation constant (km), (C) 
velocity of coacervation (Vc) and (D) velocity of maturation (Vm) for C12ELP 
solution (y-axis) and GNR-C12ELP dispersion (x-axis) at different CTAB 
concentrations. In all cases, GNR and C12ELP concentrations were fixed at 0.24 
and 0.023mM, respectively, while the CTAB concentration varied from 0.5 to 1 
mM. All points fall below the y=x line(except one point which is on the y=x line), 
indicating that phase separation processes (coacervation and maturation) 
proceed faster in the case of GNR-C12ELP dispersions compared to the C12ELP 
system. 
 
Taken together, comparing the model parameters across different conditions 
indicate that the coacervation process is dominated by ELP and CTAB 
interactions, while GNRs play a more important role in the maturation and 
precipitation, leading to nanocomposite formation. 
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The predictive ability of the model was investigated by determining the 
coacervation velocity of C12ELP in presence of0.8 mM CTAB. The coacervation 
velocity (Vc) of C12ELP at CTAB concentrations of 0.5, 1, 1.5 and 2 (Figure 47C) 
were plotted and the data were fit using a polynomial model as shown in 
Supplementary Figure 6A. Based on this regression, the ELP coacervation 
velocity at a CTAB concentration of 0.8 mM was predicted to be 0.56 (O.D./min). 
The coacervation velocity for C12ELP at 0.8 mM CTAB was also determined 
experimentally using the spectrophotometric assay in concert with the double-
exponential model (Supplementary Figure 46B). The experimentally determined 
value of Vc was 0.6 OD/min while the predicted value was 0.56 OD/min, 
indicating a difference of only 7%. These data demonstrate the ability of the 
model to successfully predict the phase separation under different experimental 
conditions, leading to formation for C12ELP coacervates as well as GNR-C12ELP 
nanocomposites. 
 
6.3.5. Phase Separation of GNR-C12ELP Nanoassemblies Leading to 
Nanocomposite Formation: Effect of GNR Concentration 
The effect of GNR concentration on nanocomposite formation of GNR-C12ELP 
dispersions was also studied. In the study, both CTAB (0.25 mM) and C12ELP 
(0.023 mM) concentrations were held constant, while GNR concentrations varied 
from 0.1 to 1 mM. The optical density of GNR-C12ELP dispersions at λmax of 
nanorod (780 nm) was monitored using a spectrophotometer. The different data 
points in Figure 9A indicate the GNR-C12ELP dispersion optical density at 780 
nm, while the red dotted line is the dispersion temperature profile.  
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At t= 0 and 4°C, GNR-C12ELP nanoassemblies have different optical densities 
that corresponded to different GNR concentrations. Prior to coacervation, seven 
minutes after incubation, a slight decrease in optical density (~0.03) was 
observed at 0.24 mM GNR concentration, while a more pronounced decrease in 
optical density (0.26± 0.01) was seen at higher GNR concentrations (0.72 and 1 
mM) (Figure 49A). This decrease in optical density was possibly due loss in 
stability of a portion of GNRs upon increase in temperature, presumably due to 
initiation of ELP phase change. All samples followed similar coacervation and 
maturation trend once the characteristic Tt was reached. A maximal optical 
density was reached at approximately 13±1 minutes for all conditions, and the 
intensity of the maximal optical density rose as the nanorod concentration 
increased. 
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Figure 49.Formation kinetics of GNR-C12ELPas a function of GNR concentration 
(0.1 to 1 mM). 
(A) Coacervation and maturation kinetics of GNR-C12ELP as a function of GNR 
concentration (0.1 to 1 mM). CTAB (0.25 mM) and C12ELP (0.023 mM) were kept 
constant. Open markers indicated measured optical densities at 780 nm (OD780) 
and solid lines are mathematical fits of the data generated using equation 7. The 
red dotted line represents the dispersion temperature profile. Analyses of GNR-
C12ELP coacervation and maturation kinetics as a function of GNR concentration 
are shown:(B) GNR-C12ELP coacervation constant (kc)and maturation constant 
(km) as a function of GNR concentration. (C) GNR-C12ELP coacervate velocity 
(Vc) and (D) GNR-C12ELP maturation velocity (Vm) as a function of GNR 
concentration. CTAB and C12ELP concentrations were kept constant. Increase of 
GNR concentration did not alter the coacervation or maturation constants. 
 
Unlike CTAB, increase of gold nanorod concentration did not alter the 
coacervation constant (kc= 0.28±0.01) or maturation constant (km= 0.055±0.005) 
of GNR-C12ELP nanocomposites(Figure 49B); in all cases the exponential growth 
and decay curves followed a similar trend. In Figure 9C and 9D, the coacervation 
and maturation velocity (Vc and Vm) of GNR-C12ELP dispersions at low nanorod 
concentrations (0, 0.05 and 0.1mM) were found to be similar (2.1±0.1 /min and 
0.067±0.009 /min, respectively). A slight increase in the coacervation and 
maturation velocity (Vc and Vm) was observed at high nanorod concentrations 
(0.24, 0.72 and 1 mM), which could be attributed to higher optical densities. 
These results indicated that gold nanorod content had minimal affect on the 
phase transition of GNR-C12ELP dispersions under the conditions studied. 
 
6.3.6 Dissolution Kinetics of Nanocomposites 
Reduction of disulfide bonds using 10 mM dithiothreitol (DTT) led to the 
degradation of the nanocomposites within minutes (Figure 50C). While GNE-ELP 
nanocomposites were stable in the absence of DTT, nanocomposites completely 
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degraded upon addition of the reducing agent (Figure 50). The absorbance 
spectra indicated complete recovery of the gold nanorods in the dispersion, as 
evidenced by the recovery of the transverse and longitudinal peaks at 520 nm 
and 840 nm, respectively (data not shown). The dissolution kinetics of GNR-
C8ELP and GNR-C12ELP nanocomposites were investigated at three different 
DTT concentrations (1, 5, 10 mM) as shown in Figure 50C. Nanocomposites 
were fully dissolved after 15 minutes at a DTT concentration of 10 mM, while it 
took one hour to fully dissolve nanocomposites with 1 mM DTT. 
 
 
 
Figure 50.Dissolution of nanocomposites using DTT. 
Digital snapshots of C8ELP-GNR and GNR-C12ELP nanocomposites in presence 
and absence of DTT.GNR-C8ELP, GNR-C12ELP nanocomposites were formed 
by incubation at 37°C for 6 h as described above, followed by cooling and 
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Field Emission-Scanning Electron Microscopy (FE-SEM) images showed that 
gold nanorods (~ 50 nm in length) were well dispersed in the nanocomposites 
(Figure 52), indicating the possibility that the nanocomposites possess stable 
plasmonic / photothermal properties.  
 
 
Figure 52.FE-SEM images of GNR-C8ELP and GNR-C12ELP nanocomposites. 
Environmental field-emission scanning electron microscopy (PHILIPS FEI XL-30 
SEM) operating an accelerating voltage of 25 kV) images indicate a fairly uniform 
distribution of gold nanorods throughout GNR-C8ELP and GNR-C12ELP 
nanocomposites. 
 
6.4. Conclusions 
This study describes an investigtion into the phase separation of cysteine-
containing elastin-like polypeptdie (C12ELP) self-assembled oncetyltrimethyl 
ammonium bromide (CTAB)-stabilized gold nanorods (GNRs), leading to 
nanocomposite formation. The following conclusions can be summarized.(1) 
Increase in CTAB concentration resulted in a rise of the transition temperature of 
both,C12ELP solution as well as GNR-C12ELP nanoassemblies. (2) At 37oC and 
at CTAB concentrations less than 1.5 mM, GNR-C12ELP 
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nanoassembliesunderwent phase separation resulting in extensively cross-linked 
nanocomposites, which demonstrated a reliable photothermal response. Higher 
CTAB concentrations (>2mM) inhibited the formation of these nanocomposites at 
37oC. (3) Unlike the concentration-dependent effects of CTAB, GNR content in 
GNR-C12ELP nanoassemblies has negligible effect on the transition temperature, 
coacervation and maturation kinetics, and ultimately, on nanocomposite 
formation. (4) Nanocomposites formed at lower CTAB concentrations and 
temperatures demonstrated a superior photothermal response compared to 
those generated using higher CTAB concentrations, which required higher 
temperatures for formation. These results indicate that it is important to keep the 
concentration of CTAB to a minimum while forming plasmonic nanocomposites 
for photothermal delivery of encapsulated drugs. Low CTAB concentrations 
facilitate straightforward formation of the composites, which also show more 
robust photothermal responses for simultaneous NIR radiation-triggered delivery 
of hyperthermia and encapsulated drugs. Taken together, the current study 
provides a fundamental understanding into factors influencing formation of 
photothermally active plasmonic nanocomposites, which can have applications in 
sensors, tissue engineering and regenerative medicine, and drug delivery.  
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CHAPTER 
7. Plasmonic Nanocomposite for Simultaneous Administration of 
Hyperthermia and Chemotherapeutic Drug to Cancer Cells 
 
7.1 Introduction 
Cancer diseases are among the leading causes of death in the United States and 
account for approximately 1 in every 4 deaths. Hyperthermia involves raising 
tissue temperature to 43-46oCto induce tumor ablation248and has been 
investigated as an adjunctive cancer therapy180. Cellular injury/death at 
temperatures above 43oC is attributed to protein denaturation triggered by these 
elevated temperatures.249,250 Consequently, microwaves and radio waves,251,252 
magnetic heating,253 or ultrasound254 have been employed for hyperthermic 
ablation of cancer cells.  
 
The ability to generate high temperatures at a desired site with externally tunable 
control holds significant promise for cancer therapy compared to whole-body 
hyperthermia. Nanomaterials localized at tumor vicinity can be subjected to laser 
irradiation from an external source, leading to the selective administration of the 
hyperthermic treatment.255 In addition to gold nanoshells256 and nanocages,257 
gold nanorods145,258,259 are attractive candidates for ablation of tumors. Recently, 
photothermolysis, strong NIR absorbance, and magnetic functionality were also 
demonstrated using 30 nm gold /iron oxide nanoclusters for application in 
combined imaging and therapy260.   
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However, resistance of cancer cells and spatial limitations associated with 
nanoparticle-induced hyperthermia necessitates the identification of effective 
combination treatments to enhance therapeutic efficacy. Sub-optimal 
administration of hyperthermia leads to thermotolerance in cancer cells, which is 
caused, in part, due to the induction of the heat shock response mediated by 
heat shock proteins (HSPs)261. In particular, HSPs 27, 72, and 90, play a 
significant role in enabling the survival of cancer cells to hyperthermic 
conditions262,263. In addition, spatial limitations and sub-optimal administration 
associated with hyperthermia can lead to selection of resistant tumor clones, 
which further complicates therapy. As a result, therapeutic strategies that can 
synergistically enhance the efficacy of hyperthermic ablation (e.g. by overcoming 
HSP resistance) can help advance the potential of this approach in cancer 
therapy. 
 
In this Chapter, GNR-C12ELP “plasmonic nanocomposites” demonstrate reliable 
photothermal responses due to the presence of gold nanorods within the 
polypeptide nanocomposite. Laser irradiation of the nanocomposite led to death 
of only those cancer cells directly in the path of the laser revealing spatial 
limitations associated with nanoparticle-induced hyperthermia. In order to 
simultaneously overcome spatial limitations and cancer cell resistance 
associated with nanoparticle-induced hyperthermia, the clinically relevant 
chemotherapeutic drug 17-demethoxy-17-allylaminogeldanamycin (17-AAG), an 
inhibitor of heat shock protein 90 (HSP90), 264,265, was incorporated in the 
nanocomposite. Laser irradiation of 17-AAG containing nanocomposites resulted 
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in hyperthermic temperatures which, in turn, induced the release of 17-AAG from 
the nanocomposite under these elevated temperatures. This resulted in the 
synergistic administration of both, hyperthermia and chemotherapy (17-AAG), 
resulting in death of the entire population of cancer cells, while ‘single treatments’ 
(i.e. hyperthermia alone and 17-AAG alone) demonstrated minimal (< 10%) loss 
of cancer cell viability.  
 
7.2 Material and Methods 
7.2.1 Materials 
Silver nitrate was purchased from Spectrum and dithiothreitol (DTT) was 
purchased from EMD. Cetyltrimethylammonium bromide (CTAB), 95 %, Sodium 
borohydride, powder, reagent grade, ≥ 98.5 %, gold (III) chloride trihydrate 
(HAuCl4·3H2O), 99.9+ %, L-ascorbic acid, reagent grade were purchased from 
Sigma. All materials were used as received without further purification. 
 
7.2.2 Gold Nanorod (GNR) Synthesis 
Gold nanorods were synthesized using the seed-mediated method as previously 
described in Chapter 6.2.2 for generating gold nanorods (GNRs) that possessed 
absorbance maxima (λmax) in the near infrared (NIR) region of the light absorption 
spectrum. 
 
7.2.3 Synthesis, Expression, and Purification of Cysteine containing 
Elastin-like Polypeptides (ELPs) 
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C12ELP were generated, expressed, purification lyophilized and stored at room 
temperature as described previously in Chapter 6.2.3. The Tt of C12ELP was 
characterized as described in Chapter 6.2.4. 
 
7.2.4 Generation of CnELP-GNR Nanoassemblies 
GNR- C12ELP nanoassemblies were prepared as following Chapter 6.2.5. 
 
7.2.5 Photothermal Properties of a GNR-C12ELP Nanocomposite Film 
GNR-C12ELP dispersion (750 µL of 1 mg/mL in 0.5X PBS; O.D. =0.25; 4°C) in 1 
mm diameter acrylic cell (home-made)was immediately incubated in 37°C, 5% 
CO2 environment for 3 hours, in order to allow nanocomposite formation on top of 
a tissue culture treated 1.5 mm diameter cover slip originally placed at the bottom 
of the acrylic cell. The supernatant was removed from the acrylic cell after 
incubation and the absorption spectrum of the GNR-C12ELP film was determined 
using a plate reader (Biotek Synergy 2) at room temperature. The spectrum of 
nanocomposite was measured between 300-999 nm five individual times.  
 
The photothermal properties of the nanocomposite were determined using 
irradiation with a titanium CW sapphire (Ti:S) laser (Spectra-Physics, Tsunami) 
pumped by a solid state laser (Spectra-Physics, Millennia). Briefly, the excitation 
source was tuned to 850 nm in order to coincide with the longitudinal absorption 
maximum of the GNR-C12ELP nanocomposite. GNR-C12ELP nanocomposite was 
placed at the bottom of a 24 well plate (Corning) with 500 μl of 1X PBS as the 
supernatant over the nanocomposite. The well was irradiated with laser light at 
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850 nm at power densities of 20 W/cm2 or 25 W/cm2 for 15 minutes and the 
dispersion temperature was monitored by FLUKE 54 II (Type K) thermocouple 
during laser exposure. Controls with only 500 μl of 1X PBS solution in 24 well 
plates (i.e. without GNR-C12ELP nanocomposite) were carried out; temperature 
remained invariant at 24 ± 0.5°C after 15 minutes laser exposure in this case. 
 
7.2.6 Formation of 17-demethoxy-17-allylaminogeldanamycin (17-AAG) 
Loaded GNR-C12ELP Nanocomposite Film (24 well plate) 
GNR-C12ELP dispersion (750 µL of 1 mg/mL, 0.5X PBS, O.D. = 0.25 at 4°C), 
containing 750 μg of 17-demethoxy-17-allylaminogeldanamycin (17-AAG) (LC 
Laboratories, MA) was placed in the 1 mm diameter acrylic cell, and immediately 
transferred to an incubator (37°C, 5 % CO2) for 3 hours, allowing phase 
separation and formation of 17-AAG loaded GNR-C12ELP (17AAG-GNR-C12ELP) 
nanocomposite on top of a tissue culture treated 1.5 mm diameter cover slip. 
While 6 hours were previously employed for generating C12ELP-GNR 
nanocomposites (without 17-AAG), analysis of nanocomposite formation kinetics 
indicated that three hours were sufficient to generate the nanocomposites. As a 
result, a three-hour incubation period was used for generating 17AAG-GNR-
C12ELP nanocomposites in order to reduce processing times. Following 
incubation, the supernatant, containing free 17-AAG molecules, was removed 
from the acrylic cell after 3 hours, and assayed for concentration using 
absorbance analysis. The amount of 17-AAG encapsulated in the nanocomposite 
was determined from a mass balance on the drug. Briefly, absorbance values of 
known concentrations of 17-AAG at 335 nm were employed to generate a 
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standard calibration curve. Following nanocomposite formation, the concentration 
of 17-AAG in the supernatant was then back-calculated based on the 
absorbance and the calibration curve. Since the initial amount of 17-AAG is 
known, the amount encapsulated in the nanocomposite was calculated as the 
difference of 17-AAG before and after encapsulation. The absorption spectrum of 
the 17-AAG encapsulated GNR-C12ELP nanocomposite was determined at room 
temperature using a plate reader (Biotek Synergy 2) with five individual 
measurements. A peak at 335 nm was used to detect encapsulation of the drug.  
 
7.2.7 Release of 17AAG from 17AAG-GNR-C12ELP Nanocomposites 
Drug (17-AAG)-loaded GNR-C12ELP nanocomposites were prepared as 
described above and placed in a 24 well plate with 500 μl of 1X PBS. The 
diffusion release of 17-AAG from the nanocomposite was monitored for 24 hours. 
The laser beam was tuned to 2 mm in diameter for all near infrared (NIR) 
irradiation-triggered drug release studies. The first laser irradiation lasted for 5 
min (850 nm, 25 W/cm2). Five subsequent laser irradiations (850 nm, 25 W/cm2) 
lasted for 10 minutes, followed by a 20 minute period without laser irradiation 
each. The temperature profile during the 10-minute laser exposure was 
monitored using a K-type thermocouple. 
 
7.2.8 Cell Culture 
The PC3-PSMA human prostate cancer cell line166 was a generous gift from Dr. 
Michel Sadelain of the Memorial Sloan Cancer Center, New York, NY. RPMI 
1640 with L-Glutamine and HEPES (RPMI-1640 medium), pen-strep solution: 
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10,000 units /mL penicillin and 10,000 μg/mL streptomycin in 0.85% NaCl, and 
fetal bovine serum (FBS) were purchased from Hyclone. Serum-free medium 
(SFM) is RPMI-1640 medium plus 1 % antibiotics. Serum-containing medium is 
SFM plus 10 % FBS. Cells were cultured in a 5 % CO2 incubator at 37oC using 
RPMI-1640 medium containing 10 % heat-inactivated fetal bovine serum (FBS) 
and 1 % antibiotics (10,000 units/mL penicillin G and 10,000 μg/mL 
streptomycin). 
 
7.2.9 Cell Culture and Laser Irradiation on GNR-C12ELP Nanocomposites 
GNR-C12ELP and 17AAG-GNR-C12ELP nanocomposites on tissue culture 
cover slips were prepared as described previously. Prior to cell culture, the 
nanocomposites were pre-treated with 500 µl serum containing media in a 24 cell 
culture well plate (Corning) overnight in order to promote cell attachment. The 
serum-containing media was removed after incubation and the nanocomposite-
coated cover slips were washed twice with fresh serum-containing media. PC3-
PSMA human prostate cancer cells were seeded on top of the nanocomposites 
in several wells with a density of 150,000 cells/well and allowed to attach for 24 
hours at 37°C, in a 5 % CO2 incubator. For the laser irradiation experiment, the 
excitation source was tuned to 850 nm in order to coincide with the longitudinal 
absorption maximum of the GNR-C12ELP nanocomposite. Nanocomposites with 
PC3-PSMA cells were exposed to laser irradiation at 850 nm at a power density 
of 25 W/cm2 for 7 minutes (no laser exposure for the control samples). The 
solution temperature was monitored by a FLUKE 54 II (Type K) thermocouple 
during laser exposure. Fluorescence-based Live/dead® assay was employed to 
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investigate cancer cell viability 24 hours after laser irradiation. Briefly, cells were 
treated with 4 μM ethidium homodimer-1 (EthD-1; Invitrogen) and 2 μM calcein 
AM (Invitrogen) for 30 minutes and imaged using Zeiss AxioObserver D1 
inverted microscope (10 × X/0.3 numerical aperture (NA) objective; Carl Zeiss 
MicroImaging Inc., Germany). Dead/dying cells with compromised nuclei stained 
positive (red) for EthD-1, viable / live cells stained green for calcein AM. 
 
7.3 Results and Discussion 
The absorbance spectrum of the GNR-C12ELP nanocomposite (Figure 53) 
showed uniform distribution of gold nanorods in the nanocomposite resulted in 
optical properties similar to that of gold nanorod dispersions; characteristic peaks 
at 520 nm and in the near infrared (approximately 850 nm) region in the 
spectrum can be seen, indicating that the nanocomposites indeed demonstrated 
plasmonic properties due to the uniform distribution of the gold nanorods. 
Photothermal properties of CnELP-GNR nanocomposites were investigated by 
recording the temperature of PBS supernatant (500 µl) above the nanocomposite 
in 24 well plates. Temperatures in each case reached their respective steady-
state values (approximately 46oC) five minutes following laser irradiation, 
consistent with our previous observations with gold nanorods;237,266,267 the 
steady-state temperatures did not change following the relatively minor change in 
power density from 20 W/cm2 to 25 W/cm2. 
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Figure 53.Optical and photothermal response of GNR-C12ELP nanocomposites. 
GNR-C12ELP nanocomposites were formed on a glass cover slip (inset) and the 
absorbance (optical density) spectrum of the film was analyzed using a plate 
reader. The nanocomposite was immersed in PBS was irradiated using an 850 
nm laser at two different power densities and the temperature of PBS was 
measured using a K-type thermocouple.  
 
Sub-optimal administration of hyperthermia can result in the incomplete ablation 
of tumors and selection of clones that are resistant to treatment. While 
temperatures above 46oC result in significant loss of cell viability, mild or 
moderate hyperthermic temperatures (40-46°C) can have differential cytotoxic 
effects on cells leading to variable efficacies. Constitutive and induced 
expression of heat shock proteins (HSPs), including HSP90, lead to the refolding 
of proteins denatured by hyperthermia, and therefore results in overcoming the 
apoptotic effects of the treatment. In particular, HSP90 is a stress-related protein 
which interacts with several client proteins and regulates key processes inside 
cells, including protein degradation, and aids cancer cell survival following 
hyperthermia. Strategies that combine hyperthermic ablation with 
chemotherapeutic drugs that can overcome HSP-induced resistance can result in 
enhancing the efficacy of hyperthermia as an adjuvant treatment. As a 
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representative example of this approach, the chemotherapeutic HSP90 inhibitor, 
17-demethoxy-17-allylaminogeldanamycin (17-AAG) was incorporated in the 
nanocomposite, with an eye towards generating a multifunctional nanocomposite 
capable of simultaneously administering both, hyperthermia and chemotherapy, 
in order to enhance the ablation of cancer cells. The HSP90 inhibitor was 
incorporated within GNR-C12ELP nanocomposites during their formation leading 
to 17-AAG-GNR-C12ELP nanocomposites (Figure 54 b inset) The absorbance 
spectrum of 17-AAG-GNR-C12ELP nanocomposites demonstrated an additional 
peak at 335 nm (Figure 54 a and b), which was indicative of the incorporation of 
17AAG within the polypeptide nanocomposite; approximately 550 ug of the drug 
were incorporated within a single nanocomposite.  
 
 
Figure 54.Spectrum of 17-AAG loaded GNR-C12ELP nanocomposites. 
C12ELP-GNR nanocomposites loaded with heat shock protein 90 (HSP90) 
inhibitor, 17-AAG, for ablation of cancer cells using a combination treatment of 
hyperthermia and heat shock protein inhibition. (a). Absorbance spectrum 17-
AAG shows a peak at approximately 330 nm which is reflected in the 17-AAG-
GNR-C12ELPnanocomposite (b). The inset in (b) shows a digital snapshot of the 
17-AAG-GNR-C12ELP nanocomposite loaded with 0.55 mg of the HSP90 
inhibitor drug.  
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Figure 55 shows the diffusion release (leaching) of 17-AAG from the 17-AAG-
GNR-C12ELPnanocompositewas monitored for 24 h to a supernatant of 1XPBS 
(volume 500  ul). Approximately 10 g of the drug were released in the first hour, 
following which, an additional 7 g of the drug were released over the next 23 
hours, indicating that a total of only 3% of the encapsulated drug leached out due 
to diffusion. This demonstrates that the nanocomposites are able to stably 
incorporate chemotherapeutic drugs with minimal loss due to leaching. This is 
significant since unintended drug loss from the nanocomposite can result in 
undesired side effects. Subjecting the nanocomposite to laser irradiation resulted 
in an increase in local temperature due to the photothermal effects of gold 
nanorods, which in turn, led to enhanced release of 17-AAG from the 
nanocomposite, presumably due to ELP structural changes and aggregation 
above the transition temperature, which in turn, can result in contraction of the 
nanocomposite leading to drug efflux. The concomitant temperature increase is 
shown in Figure 55 b and is similar to that observed with the nanocomposite in 
the absence of the drug (Figure 53). A five-minute laser irradiation pulse (850 nm 
laser, 25 W/cm2) resulted in the release of only 2.5 µg of 17-AAG, indicating 
longer exposure times were necessary for increased release of the drug. 
Subsequent laser exposures were therefore carried out for ten minutes each 
(850 nm, 25 W/cm2), which resulted in the release of 12.6 µg ± 2.4 µg for each 
round of laser irradiation. Discolored spots on the GNR-C12ELP 
nanocomposite(Figure 55a, inset) indicate regions of drug release following 
exposure to the laser. This is consistent with the temperature profiles in Figure 
55 b, which indicated that merely reaching hyperthermic temperatures may not 
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be enough to trigger drug release and that sustained hyperthermic temperatures 
may be required.  
 
In order to further investigate the role of laser-induced drug release, 
nanocomposite for diffusion drug release was first investigated, which is followed 
by incubation at moderately hyperthermic temperatures (42oC), and finally laser 
treatments. The total amount of drug originally encapsulated in this 
nanocomposite was approximately 614 g, which was higher than the amount 
encapsulated in the nanocomposite shown in Figure 55 a. As seen in Figure 55 
c, higher 17-AAG quantities were released following laser irradiation compared to 
the water bath incubation treatment. It is possible that temperatures directly in 
the path of the laser are significantly higher than 42-44oC and lead to greater 
drug release due to more significant changes in the nanocomposite at these 
locations. This is currently under investigation in our laboratory. 
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Figure 55.Photothermally activated release of the HSP90 inhibitor drug, 17AAG 
from 17-AAG-GNR-C12ELPnanocomposites. 
(A) Diffusion release (leaching) of 17-AAG from the17-AAG-GNR-
C12ELPnanocomposite was monitored for 24 h to a supernatant of PBS (volume 
500  ul). The nanocomposite was then subjected to laser irradiation for releasing 
the drug. The first laser irradiation last for 5 minutes (850 nm, 25 W/cm2), the 
second to sixth laser irradiations (850 nm, 25 W/cm2), were for 10 minutes, with 
20 min interval without laser in between each irradiation. Data shown is mean ± 
one standard deviation from four independent experiments (n= 4) 
(B) The temperature profile during 10 minutes laser exposure was monitored with 
a Type-K thermocouple. The temperature reached 43-44oC (heat shock 
conditions) following 5 minutes of laser irradiation, and remained invariant 
thereafter. Laser irradiation resulted in an additional 45-50 µg of 17-AAG 
released from the 17-AAG-GNR-C12ELP nanocomposites indicating the potential 
for combined hyperthermia and heat shock inhibition. 
(C) Role of laser irradiation on enhancing 17-AAG release from GNR-C12ELP 
nanocomposites. Nanocomposites were first investigated for diffusion leaching of 
the drug, followed by incubation a water bath at 42oC, and were finally irradiated 
with an NIR laser. Higher amounts of drug were released following laser 
treatment, presumably due to higher localized temperatures in the path of the 
laser. 
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Taken together, these results indicate that the photothermal properties of the 
polypeptide nanocomposite facilitates local increases in temperature following 
laser irradiation, which in turn, triggers release of the encapsulated drug, 
presumably due to a combination of increased drug diffusivity and ELP 
aggregation and contraction at temperatures above the polypeptide transition 
temperature.  
 
I next evaluated the efficacy of the simultaneous administration of hyperthermia 
and HSP90 inhibitor for the ablation of prostate cancer cells. In order to account 
for the efficacy of this combination treatment, two ‘single-agent’ treatments were 
first carried out: (1) hyperthermia alone, in which the nanocomposite without the 
17-AAG drug was employed for killing cancer cells only due to hyperthermic 
temperatures in the absence of the drug, and (2) 17-AAG alone, in which loss of 
cancer cell viability due to constitutive 17-AAG diffusion release from the 
nanocomposite was evaluated in the absence of laser-induced hyperthermia.  
 
GNR-C12ELP nanocomposites (without 17-AAG) supported the growth of PC3-
PSMA human prostate cancer cells, indicating that the plasmonic nanocomposite 
was not toxic to cells. For the ‘hyperthermia alone’ treatment, cells were 
irradiated with an 850 nm laser (25 W/cm2 laser for 7 minutes) and cell viability 
was determined using the Live/dead® assay 24 hours after the laser treatment. 
Phase contrast and fluorescence microscopy images were recorded immediately 
after staining. As expected, laser irradiation resulted in significant death of PC3-
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PSMA cells directly in the path of the laser beam as seen from the red stained 
cells in Figure 56, consistent with previous observations in literature.223,268 
However, cells outside the path of the laser beam did not undergo any loss of 
viability as seen from the green-stained living cells in Figure 56. These results 
highlight spatial limitations associated with nanoparticle-mediated hyperthermic 
ablation of cancer cells; while nanoparticles and laser irradiation can be 
employed for localized treatments, effective treatment can be administered only 
over a limited region leading to ineffective treatment. Importantly, the plasmonic 
nanocomposite is biocompatible, can be used for the hyperthermic ablation of 
cancer cells, and in implantable treatments where the spatial limitations of 
hyperthermia are not a concern. 
 
 
Figure 56.GNR-C12ELP nanocomposites forcell ablation. 
GNR-C12ELP nanocomposites cell ablation set up with fluorescence (A, B) and 
phase (C, D) images. PC3-PSMA human prostate cancer cells were cultured on 
GNR-C12ELP nanocomposites (without 17-AAG drug) for 24 h, and irradiated 
with an 850 nm laser (25 W/cm2) for 7 minutes. Viability of cells directly under the 
1mm laser irradiation spot (top; circled area) and outside the laser spot (bottom) 
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cultured on 17-AAG-GNR-C12ELP nanocomposites for 24 h and irradiated with 
an 850 nm laser (25 W/cm2) for 7 minutes. Cell viability was investigated after 24 
h of the laser treatment using the Live/ Dead® assay (total cell culture time = 48 
h). Representative images at two different locations away from the laser 
irradiation spot demonstrate approximately 90 % cell death due to the 
combination of mild hyperthermia (43oC; Figure 7.6 b) and release of the heat 
shock inhibitor drug 17AAG (Figure 7.6 a). This pattern of uniform cell death 
throughout the well is higher than what was seen with the ‘single agent (i.e. mild 
hyperthermia alone and 17-AAG release alone) treatments. Approximate 
locations of the images on the nanocomposite are shown. Representative 
images from three independent experiments (n= 3). Scale bar: 500 µm. 
 
The synergistic action between these combination treatments is demonstrated by 
quantitative analysis of the cell death results (Figure 59). ‘Drug-alone’ and ‘laser-
alone’ treatments resulted in minimal loss of cell viability (< 10 % of the cell 
population). However, the combination treatment (laser-induced hyperthermia 
and release of the HSP90 inhibitor) resulted in over 90% loss in cell viability 
(Figure 59). These results indicate that drug-loaded nanoparticle-polypeptide 
nanocomposites can simultaneously overcome (1) cancer cell resistance to 
nanoparticle induced hyperthermia which is mediated by heat shock protein 
overexpression and (2) spatial limitations of laser-induced hyperthermia using 
plasmonic nanoparticles (Table 6.1).  
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Figure 59.Quantitative analysis of cell death 
Analysis of cell death demonstrates the efficacy of the laser-induced combination 
treatment of hyperthermia and heat shock inhibitor 17-AAG using GNR-C12ELP-
17AAG nanocomposites. X-axis legend: Nanocomposite indicates the GNR-
C12ELP nanocomposite and 17AAG nanocomposite indicates GNR-C12ELP-17-
AAG (i.e. drug-loaded) nanocomposites. (nؤ  3 for all conditions). 
 
Table 8.Summary of Combination Treatments. 
Nanocomposite Laser Power Density (7 min irradiation) 
Cell Death 
Laser 
Spot Periphery 
GNR-C12ELP 0 W /cm2 No No 
GNR-C12ELP 25 W /cm2 Yes No 
17-AAG-GNR-C12ELP 0 W /cm2 No No 
17-AAG-GNR-C12ELP  25 W /cm2 Yes Yes 
 
 
7.4 Conclusions 
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In this chapter, it was demonstrated that GNR-
C12ELPnanocompositesmaintaining the photothermal properties of the gold 
nanorods can be employed for the hyperthermic ablation of cancer cells. 
However, spatial limitations of the administered hyperthermia treatment, in 
addition to the pro-survival heat shock response associated with cancer cells, led 
us to incorporate the HSP90 inhibitor, 17-AAG, in the nanocomposite. Laser 
irradiation of the plasmonic nanocomposite3resulted in simultaneous 
administration of hyperthermic temperatures and release of 17-AAG. Synergistic 
action between hyperthermia and HSP90 inhibition led to significant 
enhancement of cancer cell death. To our knowledge, this is the first report that 
describes the use of a heat shock protein inhibitor in combination with 
nanoparticle-induced hyperthermia for the ablation of cancer cells. Our results 
indicate that such nanocomposites can be used for enhancing the efficacy of 
hyperthermia as an adjuvant treatment. In addition, this is the first report that 
describes GNR-ELP nanocomposites as plasmonic nanobiomaterials. The 
availability of a variety of engineered polypeptides, nanoparticles, and 
chemotherapeutic drugs, should advance this approach leading to biocompatible 
plasmonic nanocomposites for different therapeutic modalities and other 
biomedical applications, including biosensing and regenerative medicine. 
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CHAPTER 
8. Ex vivo Laser Tissue Welding using Polypeptide-Gold Nanorod 
Nanocomposite Solders 
 
8.1 Introduction 
Chapter 6 investigated different physicochemical conditions that influence GNR-
C12ELP nanocomposite formation. The effect from both cetyltrimethyl ammonium 
bromide (surfactant used to template the formation of gold nanorods) and GNR 
were investigated using optical measurements and model fitting. Chapter 7 
employed solid phase nanocomposites, which retained the photothermal 
properties of nanorods, for simultaneous administration of laser-induced 
hyperthermia and chemotherapeutic drugs to prostate cancer cells. This chapter 
involves a detailed investigation into biocompatible, light responsive bioadhesive 
for laser tissue welding (LTW) of colorectal tissue, using porcine intestinal model, 
to establish a fluid-tight sealing. 
 
Every year, over 600,000 people in the United States will undergo surgical 
procedures to treat a number of colorectal diseases such as colorectal cancer, 
inflammatory bowel disease (IBD), and diverticulitis 
(http://www.lapsurg.org/colon.html). Patients undergo either conventional open 
surgery or laparoscopic surgeries to remove diseased tissue require end-to-end 
anastomoses (connection) of the healthy sections. Surgical suturing and stapling 
are still the most common and important procedures in colorectal anastomoses, 
however, both techniques rely on piercing healthy tissue and can cause 
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anastomosis leakage. Leakage of intestinal bacteria from bacteria-rich colorectal 
system into abdominal lumen can cause serious infection in the potentially 
deadly form of peritonitis269-272. Incidence of anastomotic leakage following 
standard surgical anastomosis in colorectal surgery are reported from 4% to 
17%269,270,273, and accounts for one-third of the mortality after colorectal 
surgery274. Alternative or supportive anastomosis techniques are urgently 
required in order to decrease anastomosis leakage rate after colorectal surgery. 
 
Laser tissue welding (LTW) emerged as a “sutureless” surgical method for the 
anastomosis of ruptured tissues  (e.g. vessels, bowel, urinary tract, skin and 
others275-283). Laser tissue welding holds several advantages over conventional 
suturing and stapling procedures, these include short operation time, immediate 
fluid-tight sealing, reduced foreign-body reactions (e.g. inflammatory response), 
scar reduction and accelerated healing278,284-288. The mechanism for the LTW 
involves the tissue absorption of laser light, which converts into heat energy to 
induce alteration of tissue proteins282,289. Interdigitation of the photothermal-
altered tissue proteins via covalent and electrostatic interaction279,290,291 is 
considered to be the basic effect for the LTW. Laser-assisted colorectal 
anastomosis have been demonstrated to provide an immediate fluid-tight sealing, 
and may reduce the frequency of colonic anastomosis leakage292. Cilesiz et al. 
reported in vivo Ho:YAG and argon laser welding of rat Intestine resulted in a 
comparable bursting pressure and healing rate to suture anastomoses293.  In a 
canine jejunum study, strong tissue fusion was not possible at or below a surface 
temperature of 70°C, but was accomplished above 80 °C284. Overall, reports 
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recognized heating tissue above 60 °C is necessary to provide robust closure294. 
The photothermal damaging of tissue is irreversible; possessing the ability to 
precisely provide, adjust and predict laser dosage based on real-time 
temperature monitoring systems is critical and has been demonstrated by several 
groups284,293,295. 
 
Major concerns associated with LTW include insufficient anastomoses strength, 
limited light penetration depth and peripheral tissue thermal damage. These 
problems can be addressed by the introduction of protein-based solders (e.g. 
albumin-, elastin- and chitosan-based) in concert with near infrared (NIR) light 
absorbing chromophores (e.g. indocyanine green, fluorescein, and gold 
nanoparticles)296,297. Upon laser irradiation, protein solders denatured and 
incorporated into welding site to (i) improve the tensile strength of the closure, (ii) 
minimize peripheral tissue destruction, and (iii) further reduce foreign body 
responses. Near infrared light (NIR) enabled deeper penetration, while, presence 
of chromophores can efficiently transfer lower dose light energy into sufficient 
localized heat energy to reduce unwanted thermal damage298,299.It has been 
demonstrated, introduction of protein-based solders in combination with light-
absorbing chromophores and growth stimuli is critical for the improvement of 
anastomoses strength, reduction of tissue thermal damage and acceleration of 
wound healing process296-299. Lauto et al. reported genipin-crosslinked albumin 
can significantly increased the tensile strength of adhesive-tissue bonds after 
laser welding292. Transforming growth factor-beta (TGF-β), a key component in 
the fibrogenic process and inflammatory response, has been incorporated into 
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human albumin solder to accelerate wound healing process after laser 
welding300. 
 
 
Figure 60.Colorectalsurgery followed by laser tissue welding using 
nanocomposite solder and laser light. 
(A) Removal of diseased tissue. (B) Reconnect of the healthy sections 
(anastomosis). (C) Achieving a fluid-tight sealing. 
 
In this chapter, It was hypothesized that LTW of colorectal tissues using GNR-
C12ELP nanocomposite can result in rapid fluid-tight anastomosis and potentially 
accelerate wound healing process. Specifically, gold nanorods can maximize the 
photothermal effect and crosslinked elastin-like polypeptide can improve the 
anastomoses strength (Figure 60). The GNR-C12ELP nanocomposite advances 
current solders in several aspects: (i) The light dosage required to induce similar 
thermal response using gold nanostructures is 10- to 25- fold lower than with 
photoabsorbing dyes301. Among various types of gold nanoparticles, gold 
nanorods with highest near infrared (NIR) absorption cross-section302 can convert 
light into heat most efficiently. Moreover, light in NIR region can provide maximal 
tissue penetration, due to minimal light absorption by water and blood4. In 
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summary, Presence of NIR light responsive gold nanorods can provide sufficient 
localized heating with reduced thermal damage of the periphery tissue. (ii) 
Artificial elastin like polypeptides have been repeatedly reported to be 
biocompatible and low immunogenicity303. Our collaborator successfully 
demonstrated keratinocyte growth factor modified elastin-like peptides can be 
used for the in vivo treatment of chronic wounds304. However, low dynamic shear 
stiffness associated with hydrogels formed from ELP coacervates can potentially 
limit their tissue engineering applications where significant load supporting is 
required305.  
In this study, it first was time reported that crosslinking of elastin-like polypeptide 
using gold nanorods can provide improved dynamic shear stiffness of 
nanocomposite. Secondly, unmodified- and surfaced (PEG)modified-
nanocomposites were able to support murine fibroblasts (NIH 3T3) growth with 
minimal cytotoxicity (< 90%). Last, laser tissue welding of porcine intestine using 
GNR-C12ELP nanocomposites led to a rapid enhancement of tissue mechanical 
strength (tensile strength, bursting pressure and leaking pressure) of ruptured-
tissue. In summary, multifunctional nanocomposite with capabilities of (1) 
controlled releasing of small molecules (Chapter 7), (2) cell culture supporting 
with minimum toxicity, and (3) providing robust and stable photothermal 
responses for laser tissue welding, are promising for tissue regeneration and 
repair applications.  
 
8.2 Materials and Methods 
8.2.1 Materials 
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Gold (III) chloride trihydrate (HAuCl4·3H2O), cetyltrimethyl ammonium bromide 
(CTAB), L-ascorbic acid, sodium borohydride and silver nitrate were purchased 
from Sigma-Aldrich. All chemicals were used as received without further 
purification. DMEM cell culture medium was purchased from Invitrogen.  Pen-
Strep solution (10,000 units/mL penicillin and 10,000 μg/mL streptomycin in 
0.85% NaCl) and fetal bovine serum (FBS) were purchased from Hyclone. Fresh 
porcine small intestines were purchased from Animal Technologies Inc., Texas. 
 
8.2.2 Generation of Gold Nanorods 
Gold nanorods were synthesized using the seed-mediated method155 following 
the same procedure in Chapter 3.2.2, this method was employed to generate 
gold nanorod population that possessed absorbance maxima (λmax) in the near 
infrared (NIR) region of the optical spectrum. Nanorod aliquots, with an initial 
CTAB concentration of 100 mM, were pelleted by centrifugation (6000 rcf, 10 
min), following which, the clear supernatant was removed, and resuspended in 
nanopure water to various final volumes. Further centrifugation, decantation and 
dilution steps allowed the generation of a series of nanorod samples (ODλmax= 
0.125-2.5; corresponded to 9.5-190 µg/mL) with CTAB concentration less than 
0.25 mM. In all cases, the concentration of gold in GNRs was determined using 
inductively coupled plasma optical emission spectrometry (ICP-OES, iCAP 6000 
Series, Thermo Electron Corporation); NIR absorption characteristics of the 
nanorods were determined using a plate reader (Biotek Synergy 2).  
 
8.2.3 Preparation of Polyethylene Glycol (PEG)-modified Gold Nanorods 
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Polyethylene glycol (PEG)-modified gold nanorods (PEG-GNRs) were prepared 
as follows. Aliquots of gold nanorod dispersions (19 µg/mL) were centrifuged at 
6,000 rcf for 10 minutes; the supernatants were decanted, and nanorod 
precipitants were resuspended in thiol-functionalized polyethylene glycol 
(mPEG5000-SH) solutions (Creative PEGWorks) to various concentrations (50-250 
µg/mL) for 2 hours at room temperature. The free mPEG5000-SH molecules were 
removed by centrifugation at 6,000 rcf for 10 minutes. The final PEG-GNRs 
samples were resuspended in nanopure water to their original volume. 
 
8.2.4 Synthesis, Expression, and Purification of Cysteine containing 
Elastin-like Polypeptides (ELPs) 
Elastin-like polypeptides containing twelve cysteines (C12ELP), were generated 
using recursive directional ligation method described previously237. C12ELP 
contain eight and twelve cysteines residues (shown in bold) in the sequence: 
MVSACRGPG-(VG VPGVG VPGVG VPGVG VPGVG VPG)8-(VG VPGVG 
VPGVG VPGCG VPGVG VPG)12-WP. C12ELP were generated, expressed, 
purification lyophilized and stored at room temperature as described previously in 
Chapter 5.2.1237. The transition temperature (Tt) of C12ELP was characterized as 
described in Chapter 5.2.2 previously. The temperature response of the C12ELP 
indicated transition temperature (Tt) value of 30.5°C. 
 
8.2.5 Preparation of GNR-C12ELP Nanocomposites 
Preparation of GNR-C12ELP nanocomposites can be summarized into two steps 
as described previously in Chapter 6 and 7; the process involves: (i) self-
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assemble of C12ELPs on GNRs via gold-thiol bond at 4 °C leading to the 
formation of nanoassemblies in dispersion form, and (ii) phase separation 
nanoassemblies leading to the irreversible formation of solid-phase 
nanocomposites at 37 °C. Briefly, gold nanorod samples (9.5 – 190 µg/ml, 
nanopure water) at a volume of 1 mL were mixed with 1 mL of C12ELP (2 mg/ml, 
1 X PBS) overnight at 4°C. This led to the formation of GNR-C12ELP 
nanoassemblies at various GNR weight percentages (0.47 – 8.68 % wt). GNR-
C12ELP nanoassemblies (2 mL) were placed in our homemade device, and 
incubated at 37 °C for 6 hours; this led to the formation of GNR-C12ELP 
nanocomposite (~2 mg, 10 mm diameter, thickness = 247 ± 65 µm) on top of a 
glass coverslip. In case of preparing PEG-modified gold nanorod-C12ELP (PEG-
GNR-C12ELP) nanocomposite, PEG-GNRs were used instead of GNRs, same 
procedure was followed. In case of C12ELP alone controls, no gold nanorods 
were introduced. 
 
8.2.6 Swelling Experiments 
Nanocomposite was incubated in 2 mL of 1 X PBS (pH 7.4) at room temperature 
for 24 hours, following which, the mass of nanocomposite plus the tube was 
measured. The mass of the swollen nanocomposite (Ms) was determined by 
subtracting the mass of the tube from the total mass. The nanocomposites were 
freeze-dried using lyophilizer (FreeZone, Labconco Corporation). The dry mass 
(Md) was calculated by subtracting the mass of the tube from the total mass. 
Swelling ratio (Q) was defined as the ratio of the mass of swollen nanocomposite 
to the mass of dry nanocomposite. 
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8.2.7 Rheological Measurements 
The mechanical behaviors of the GNR-C12ELP nanocomposites and C12ELP 
coacervates were assessed using AR-G2 rheometer (TA Instruments) in a 
parallel plate configuration (8 mm diameter). The samples (10 mm diameter, ~1 
mm thickness) were loaded between the plates, the gap was closed until the 
sample was in good contact with both plates (normal force <0.1 N). Prior to 
measurement, samples were equilibrated on the temperature-controlled peltier 
plate for 30 minutes in order to exclude the time-dependent relaxation during the 
measurement. The dynamic frequency sweep was conducted over an angular 
frequency range of 1 – 40 rad/s, at fixed strain amplitude of 0.05, and 25 °C. 
Temperature sweep was performed between 25 °C and 45 °C at a temperature 
increment rate of 1 °C/min, the frequency and strain amplitude were controlled at 
20 rad/s and 0.05, respectively. The absolute shear modulus (|G*|) and loss 
angle (δ), representing the stiffness and the relative measure of viscous to elastic 
effects of the nanocomposite under dynamic loading, respectively, were 
calculated and reported. The absolute magnitude of the shear modulus, |G*|, was 
determined based on the definition |G*| = (G'2 + G"2)0.5; where, G' is the elastic 
storage modulus and G" is the viscous loss modulus. For pure elastic idea solid 
the loss angle(δ) is 0 degree; whereas, pure viscous Newtonian fluid has a loss 
angle (δ)equal to 90 degree. 
 
8.2.8 Biocompatibility of Nanocomposites 
8.2.8.1 Murine Fibroblast Culture 
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Fibroblast cells were generous gifted from Dr. Christine Pauken at the 
Department of Biomedical Engineering, Arizona State University, Tempe, AZ. 
Cells were cultured in a 5% CO2 incubator at 37°C using DMEM medium 
containing 10% heat-inactivated fetal bovine serum (FBS) and 1% antibiotics 
(10000 units/mL penicillin and 10000 μg/mL streptomycin). Murine fibroblast 
(3T3) cells were used for: (i) evaluation of the nanocomposite biocompatibility 
(Chapter 8.2.8.2) and (ii) nanocomposite cellularization (Chapter 8.2.8.3).  
 
8.2.8.2 Cell Monolayer Culture 
The biocompatibility of nanocomposites at various GNR (1.9-5.4 wt%) and PEG 
(0-19.7 wt%) weight percentages, prepared in 96-well plate, was first evaluated. 
Briefly, aliquots 200 µL of GNR-C12ELP (or PEG-GNR-C12ELP) nanoassemblies 
(prepared as described previously) were added into each well at 4°C. The 
samples were then subjected to 37°C incubation for 6 hours leading to 
nanocomposites formation at the bottom of the wells. After incubation, the clear 
supernatants were decanted; the nanocomposites were washed twice with 1 X 
PBS and pretreated with 200 µL of cell culture medium for 30 minutes. Fibroblast 
cells were seeded on top of the cell culture medium-pretreated nanocomposites 
with a density of 5,000 cells per well. The cell viabilities at 24, 48 and 72 hours 
after seeding were determined using fluorescence-based Live/dead®. Briefly, 
cells were treated with 4 μM ethidium homodimer-1 (EthD-1; Invitrogen) and 2 
μM calcein AM (Invitrogen) for 30 minutes and imaged using Zeiss AxioObserver 
D1 inverted microscope (10X/0.3 numerical aperture (NA) objective; Carl Zeiss 
MicroImaging Inc., Germany). The nucleic acids of membrane-compromised 
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(dying/dead) cells were labeled red fluorescence with membrane-impermeant 
EthD-1; the esterases in viable/live cells cleaved membrane-permeant calcein 
AM to yield cytoplasmic green fluorescence. Quantitative analysis of cell viability 
was carried out by cell counting using the Cell Counter plug-in in ImageJ 
software306 as described previously307. The number of live (NL) and dead (ND) 
cells were used to determine the cell viability (NL/(NL+ ND)*100%). Data reported 
represent the cell viability mean from more than 6 individual samples. 
 
8.2.8.2 Cell Encapsulation 
For nanocomposite cellularization, fibroblast cells were encapsulated in the 
nanocomposite. Briefly, PEG(4.7 wt%)-GNR(1.9 wt%)-C12ELP nanoassemblies 
were prepared as described previously, but resuspended in cell culture media 
instead. A number of 250,000 cells were introduced to 2 mL PEG-GNR-C12ELP 
nanoassembly dispersion during incubation at 37 °C and 5% CO2 in our 
homemade device. After 6 hours, the cell-encapsulated nanocomposite (10 mm 
diameter), on top of a glass coverslip, was collected and wash thoroughly with 1X 
PBS three times in order to remove any  loosely attached cells. The cell-
encapsulated nanocomposite, covered with medium and placed in a 6-well plate, 
was cultured in a 5% CO2 incubator at 37 °C. The distance of cell proliferation 
was monitored up to 14 days using a Zeiss AxioObserver D1 inverted 
microscope (10 × X/0.3 numerical aperture (NA) objective; Carl Zeiss 
MicroImaging Inc., Germany), where the cell culture medium was changed in 
every three days. The encapsulated cells were stained using fluorescence-based 
Live/dead® as described in previous section, and imaged using both 
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AxioObserver D1 inverted microscope and laser scanning Nikon C2 confocal 
microscope (Nikon Instruments Inc., Melville, NY). For confocal imaging, images 
were acquired and stacked using NIS-Elements Microscope Imaging Software 
(Nikon Corporation) at 60× water objective with a z-step of 0.225 μm slice and 
with PMT scanners at 512 × 512 pixels. 
 
8.2.9 Laser Tissue Welding 
A titanium continuous wave (CW) sapphire (Ti: S) laser (Spectra-Physics, 
Tsunami) pumped by a solid-state laser (Spectra-Physics, Millennia) was 
employed for laser tissue welding. The excitation source was tuned to overlap 
with the longitudinal maxima of the nanocomposites (~ 800 nm). The laser output 
power and the beam diameter were fixed at 20 W/cm2 and 2 mm, respectively. 
Porcine small intestines were harvested, cleaned with phosphate buffered saline 
(1 X PBS, pH 7.4) and stored at -20°C (Animal Technologies Inc.). Prior to laser 
welding, tissue samples were defrosted in nanopure water for 30 minutes and 
kept moist using 1 X PBS at 25°C throughout the laser tissue welding and tensile 
testing. Rectangular intestine sections (~0.1 cm thick, 4x1 cm) were placed on a 
glass slide with serosa layer facing up, following which, a full thickness incision (~ 
8 mm in width) was applied at the center of the tissue using serological scissors. 
Prior to welding, the incision edges were brought into contact with one another, 
and nanocomposite solder (~2 mg, 10 mm diameter, thickness= 247 ± 65 µm, 
GNR wt%= 1.9, 5.7 or 9.5) was applied on top of the serosa layer and across the 
full thickness incision with full contact. Laser light (20 W/cm2) was applied 
vertically at a speed of 1 mm/second across the nanocomposite for different 
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durations. The temperature at the nanocomposite-tissue interface was monitored 
using a k-type thermocouple. Samples were remained moist during welding to 
prevent charring. 
 
8.2.10Tensile Strength Characterization 
Tensile strength was measured using TA XT plus Texture Analyser (Texture 
Technology Corp., NY) with a 5Kg load cell. Welded tissues were held with 
pneumatic grips to prevent slipping during testing. Testing was done in tension 
mode at a rate of 0.5 mm/second until failure. The maximum force (N) achieved 
before a sample breaks was recorded and reported in ultimate tensile strength 
(UTS, kPa). Intact porcine small intestine sections were subjected to mechanical 
testing to determine the UTS of uncut specimens. Data reported represent the 
mean from at least 10individual samples. 
 
8.2.11 Bursting and Leaking Pressure 
Bursting and leaking pressure tests were conducted on intact porcine 
intestines.  A homemade pressure detection system was designed and 
built (Figure 61).The intact porcine intestines were cut into approximately 
10cm sections.  A full thickness incision(~ 5 mm) was applied to the intact 
intestine.  The nanocomposite was placed on top of the incision and the 
surrounding tissue.  The CW laser was then applied to the nanocomposite 
and tissue for various times.  After LTW was complete, the intestines were 
tightly clamped at both ends.  A 21G1 Precision Glide needle was inserted 
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into the tissue and dyed water was fed into the intestine sections.  The 
pressure was monitored and recorded at the leaking and bursting points.  
The leaking pressure was defined as when the first drop of colored water 
was seen coming out of the weld site.  The bursting pressure was defined 
as when a stream of water was seen coming out of the weld site.  Control 
bursting and leaking pressure tests were conducted on intact and cut 
tissues.  The bursting pressure site was always along the length of the 
intestine.  Leaking from the needle puncture site was considered 
negligible. 
 
 
Figure 61. Apparatus used to measure bursting and leaking pressure of 
anastamoses. 
 
8.2.12Statistical Analysis 
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Two-tailed Student's t-test and one-factor analysis of variance (ANOVA) were 
employedfor statistical analysis. Statistical significance was determined at a 
value of 0.05.  
 
8.3 Results and Discussion 
Self-assembly of C12ELPs (Tt = 30.4°C, Figure 37) on GNRs (λmax = 780 nm) by 
means of gold-thiol bonds at 4 °C resulted in the formation of well-dispersed 
nanoassemblies. Incubation of the nanoassemblies at 37 °C (>Tt of C12ELP) for 6 
hours led to temperature-triggered, entropy-dominated phase transition of 
C12ELP204, which, in concert with GNR-thiol and intra-and inter-molecular 
cysteine-cysteine cross-linking, resulted in the formation of maroon-colored 
plasmonic nanocomposite238. After nanocomposite formation, clear supernatant 
containing the majority of free CTAB molecules (~ 0.25 mM) was decanted. The 
residual CTAB molecules (0.8-32.5 nM) on the surfaces of nanorods (4.8-190 
μg/ml) is minimal in the final nanocomposite 236. 
 
As-prepared GNR-C12ELP nanocomposites were 10 mm in diameter, 2.2 ± 0.2 
mg in weight and 247 ± 65 µm thick (determined using digital caliper and 
confirmed with a light microscopy). These nanocomposites were flexible and 
stable at physiological environment up to at least 2 years. The absorbance 
spectra of the nanocomposites (Figure 40) displayed the transverse (520 nm) 
and red-shifted longitudinal band (~800 nm) characteristic of gold nanorods, 
indicating that the nanocomposites indeed demonstrated plasmonic properties 
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due to the uniform distribution of the gold nanorods, which was confirmed using 
field emission scanning electron microscopy in our previous study238.  
 
The swelling ratios of nanocomposites, with five gold nanorod weight 
percentages (GNR wt% at 0, 0.9, 1.9, 3.7 and 5.4), were determined according 
the protocol described in the experimental section. Swelling experiments reveal a 
statistically significant (p< 0.001) reduction of swelling ratio from 12 to 6 as GNR 
weight percentage increased from 0 to 5.4 wt% (Figure 62). The decrease of 
water uptake can be explained by the presence of gold nanorods, which 
facilitated nanocomposite covalent cross-linking, and resulted in the formation of 
rigid network to prevent swelling. 
 
 
Figure 62.Swelling ratio of nanocomposites as a function of GNR weight 
percentage. 
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The rheological properties of C12ELP hydrogel controls (without GNR) and GNR-
C12ELP nanocomposites (GNR wt% at 0.5, 0.9, 1.9 and 3.7), were measured 
under frequency sweep (Figure 63) and temperature sweep (Figure 64). In 
Figure 62A, the absolute shear modulus of C12ELP hydrogels (|G*|= 0.56 ± 0.1 
kPa) was larger than others report on un-crosslinked ELP (|G*|≈ 0.08 kPa)308, 
and similar to chemically cross-linked ELP (|G*|= 0.26 - 3 kPa)305,309 under similar 
experimental condition. This is presumably due to the presence of intra-and inter-
molecular cysteine-cysteine cross-linking in the C12ELP hydrogels238. The 
mechanical integrity of C12ELP was further improved upon the introduction of 
nanorods. The |G*| of GNR-C12ELP nanocomposite increased from ~2 to ~8 kPa 
as a gold nanorod weight ratio rose from 0.47 to 3.7 wt%. Increase in 
nanocomposite stiffness (or |G*|) at higher GNR wt% is due to the presence of 
gold nanorods, their contribution to the gold-thiol bond cross-linking in addition to 
intra-/inter- molecular disulfide cross-linking, and loss of water volume 
(decreased swelling ratio). The mean value for the loss angle (δ) of the 
nanocomposite was found independent of gold nanorod concentration (Figure 
63B). All nanocomposite samples showed a predominantly elastic behavior, with 
loss angle degree less than 10.  
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Figure 63.The rheological behavior of nanocomposites at different gold nanorod 
content (0-3.7 % w/w) was characterized at 25 °C. 
The effect of gold nanorod concentration on the magnitude of the complex shear 
modules (|G*|) and phase angle (δ) is shown.  
 
The effect of the temperature on the shear properties of GNR-C12ELP 
nanocomposites is shown in Figure 64A. Increase in temperature from 25 to 45 
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°C did not attenuate the absolute shear moduli of nanocomposites. Furthermore, 
the loss angle of the nanocomposite was independent of temperature with a 
steady value of < 10°, again reflected the intrinsically elastic behavior of 
nanocomposites. Artificial elastin-like polypeptides have been repeatedly 
reported to be biocompatible and low immunogenicity310. However, low dynamic 
shear stiffness associated with organic crosslinker-, chemically- and 
enzymatically- crosslinked ELP can potentially limit their tissue engineering 
applications238,305,309, specifically, in case where significant load supporting is 
required305,311. Here it was first time demonstrated crosslinking of ELPs using 
biocompatible inorganic gold nanorod crosslinkers can significant improve the 
ELP dynamic shear stiffness in a controllable manner. 
 
 183 
0
4
8
12
16
25 30 35 40 45
lG
*l 
[k
P
a]
Temperature (°C)
GNR 1.9 wt%
GNR 0.9 wt%
GNR 0.47 wt%
GNR 0 wt%
A
0
10
20
30
25 30 35 40 45
δ[
de
gr
ee
s]
Temperature (°C)
B
 184 
 
Figure 64.The effect of gold nanorod concentration and temperature on the 
magnitude of the complex modules (|G*|) and phase angle (δ) at angular 
frequency of 20 rad/s. 
 
Biocompatible elastin like polypeptide-based hydrogels, aggregates, micelles and 
others have been repeatedly reported to support cell proliferation and/or 
differentiation for vascular graft, cartilage, ocular, vascular graft and liver tissue 
engineering305,312-316. In this study, the murine fibroblast cell adhesion and 
proliferation on top of nanocomposites (Figure 65) and cellular encapsulation 
inside the nanocomposite for sustained proliferation (Figure 67) were 
demonstrated. 
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Figure 65. Fibroblast cell (A) adhesion, proliferation and (B) cell viability on top of 
unmodified nanocomposites at different gold nanorod weight ratios monitored up 
to 72 hours. 
 
In Figure 65A, at 24 hours after cell seeding, the number of cell attached on top 
of nanocomposites was approximately 60% of the tissue culture plastic control. 
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resulted in an increased cell adhesion from 98 to 75 cells per mm2. Moreover, 
cell proliferation, from 24 to 72 hours after cell seeding using tissue culture 
plastic (from 143 to 331 cells per mm2) is significantly higher than that of 
nanocomposites (from ~100 to 140 cells per mm2). A higher 3T3 cell doubling 
time (> 18h) was observed when using tissue culture plastic; this is presumably 
due to serum depletion and spatial confinement during 72 hours cell culture. 
Decreased cell adhesion and proliferation on nanocomposite can be explained 
by the presence of CTAB-capped gold nanorods. Several studies demonstrated 
the CTAB surfactant associated with nanorod to be cytotoxic, in which further 
surface modification is necessary to increase material biocompatibility and 
stability241,267,317.   
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Figure 66.Fibroblast cell (A) adhesion, proliferation and (B) cell viability on top of 
PEG-modified nanocomposites at different gold nanorod weight ratios monitored 
up to 72 hours. 
 
Here, polyethylene glycol (PEG)-modified gold nanorods was employed for 
crosslinking of elastin like polypeptide, leading to the formation of polyethylene 
glycol coated-GNR-C12ELP nanocomposites, with various PEG weight 
percentages (4.7-19.7 wt%) and a fixed GNR concentration (1.9 wt%). In figure 
66A, at 24 hours after cell seeding, a higher cell adhesion density on top of PEG-
GNR-C12ELP nanocomposite (~110 cells per mm2) was observed, compared 
toGNR-C12ELP nanocomposite (~75 cells per mm2). Moreover fibroblast cell 
proliferation on top of PEG-GNR-C12ELP nanocomposites is 5 to 35% higher 
than unmodified GNR-C12ELP nanocomposite. These results suggested CTAB 
molecules around GNR inhibited cell adhesion and proliferation on top of gold 
nanorod-crosslinked C12ELP nanocomposite; this can be potentially addressed 
by the introduction of appropriate surface modifiers. Although, the cell adhesion 
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and proliferation on top of the both modified and unmodified nanocomposites 
were less than using tissue culture plastic (Figure 65A and 66A), the viability of 
cells adhered on the all tested nanocomposites were found higher than 90 %, in 
most cases higher than 95% (Figure 65B, 66B and 67). 
 
Figure 67.Florescence images of 3T3 fibroblast cells dual stained with ethidium 
homodimer and Calcein AM for visualization of dead/dying (colored red) and live 
cells (colored green). Fibroblast cells were cultured on top of (A,D) GNR (1.9 
wt%)-C12ELP nanocomposite, (B,E) GNR (1.9 wt%)-PEG (4.7 wt%)-C12ELP 
nanocomposite and (C,F) tissue culture-treated well plate for 24 (upper row) and 
72 (lower row) hours. Scale bar: 250 nm. 
 
In addition to cell monolayer culture, success encapsulation of fibroblasts cell 
inside the PEG-GNR-C12ELP nanocomposite (Figure 68) allowed sustained cell 
proliferation from inside the nanocomposite to its peripheral tissue culture plastic 
(Figure 69). Cellularized nanocomposites were less reddish in color due to the 
presence of cells (Figure 68A); the cell viability was analyzed using Live/dead 
assay followed by florescence microscopy and confocal microscopy imaging. 
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Florescence imaging (Figure 68B) suggested the majority of cells were viable at 
least three days after encapsulation (stained green) with minimum dead/dying 
cells (stained red). Blurriness of the florescence image is due to the presence of 
our-of-focused cells at different z-heights; the image quality was further improved 
by using confocal imaging (Figure 68C), in which, viable cells stained in green 
were observed inside the nanocomposite. Moreover, the proliferation of 
encapsulated cells was observed and monitored using light microscopy (Figure 
69A). Sustained cell proliferation distance was expanding approximately 0.3 mm 
per day in a radial fashion up to 14 days (Figure 69 B and C).  
 
 
Figure 68.Cellularized nanocomposite.(A) Digital snap shot of cellularized PEG-
GNR-C12ELP cultured in serum containing medium. Encapsulated 3T3 fibroblast 
cells (at day 3) were dual stained with ethidium homodimer 1 and Calcein AM 
(dead/dying cells colored in red, live cells colored in green) and visualized using 
(C) florescence microscopy and (D) confocal microscopy. Blurriness of the 
florescence image (B) is due toout-of-focused cells at different focal plane (z-
height). 
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Figure 69. (A) Cell proliferation from nanocomposite was confirmed using 
microscopy imaging. (B) Schematic depicting the cell proliferation distance (black 
line) at day 14, scale bar: 5 mm. (C) The proliferation of cells (distance, mm) from 
GNR-ELP nanocomposite is plotted as a function of time. 
 
In this study, the GNR-C12ELP nanocomposites were first time employed for laser 
tissue welding of porcine small intestines ex vivo. Tensile strength 
measurements were employed to evaluate the tensile strength of tissue after 
LWT using GNR-ELP nanocomposites. In Figure 70, small intact intestine section 
and incised intestine posses the highest and lowest ultimate tensile strength 
(UTS) at 0.45±0.02 and 0.11±0.01 MPa, respectively. Laser irradiation (20W/cm2, 
1 mm/sec and 3 min) on top of the incision did not enhance the UTS of ruptured 
intestine. Without laser irradiation, nanocomposite alone demonstrated minimum 
adhesive property, which slightly enhanced the UTS of ruptured tissue by ~0.03 
MPa (p= 0.05, N=11). Upon near infra-red light irradiation (20W/cm2) of 
nanocomposites (GNR wt% at 1.9, 5.4 and 8.7 wt%), heat transfer form 
nanocomposites resulted in temperature increase up to 46±1, 61±1.5, 64±1°C 
(N=9), respectively. One minute laser irradiation of ruptured tissue using 
nanocomposites (GNR wt% 1.9 and 5.4 wt%), resulted in UTS increase from 
0.11±0.01 MPa to 0.17±0.01 MPa and 0.22±0.01 MPa (~ 50% UTS of intact 
intestine), respectively. Higher UST observed in using nanocomposite at GNR 
wt% of 5.4, can be explained by higher welding temperature 61±1.5. Increased 
laser power (from 1 to 3 minute) and gold nanorod weight percentage (from 5.4 
to 9.5 wt %) of nanocomposite did not further enhance the UTS of rupture tissue.  
It should be noted that the comparison of GNR-ELP based LTW to standard 
suturing has not yet be conducted. However, based on literature reports, 
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standard suturing techniques were able to recover ruptured tissue up to ~80 % of 
its original intact form will be employed as a standard threshold for comparison318. 
 
 
Figure 70. (A) Schematic depicting the experimental set up for laser tissue 
welding. (B) Ultimate tensile strength of tissues before and after laser tissue 
welding using nanocomposites. 
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Nanocomposites, at a GNR weight percentage of 5.4 wt% and providing heating 
up to 61±1.5°C, were further employed for leaking and bursting tests (Figure 71).  
 
 
Figure 71. Bursting and leaking pressures of tissues before and after laser tissue 
welding using nanocomposites (GNR, 5.4 wt%). 
 
Ruptured intestines and laser-welding rupture intestines had minimum bursting 
and leaking pressures. Laser irradiation of nanocomposite at the incision 
increased the tissue bursting and leaking pressures from ~ 2 psi up to 7 psi, 
where laser irradiation time increased from 1 to 7 minutes. Laser irradiation for 5 
and 7 minutes resulted in similar tissue bursting and leaking pressure; whereas, 
obvious charring was observed after 7 minutes irradiation only. Laser irradiation 
of nanocomposite (GNR 5.4 wt%) for 5 minutes resulted in an optimal tissue 
welding, and resulted in tissue leaking and bursting pressure recovery up to 71 
and 45 % of the their original intact forms .  
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Several reports recognized heating tissue above 60 °C is necessary to induce 
coagulation of photothermal-altered tissue proteins and providing robust closure 
284,294. Moreover, the photothermal damaging of tissue is irreversible; possessing 
the ability to precisely provide, adjust and predict laser dosage based on real-
time temperature monitoring systems is critical and has been demonstrated by 
several groups284,294,295,319. This study focus on conveying the concept of laser 
tissue welding using biocompatible gold nanorod-crosslinked elastin-like 
polypeptide as a novel solder suitable for colorectal anastomosis, optimization of 
laser tissue welding using GNR-C12ELP nanocomposites and its comparison with 
standard suturing and fibrin glue will be discussed in Chapter 9 (Future 
Directions). 
 
8.4 Conclusions 
In this chapter, it was demonstrated that the stiffness and swelling property of 
GNR-C12ELPnanocompositescan be easily attenuated by controlling the gold 
nanorod concentration. This expanded the potential use of GNR-
C12ELPnanocomposites to a wide range of tissue engineering applications. 
Furthermore, the biocompatibility was evaluated by fibroblast cell monolayer 
culturing on top of the nanocomposite as well as encapsulating cells inside the 
material. Fibroblast cell can be cultured on top of nanocomposite with low toxicity; 
encapsulated cells enabled sustained proliferation. Last it was demonstrated the 
laser tissue welding using nanocomposite to successfully increase the 
mechanical integrity of the rupture tissue from ~ 45 % of its original intact form. 
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The studies supported or hypothesis, in which, laser tissue welding approach 
using novel GNR-C12ELPnanocomposites can be employed for tissue 
regeneration and repair applications. Findings from this research will guide the 
future direct proposed in testing in larger animal models, and ultimately 
translation to human patients.  
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CHAPTER 
9. Future Directions 
 
9.1 Introduction 
The field of nanotechnology has the potential to revolutionize numerous research 
fields. Myresearch focuses especially on the development of novel advanced 
nanobiomaterials towards cancer therapeutics (Chapter 3, 4 and 7), sensing 
(Chapter 5) and tissue engineering (Chapter 8) applications. Specifically, gold 
nanorods were surface modified with polyelectrolytes and polyethylene glycols 
for photothermal ablation of human prostate cancer cells in vitro (Chapter 3 and 
4). Moreover, gold nanorods were interfaced with elastin-like polypeptides (ELPs) 
via gold-thiol covalent bonds and successfully employed, by means of 
optical/photothermal manipulation, for potential sensing applications (Chapter 5). 
Engineering of polypeptides resulted in the formation of plasmonic 
nanocomposites, which were employed for drug encapsulation and release. Most 
importantly, the nanocomposites were employed for the simultaneous 
administration of combination chemotherapy and hyperthermia to cancer cells in 
vitro(Chapter 7)and laser tissue welding of bowel tissue (Chapter 8) for the first 
time. 
 
The inherent optical, photothermal and degradation properties made the 
plasmonic synergistic nanocomposites well suited for the development of 
verifiable unattended sensors, in which visible phase change occurs in response 
to photothermal changes and gamma irradiation. Moreover, the capability of cell 
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encapsulation and photoactivable release of small molecules made the 
biocompatible nanocomposite an excellent material for simultaneous laser tissue 
welding, drug(growth factor) delivery to facilitate wound healing with antimicrobial 
activity. 
 
The chapter will discuss the use of multifunctional nanocomposites derived from 
nanoparticles (e.g. plasmonic nanoparticles) and biomolecules (engineered 
polypeptides) in two directions: (i) Investigation into how polypeptide-
nanoparticle nanoassemblies / nanocomposites interact with gamma 
radiation or into the use of these advanced materials for detecting gamma 
radiation.(ii)Detailed investigation into cell-based, light responsive 
bioadhesive for laser tissue welding (LTW) of colorectal tissue, to establish 
a fluid-tight sealing, stimulate wound healing and minimize infection after 
colorectal resection.  
 
9.2 Engineered Polypeptide-Based Nanomatrices for Unattended Gamma 
Radiation Sensing 
9.2.1 Background 
The use of unattended sensors to detect low levels of weapons’ agents is 
indispensible in combating mass destruction weapons. Traditional radiation 
detection has been performed using ionization chamber, scintillation crystals and 
semiconducting sensors. Ionization chamber and scintillation crystals measure 
instantaneous radiation dose; cumulative dose measurements requires additional 
electronic equipment. Semiconducting sensors can detect both instantaneous 
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and cumulative radiation, however, the device can be can be tampered with by 
thermal annealing. In medicine, radiation badges consisting of radiation sensitive 
film can be used to measure cumulative radiation dose, however, their 
temperature sensitivity and gradual decay can potentially limit their application in 
battle field. The goal of this proposed future direction involves the fundamental 
studies on polypeptide-nanoparticle nanocomposite (small molecules-
encapsulated)for instantaneous and cumulative radiation dose sensing. 
Specifically, radiation interaction with nanoparticles and polypeptide facilitating 
molecules release and nanocomposite disintegration will be employed as the 
fundamental basis for instantaneous and cumulative dose detection. Successful 
delivery of this proposed research will not only play a key role in safeguarding 
field personnel from weapons of mass destruction, but can also translate into 
medicine, specifically the war of cancer for combination chemotherapeutics and 
radiotherapy (radiation induced controlled release of drug molecules).  
 
9.2.2 Specific Goals 
Research will focus disintegration of gold nanorod-elastin like polypeptide 
nanocomposite upon gamma radiation. Moreover, release of indicator molecules 
from nanocomposite upon radiation exposure will also be conducted. 
Task1: Gamma radiation inducing nanocomposite structural damage will be 
investigated using different analytical methods. The role of radiation dosage, 
nanoparticle and polypeptide content on the structural integrity will be determined. 
Parameters that lead to dissolution of solid-phase matrices to liquid phase 
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dispersions will be identified leading to fundamental information on these 
materials as elements for sensing radiation. 
Task2: Release of colored indictor molecules from solid-phase matrices into 
liquid medium above the matrices will be employed as the sensing mechanism 
for gamma radiation. Small molecules, as indicators, will be encapsulated inside 
GNR-ELP nanocomposites (Chapter 7). Different indicator (e.g. molecular weight, 
hydrophobicity and others) will be investigated in order to demonstrate how 
chemistry of the molecules affects loading and subsequent gamma radiation-
induced release. As the role of radiation dose strength, ELP and nanoparticle 
content will again be investigated. Moreover, the integrity and state of the GNR-
ELP nanocomposites (e.g. loss of color following expulsion of indicator molecules) 
will also be investigated. 
 
9.3GNR-ELP nanocomposites for simultaneous laser tissue welding, drug 
delivery, and tissue healing in a multifunctional manner. 
 
9.3.1 Background 
Cellularized GNR-ELP nanocomposites will be used simultaneously for laser 
tissue welding, drug (e.g. doxycycline) delivery, tissue healing and multifunctional 
manner. Detailed background and motivation were presented in Chapter 8.1. 
 
9.3.2 Specific Goals 
Task1: Chapter 8 demonstrated that GNR-ELP nanocomposites support 
fibroblast culture and proliferation; upcoming studies include culture of colon 
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epithelial cells in the nanocomposites. Cellularized nanocomposites can further 
participate in repair and regeneration of welded tissues. 
Fibroblast-cellularized hydrogels demonstrate collagen deposition320 which 
increases mechanical stiffness321 of the hydrogel compared to the acellular 
material. I anticipate that cellularized nanocomposites can facilitate rapid 
collagen deposition that can impart mechanical strength to the weld promoting 
tissue regeneration. The normal colon epithelial cell line, 
NCM460322,availablefromINCELL Corporation, LLC, will be employed for 
encapsulation within PNP-ELP nanocomposites; fibroblasts and 50-50% co-
cultures of the two cell types will also be used. Cell viability and proliferation of 
NCM46 cells from the nanocomposite towards the peripheral areas of the 
nanocomposites will be characterized using fluorescence microscopy. 
Task 2:Matrix metalloproteinases (MMP) overexpression breaks down early 
tissue formed during anastomoses in the colon, which compromises 
healing323,324. GNR-ELP nanocomposites can be employed for diffusion-based as 
well as laser-triggered localized delivery of MMP inhibitors (e.g. doxycycline).  
Task 3:Silver (Ag), including Ag nanoparticles (AgNP)325-327, demonstrates 
antibacterial properties328. Generation of GNR, AgNP and GNR-AgNP (hybrid) 
nanocomposites (nanoparticle content 1-20 wt%) and investigation of their 
antibacterial activities against E.coli and Staphylococcus aureus using the agar 
Kirby-Bauer disk-diffusion method will be carried out.  
 
9.3.3 Anticipated Results and Potential Pitfalls 
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Successful completion of this aim will set the stage for translation to pre-
clinicaland clinical investigations. The study will have investigated the weld 
efficacies of both, cellularized and non-cellularized plasmonic nanocomposites 
for colorectal anastomoses. It is possible that there is cell death in the path of the 
laser due to high localized temperatures, but this will be restricted to a small area 
(laser diameter 1 mm). In addition, the viability of cells outside the laser path can 
promote wound healing. In case of insufficient mechanical strength with GNR-
ELP nanocomposites, an investigation into GNR-collagen and GNR-collagen/ 
ELP blends using collagen peptides described in the literature329 as potential 
weld biomaterials will be studied. 
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